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AN EFFICIENT AND CONVENIENT SYNTHESIS OF 
NOVEL HIGHLY SUBSTITUTED THIOPHENES AND 
THEIR ANTIMICROBIAL ACTIVITY. 
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1.1 Introduction 
 
 Thiophene is the heterocyclic compound with the formula C4H4S. The simple 
thiophene consist of five-member ring, are stable liquids which closely resemble the 
corresponding benzene derivatives in boiling points and even in smell1. Thiophene is 
considered aromatic, although theoretical calculations suggest that the degree of 
aromaticity is less than that of benzene. This could be demonstrated by its ability to 
undergo substitution reaction. The "electron pairs" on sulfur are significantly 
delocalized in the π-electron system2. Thiophene and its derivatives exist in petroleum 
or coal. Historically, Thiophene was discovered as a contaminant in benzene.3 
 
Certain aryl thiophenes have been patented as herbicides4 or for fungicidal5 
and others have antileishmanial and antifungal activities6 Highly substituted 
thiophene derivatives are important heterocycles found in numerous biologically 
active and natural compounds.7-12 Especially 2-Amino-3-aroylthiophenes are agonist 
allosteric enhancers at the A1 adenosine receptor.13,14 The interest in this kind of 
heterocycles has been spread from or inhibit c-Jun-N-terminal kinases and other 
kinases,15 conductivity-based sensors,16 dye chemistry,17 to modern drug design,18 
biodiagnostics,19 electronic and optoelectronic devices,20 self-assembled 
superstructures.21 
A novel class of thiophene-derivatives as antagonists of the human glucagon 
receptor has been discovered.22 During literature survey, several articles have been 
found with good therapeutic activities of 3-arylthiophene derivatives. Some of them 
display anthelmintic activity against Haemonchus contortus,23 HLADMactivities.20 
The newly synthesized 3-aryl-4-cyano-5-substituted thiophene 2-carboxylic acid 
family found as AMPA receptor allosteric modulators.24,25 They are important 
heterocyclic compounds that are widely used as building blocks in many 
agrochemicals.26 
 
1.2  Synthetic strategies for the highly substituted Thiophenes 
 
There were reported synthetic methods to different types of substituted 
thiophene. The procedure described method developed by Paal27-28 for the synthesis of 
1-phenyl -5-methylthiophene from 1-phenyl-1, 4-pentadione with phosphorus 
pentasulphide as the sulphur source (figure-1). 
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Figure-1 
John et al. reported the metalation of the thiophene and 2-halothiophenes to 
yield 2- thienyl sodium and 5-halo-2-thienylsodium. Subsequent carbonation and 
acidulation yielded the 2-thiophene carboxylic acid and 5-halo-2-thiophenecarboxylic 
acids29 respectively. 5-Methyl-2-thiophenecarboxylic acid was prepared in low yield 
by Gilman and Breuer30 from 2- methylthiophene, dibenzylmercury and sodium. 
Hartough and Conley31 have prepared the substituted of the acetylalkylthiophenes 
(figure-2). 
 
S
R
Na(NaHg) R'HR'X NaX HgNaS
R
 
 
Figure-2 
The reduction of thienyl ketones to the corresponding alkyl thiophenes was 
usually carried out by means of the Clemmensen reduction32. This method has the 
disadvantage, in many cases, of giving low yields, since excessive decomposition of 
the thiophene nucleus occurs. Although the yields can be improved by applying low 
temperatures, such a procedure proves time-consuming, sometimes requiring as much 
as fifty hours.33 The Wolff-Kishner reaction has been utilized occasionally in the 
thiophene series, but without particular success. Steinkopf et al.34 prepared 2-
ethylthiophene by first isolating the hydrazone of 2-acetylthiophene and then 
decomposing it by autoclaving for ten hours with sodium ethoxide.  
 
In this procedure they obtained an over-all yield of about 400/0. Shepard35 
prepared 2-methyl-5-ethylthiophene in 40% yield by forming the semicarbazone of 2- 
methyl-5-acetylthiophene and heating it with potassium hydroxide. There appears to 
be no mention in the literature of the reduction of thiophene aldehydes to 
methylthiophenes. In view of the rather low yields obtained by the above methods and 
to avoid the application of autoclave equipment, it was decided to attempt the 
reduction at atmospheric pressure using ethylene glycol as a solvent.36 William  J. 
King And F. F. Nord37 now been found that various thiophene aldehydes and ketones 
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can easily be reduced, without isolating the intermediate compound, via a simplified 
Wolff-Kishner reduction to give the corresponding alkyl compound in yields of 41-
70% (figure-3). 
S CH3H3C S CH3H3C
CHO
(I)
 
 
Figure-3  
? Catalysts 
 Having tremendous important of thiophenes in medicinal chemistry, a 
literature survey on the synthetic methods for the biologically active highly 
substituted thiophene (HST) has been carried out and described as follows. Various 
modifications have been applied to Gewald reaction to get better yield and to 
synthesize biologically active analogs. Different catalysts have been reported to 
increase the yield of the reaction. Microwave synthesis strategies have also been 
applied to shorten the reaction time. Solid phase synthesis and combinatorial 
chemistry has made possible to generate library of HST analogs. The various 
modifications are discussed in the following section. 
 
Bryan P. McKibben et al.38 achieved tetra substituted thiophenes, obtained by 
optimizing the multi-component reaction originally developed by Gewald, served as 
key templates for structural diversification and semi-automated library synthesis. 
Conditions were developed to carry out Gewald's reaction at room temperature and in 
high yield (Figure-4).  
 
S
R2O
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NH2
O
OR4
O
R3 OR2 R4O
CN
O O O
S
1  
 
Figure-4 
In 1999 the group of Fazio et al.39 synthesized of 3, 4-bis [(methoxycarbonyl) 
methyl] thiophene and bis-, ter- and pentathiophenes, with alternating 3,4-bis 
(methoxycarbonyl)methyl-substituted tings, was reported. These new thiophene 
derivatives were possible precursors for the preparation of new conducting polymers 
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useful as materials for electronics. In this method few drawback such very harsh 
reaction condition and isomers were found (Figure-5). 
S CHO
LiH
2.H2O S
OH
SH
ZnI2
S
S
2.Et3N 45%
S
S
MeOOC COOMe
1. CO,MeOH,O2
Pd cat
 
Figure-5 
 
Ivan L. Pinto et al.40 reported method for 5-alkoxythiophenes have been 
prepared by an extension of the Gewald thiophene synthesis and a novel four 
component condensation reaction uncovered by which 5-aminothiophenes have been 
prepared (Figure-6). 
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OEt
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Figure-6 
 
Bo Sung Kim  et al.41has prepared a thioaroylketene S,N-acetals were treated 
with active methylene compounds including α-keto ester, nitro methane, cyano acetic 
acid, p-toluenesulfonylacetone, 4-nitrophenylacetic acid, and diethyl (2- oxopropyl) 
phosphonate in the presence of mercury(II) acetate in CH2Cl2 at room temperature. 
These reactions gave 3-alkylamino-5-arylthiophenes containing various substituent, 
which comprised, respectively, alkoxycarbonyl, nitro, cyano, p-toluenesulfonyl, 4-
nitrophenyl, and diethylphosphono groups at C-2 in good yields. The reaction of 3-
methylamino-3-methylthio-1-phenylthioxopropene with malonic acid or Meldrum’s 
acid under the same conditions gave 3-methylamino-5-phenylthiophene. Similarly, 
treatment of 3-methyl amino-3-methylthio-1-phenylthioxopropene with various 
enolizable cyclic ketones such as 4-hydroxy-6-methyl-2-pyrone, homophthalic 
anhydride, 2-hydroxy- 1,4-benzoquinone, and 1,3-diethyl-2-thiobarbituric acid gave 
thieno[3,2-b]pyridin-4-one, thieno[3,2-c]isoquinolin-5-one, thieno[3,2-c]benzazepine-
1,6-dione, and thieno[3,2-d]pyrimidine-2,4-dione, respectively (Figure-7). 
 
 
Figure-7 
Chapter 1  Highly Substituted Thiophene 
Department of Chemistry, Saurashtra University, Rajkot-360005  5 
Firouz Matloubi Moghaddamet al.42 has reported an efficient method for the 
preparation of 2,3,5-trisubstituted thiophenes in a one-pot synthesis from 
thiomorpholide via the thio-Claisen rearrangement (Figure-8). 
S
Ar
O N
O NH
MW 10 Min
S
Ar
O
Ar
S
N
O
K2CO3
Br
120-130 oC
o-Cl2C6H4
1 a-f 2 a-f 3 a-f  
 
Figure-8 
Ryan T. Clemens et al.43 demonstrated that vinamidinium salts can be 
effectively used for the regioselective preparation of 2-carbomethoxy-4-phenyl 
thiophenes using simple experimental conditions. The synthesized of 2, 4-
disubstituted thiophenes by the condensation of symmetrical vinamidinium salts with 
methyl thioglycolate has been accomplished for the first time (Figure-9).  
 
N N
ClO4
HS
OCH3
O
R
S
OCH3
O
DMF,
reflux
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Figure-9 
 
? Synthetic Methods for the substituted thiophene 
 The production of hetero aromatics by Eli Lilly is of fundamental importance 
in organic synthesis44. In 1999 the group of Castano mansanet et al.44 synthesized of 
thiophene and furan compounds and their pharmaceutically acceptable salts and 
further relates to their use in treating schizophrenia, cognitive deficits associated with 
schizophrenia, Alzheimer’s type, mild cognitive impairment or depression (Figure-
10). 
NC CN
DMSO,
N2 atm
NaH,CH3I
NC CN
S S
C2H5OH,TEA,N2 atm S
NC NH2
S
O
O C2H5
SEtO2C CO2Et
 
Figure-10 
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An efficient method for highly substituted thiophene was reported for Y. 
Wang et al.45The synthesis of polysubstituted thiophene 2 and polysubstituted 
thieno[2,3-b] thiophenes 3 from 1,by one pot three-component cyclization reaction of 
a 1,3-dicarbonyl compound, and 1 has been achieved in high yields catalyzed by 
tetrabutylammonium bromide (TBAB) in the presence of K2CO3 in water. TBAB in 
the aqueous phase can be recycled after the separation of organic products (Figure-
11). 
R
O O 1.K2CO3
2.CS2
3.BrCH2COOEt
R=OEt, NHR'
R=Me C6H5
S S
O
R
SS
COOEt
EtOOC
R
1
2
3  
 
Figure-11  
 
Knudsen et al.46 have synthesized the library of thiophene by using various 
diketo compounds and alkyl bromide in presence of base (Figure-12). They found 
that the yields of the one-pot reaction can be increased from 70-95%. The reaction 
time is 16-18 hrs. The oxidation of sulphite to sulphone using mCPBA and hydrolysis 
by NaOH. 
O
O
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2.CS2
3.BrCH2COOEt
O
S
S
COOEt
COOEt
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2.NaOH
3.NAOAc,ACOH
O
S
O2S
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Figure-12 
 
R. Samuelet al.47 has described the synthesis of the alkylation of aryl 3- 
oxopropane dithioate with ω-haloketones under different reaction conditions afforded 
substituted aryl[2-(methylsulfanyl)-4-phenyl-3-thienyl]methanones and [3-aryl-5-
(methyl-sulfanyl)-2-thienyl](phenyl)methanones. The same strategy was extended to 
3-amino-1-aryl -3-thioxo-1-propanones to afford aryl [2-amino-4-phenyl-3-thienyl] 
methanones and ethyl 3-phenyl -5-piperidino-2-thiophene carboxylate (Figure-13). 
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Figure-13 
? Reported synthetic approaches for preparation of  thiophene. 
The publications by Issa Yavari et al.48 described an efficient synthesis of 
ethyl 2-(4-acetyl-5-benzoylamino-3-methyl-2-thienyl)-2-oxoacetates via reaction 
between benzoyl isothiocyanates and ethyl bromopyruvate in the presence of 
enaminones (Figure-14). 
R
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S HBr
CO2Et
O
NO CH2Cl2
rt S O
O
R
N
H
O
CO2Et
1 2 3 4
 
Figure-14  
H. N. Hafez et al.49 synthesized a novel thiophene and aminothieno[2, 3-d] 
pyrimidines derivative (Figure-15), Two series of 5-ethyl-2-amino-3-pyrazolyl-4-
methylthiophenecarboxylate and 2-thioxo-N3-aminothieno[2,3-d]pyrimidines were 
prepared from 3,5-diethyl-2-amino-4-methylthio-phenecaboxylate and evaluated as 
anti-inflammatory, analgesic and ulcerogenic activities. Among the compounds 
studied, which containing the substituted hydrazide at C-3 position 7, 16, and 17a 
showed more potent anti-inflammatory and analgesic activities than the standard drug 
(Indomethacin and Aspirin) along without ulcerogenity.  
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Figure-15 
? Solid phase synthesis 
 The generation of combinatorial libraries of heterocyclic compounds by solid 
phase synthesis is of great interest for accelerating lead discovery and lead 
optimization in pharmaceutical research. Therefore, solid phase modifications of 
MCRs are rapidly become the cornerstone (foundation stone) of combinatorial 
synthesis of small-molecule libraries. 
 The solid-phase modification for preparation thiophene was reported by 
Zaragoza et al.50-57 (Figure-16). The reaction sequence was based on resin bound 
primary or secondary amines 21, which were synthesized from Wang resin 22 with 
two-step reactions. The Wang resin 22 was converted to the p-nitro phenyl carbonate 
intermediate resin 23 by reaction with 4-nitrophenyl chloroformate (step -I). The 
carbonate resin 23 was treated with appropriate amines in DMF to give the amine 
resin 21. However, this reaction sequence suffered the following limitations: generally 
no thiophenes 14 resulted when aliphatic halo ketones or halo acetic esters were used 
for the S-alkylation of thioamides 27. On the other hand, a broad range of different 
acceptor substituted acetonitriles could be used, such as aliphatic or arene 
sulfonylacetonitriles, acylacetonitriles, cyan acetic esters, and malononitrile but not 
(cyanomethyl)phosphonates. The purities of the crude products 14, determined by 
HPLC analysis, ranged from 53% to 85%. 
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Figure-16 
 
Surya Prakash Rao et al.58 have reported (tetrabutylammonium bromide) 
TBAB as an efficient catalyst for the synthesis of 2-alkylthio-3-nitrothiophenes 
(Figure-17). A readily available dipotassium 2-nitro- 1, 1-ethylyenedithiolate with α -
chloromethyl ketones in toluene catalyzed by tetrabutylammonium bromide (TBAB). 
Thiophene formation is highly sensitive and selective for chlorine, present as a 
leaving group in α- chloromethyl ketones. 
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Figure-17 
 
David Thomae et al.59 described the synthesis of new tetra substituted 
thiophenes and selenophenes achieved by an easy one-pot four-step procedure. 
expected compounds were obtained in good yield from ketene dithioacetals (Figure-
18). 
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Figure-18 
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? Various highly substituted Thiophene synthetic approach 
J. Chao et al.60 have made novel highly substituted hydroxy thiophene moiety 
were designed and synthesized as viable amido phenol and sulfonamido phenol 
bioisosteres.  Hydroxy group-directed regioselective bromination and palladium- 
catalyzed amination of thienyl bromide via Buchwald protocol were the key elements 
of the synthetic approach (Figure-19). 
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Figure-19 
 J.A. Clement et al.61 have described the synthesis of symmetrical and 
unsymmetrical naphth-annelated thienyl heterocycles has been achieved via 
thionation of hydroxyketones/diketones using Lawson’s reagent (Figure-20). 
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Figure-20 
W. You et al.62 have develop copper-catalyzed tandem S-alkenylation of 
potassium sulfide with 1, 4-diiodo-1, 3-dienes enables an efficient synthetic approach 
to variously substituted thiophenes (Figure-21). 
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Figure-21 
Chapter 1  Highly Substituted Thiophene 
Department of Chemistry, Saurashtra University, Rajkot-360005  11 
 
1.3 Biological Activity Associated with Thiophene derivatives and 
it’s synthesis method. 
Nowadays, much interest also has been focused also on aza-analogs such as 
thiophene which showed a very similar classical pharmacological profile. Over the 
past few years several lead-compounds were developed that are superior in potency 
and duration of antihypertensive activity to classical high-throughput screening 
(HTS) drugs and comparatively favorable with second-generation analogs such as 
GABITRIL63 (tiagabine hydrochloride) is indicated as adjunctive therapy in adults 
and children 12 years and older in the treatment of partial seizures. Tiagabine HC1 is 
an antiepilepsy drug (Figure-22). 
N
COOHH
S
S
.HCl
(R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-
enyl)piperidine-3-carboxylic acid hydrochloride  
 
Figure-22 
Thiophene moiety containing drugs such as, Clopidogrel64 is an oral, 
thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery 
disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by 
Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. The drug 
works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate 
ADP chemoreceptor on platelet cell membranes. Adverse effects include hemorrhage, 
severe neutropenia, and thrombotic thrombocytopenic purpura (TTP). Many HTS 
analogs have now been synthesized and numerous second-generation commercial 
products have appeared on the market. Duloxetine hydrochloride65 is a white to 
slightly brownish white solid, which is slightly soluble in water. Cymbalta is indicated 
for the treatment of major depressive disorder (MDD). The efficacy of Cymbalta was 
established in four short-term and one maintenance trial in adults (Figure-23).  
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Figure-23 
Gary M. Coppola et al.66 have prepared series of highly functionalized 
thiophene-based 3,5-dihydroxyheptenoic acid derivatives (10) from aldehydes 6 by 
homologation, aldol condensation with ethyl acetoacetate dianion and stereo selective  
3-hydroxyketone reduction. High levels of HMG-CoA reductase inhibitory activity 
have been found within the series (Figure-24).  
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R2 COOEt
OH O
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R2 COOEt
OH OH
1. Et3B
2. NaBH4
3.NaOH
10  
 
Figure-24 
Zhao-Kui Wan et al.67 studied the PTP1B inhibitors of 4 monocyclic 
thiophenes (Figure-25) toward. A series of monocyclic thiophenes was designed and 
synthesized as PTP1B inhibitors. Guided by X-ray co-crystal structural information 
and computational modeling, rational design led to key interactions with Asp48 and 
improved inhibitory potency against PTP1B.  
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Figure-25 
Johann Leban et al.68 has synthesized a novel series of substituted thiophene 
(Figure-26) and identified as initial lead was improved by a QSAR method and 
yielded low nanomolar biological activity, which came out of a docking procedure 
using 4Scan_ technology and medicinal chemistry exploration. A previously 
discovered DHODH inhibitor series was further improved by replacing the 
cyclopentene ring by aromatic heterocycles. Different isomers of these compounds 
were prepared by the directed ortho-metallation procedure. The compounds are more 
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active than the corresponding cyclopentene analogs and shown potent effects on 
PBMC_s proliferation. 
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Figure-26 
Yasuhiro Yonetoku et al.69 have modified the structure of 2-amino-1-
methylpyrrole prepared by reported method66a. Previously described thiophene 
derivative i.e. compound 4 (Figure-27). Structure-activity studies using 
phytohemagglutinin-induced interleukin-2 mice show that more potent using methyl 
group in compound than the isopropyl group in the series of compounds. Yasuhiro 
Yonetoku et al. synthesized and evaluated a series of 5-(1-methyl-3-trifluoromethyl-
1H-pyrazol-5-yl)-2-thiophene carboxamides to identify potent inhibitors of calcium-
release-activated calcium (CRAC) channels with greater selectivity than voltage-
operated calcium (VOC) channels. These efforts resulted in identification of 
compounds 22 and 24. The former exhibits highly potent and selective CRAC channel 
inhibitory activity, and the latter inhibited phytohemagglutinin-induced interleukin-2 
production by Jurkat T lymphocytes and concanavalin A-induced hepatitis in mice. 
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Figure-27 
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Khurshid I. Molvi et al.70 have examined a series of novel new tetra 
substituted thiophenes. Compounds 4a-i, 5a-i and 6a-e (Figure-28) have been 
synthesized as novel anti-inflammatory agents and were evaluated for their anti-
inflammatory activity in carrageen in-induced rat. Among ester series, the best 
compound 4c showed 71% protection at 10 mg/kg, 72% at 20 mg/kg, and 76% at 40 
mg/kg to inflamed paw; while in acid series 5a showed 79% protection at 10 mg/kg, 
80% at 20 mg/kg, and 70% at 40 mg/kg, and 5c showed 72% protection at 10 mg/kg, 
75% at 20 mg/kg, and 69% at 40 mg/kg, to inflamed paw. SAR studies revealed that 
the presence of OCH3 at R2 position and -H, -OCH3 at R1 are one of the requirements 
for eliciting comparable anti-inflammatory activity in both tetra substituted 
thiophenes’ ester and acid series. While presence of -H, -Cl at R1 and -OCH3, -CH3 at 
R2 in tetra substituted thiophene ester series enhances their analgesic activity. The 
candidates of acid series (5a-e 5i) showed poor analgesic activity as compared to the 
standard drug ibuprofen. Compounds (4a-e 4i, 5a-e 5i) were evaluated for their in 
vitro antioxidant nitric oxide radical scavenging assay. Among the ester series 4a 
showed maximum in vitro nitric oxide radical scavenging activity having IC50 value 
30.08 mg/ml while in acid series 5a has IC50  value 25.20 mg/ml. Thus the presence of 
R1 = -H, R2 = -OCH3 and R1, R2 = -OCH3 enhances nitric oxide radical scavenging 
property in tetra substituted thiophenes’ acid series (Figure-28). 
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Figure-28 
Ravi Kulandasamy et al.71 synthesized substituted thiophene derivatives and 
some of relevant compound having anticonvulsant agents. The synthesis of 3,4-
dihydroxy thiophene-2,5-diester (1) was obtained by condensing the ethyl 
thiodiglycolate with diethyl oxalate. It was derivatives using different alkyl halides to 
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give disubstituted thiophene esters (2–5), which were then converted to corresponding 
hydrazides (6–9) following usual methods. Finally, these hydrazides, on treatment 
with various substituted carbonyl compounds underwent smooth condensation to 
yield target hydrazones (10–13) (Figure-29). 
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Figure-29 
S. ebastien Lethu et al.72 have determined the binding mode of FTI series with 
the heterodimeric metallo enzyme by Screening of the ICSN chemical library, 3-(4-
chlorophenyl) -4-cyano-5-thioalkylthiophene 2-carboxylic acids has been identified as 
potent farnesyl transferase (FTase) inhibitors. Enzymatic kinetic studies showed that 
this original FTI series belongs to the CaaX competitive inhibitor class. Preliminary 
structure-activity relationship (SAR) studies on this new FTI series has shown that the 
presence of the two sulfur atoms and of the cyano function contributes to the good 
affinity of these derivatives. A carbonyl group at the 2-position is necessary to inhibit 
FTase, and compounds bearing a carboxylic acid or an amino acid are the best 
inhibitors of this series. Some modifications can be done to improve potency of FTI 
series such as the p-chlorophenyl moiety that has not been modified in this 
preliminary study. As well, other Zn-chelating functions could be introduced in the C-
5 position of the thiophene ring to improve the activity and solubility of these 
derivatives (Figure-30). 
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 K. A. Emmitte et al.73 The discovery and development of a series of 
thiophenes as potent and selective inhibitors of PLK is described. Identification and 
characterization of 2, a useful in vitro PLK inhibitor tool compound, was also 
presented (Figure-31). 
 
 
Figure-31  
Kyle A. Emmitte  et al.74 have prepared series of thiophene PLK1 inhibitors 
was optimized for increased solubility and reduced protein binding through the 
appendage of basic amine functionality. Interesting selectivity between PLK1 and 
PLK3 was also obtained through these modifications (Figure-32).  
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Figure-32 
Romeo Romagnoliet, al.75 has reported the crucial role of Microtubules in 
cellular division as an important target for cancer therapy (Figure-33). Compounds 
5e–I, all strongly inhibited tubulin assembly, and compounds 5f and 5h were to be 
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even more active than the reference compound CA-4. 5h was found to be the most 
active (IC50  = 0.62 l M) in the in vitro tubulin olymerization assay, having almost 
twice the potency of CA-4. In comparison with 4d, compound 5h was three times as 
potent as an inhibitor of tubulin assembly, but it was much less active as an 
antiproliferative agent.  
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Figure-33 
 
V. Padmavathi et al.76 have studied the reactivity of ketene dithiolates in the 
presence of different equivalents of sodium ethoxide. 2-(Bis((5-aryl-1,3,4-oxadiazol-
2- yl) methylthio)methylene) malononitriles 5 and 2-(Bis((5-aryl-1,3,4-thiadiazol- 2-
yl)methylthio)methylene) malononitriles 6 were prepared by the reaction of 
malononitrile with carbon disulfide and 5-aryl-2-(chloromethyl)-1,3,4-oxadiazoles 
3/5-aryl-2-(chloromethyl)-1,3,4-thiadiazoles 4. All the synthesized compounds were 
tested for preliminary antimicrobial and antioxidant activities. The preliminary 
antimicrobial activity of the tested compounds showed that those having thiadiazole 
moiety possess greater biological activity. The maximum activity was observed with 
the compounds 6a and 6c. However, compounds with oxadiazole unit exhibited good 
antioxidant activity (Figure-34). 
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1.4 Aim of Current research work 
 
 The highly substituted thiophene derivatives have considerable chemical and 
pharmacological importance because of a broad range of biological activities 
displayed by these classes of molecules. As we demonstrated, the tremendous 
biological potential of substituted thiophene derivatives encouraged us to synthesize 
some new highly functionalized substituted thiophene derivatives. The Various 
methodologies have been described for the synthesis of substituted thiophene 
derivatives. However, the existing methods are suffer with some drawbacks, such as; 
yield, time, product isolation, purification. The invention relates a process for the 
purification of thiophenes which non polar impurities removed by column 
chromatography, solvent purification method and acid base treatment were used. 
 As a part of our ongoing interest on the synthesis of various heterocyclic 
compounds using potassium salts of ketene dithioacetals, we have demonstrated that 
ketene dithioacetals are versatile intermediate for the synthesis of substituted 
thiophene derivatives. Thus, to explore further, we sought that the reaction of various 
ketene dithioacetals with ethyl 5-((ethoxycarbonyl)methylthio)-4-(phenylcarbaonyl)-
3-isopropylthiophene-2-carboxylate in the presence of base in DMF, THF, MDC 
could be an effective strategy to furnish the novel thiophene derivatives. Here we 
describe the novel synthetic methodology for the thiophene. During the course of our 
studies on the synthesis and applications of α-oxo ketene-(S,S)-acetals,77,78 we found 
that α-oxo ketene-(S,S)-acetals could be cleanly prepared from 1,3-dicarbonyl 
compounds catalyzed by tetraethylammoniumbromide (TEAB) or 
tetrabutylammoniumbromide (TBAB) in the presence of K2CO3 in water at room 
temperature. Thus, we started the investigation with K2CO3 as a base and TEAB as a 
catalyst. The initial study was performed on the reaction of 3-oxo-N-o-
tolylbutanamide 1a via a very simple procedure described as follows: to a suspension 
of 1a (1.0 mmol), K2CO3 in DMF, THF, MDC (4.0 mmol) (Table 1) and TEAB (1.0 
mmol) in water (5 mL) at room temperature was added CS2 (1.1 mmol) under stirring. 
After the reaction mixture was stirred at room temperature for 0.5 h, alkyl bromide 
(2.0 mmol) was added and stirred for 1.2 hrs as indicated by TLC for completion of 
reaction. A white solid (80%) was obtained after workup and purification, and 
characterized as substituted thiophene-3-carboxamide (VBA 1-36), substituted 
thiophene, based on its spectral and analytical data. All the experiments indicate that 
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the catalyst TEAB, solvent (Table 1, entry 1) plays a key role in the moderate and 
mild reaction in water at room temperature. 
1.5 Results and discussion 
Route of Synthesis: A novel substituted highly subtitled thiophene (HST) 
derivatives. 
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Where R= 2,3-(CH3)2; 3,4-(CH3)2; 4-CH3; H; 3-Cl-4-F; 4-F; 4-Cl;3-Cl ;C6H5; 4-
OCH3; 3-Br,4-Br R1,R2=-COOEt,-NO2C6H4, isopentylgp 
 
 Preparation of the target compounds was initiated by the reaction of methyl 
isobutyrylacetate (2) with aryl amines (1a-k) in toluene at reflux temperature to afford 
the 4-methyl-3-oxo-N-arylpentanamide (3) in 85-90% yields (Scheme-1). This 
product undergoes reaction with carbon disulfide in the presence of base in DMF 
followed by methylation to afford corresponding 2-(bis (potasiumthio) methylene)-4-
methyl-3-oxo-N-phenylpentanamide (4a-k). Which on reaction with aryl/alkyl halide 
undergoes cyclization to form ethyl 5-((ethoxy carbonyl) methylthio)-4-
(phenylcarbamoyl)-3-isopropylthiophene-2-carboxylate (VBA-5). 
  
 Twelve different acetoacetanilide were synthesized bearing various electron 
donating and electron withdrawing groups such as R= 2,3-(CH3)2; 3,4-(Cl)2; 3,4-
(CH3)2, 4-CH3; H; 3-Cl-4-F; 4-F; 4-Cl;C6H5; 4-OCH3; 3-Br, 4-Br on the phenyl ring. 
Thus, it has been found that reaction of substituted acetoacetanilide 3a-k derivatives 
with carbon disulfide in the presence of potassium carbonate followed by the 
alkylation with alkyl/aryl halide (Scheme-2) gave the novel thiophene (VBA1-36).  
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Table-1: Reaction of (VBA 1-36) obtained by using various solvents in the 
presence of base and PTC. 
Entry Solvent Base Time hrs Yield % 
1 DMF K2CO3 4-6 65 
2 THF K2CO3 4-5 67 
3 Toluene K2CO3 4-5 63 
4 MDC K2CO3 3-4 70 
5 DMF K2CO3+TEAB 1-2 90 
6 THF K2CO3+ TEAB 2-3 88 
7 Toluene K2CO3+ TEAB 2-3 82 
8 MDC K2CO3+ TEAB 1.5-2.5 86 
9 DMF K2CO3+TBAB 2.5-3 82 
10 THF K2CO3+TBAB 2-3 78 
11 Toluene K2CO3+TBAB 2-3 72 
12 MDC K2CO3+TBAB 1.5-2.5 80 
13 DMF K2CO3+CTAB 2-3 74 
14 THF K2CO3+CTAB 3.5-4.0 70 
15 Toluene K2CO3+CTAB 2.5-3.5 72 
16 MDC K2CO3+CTAB 3-4 74 
17 DMF K2CO3+TBAF 3.5-4.5 72 
18 THF K2CO3+TBAF 4-5 70 
19 Toluene K2CO3+TBAF 4.5-5.5 67 
20 MDC K2CO3+TBAF 4.5-5 72 
21 DMF K2CO3+TTAB 2.5-2.7 75 
22 THF K2CO3+TTAB 2.4-3.2 72 
23 Toluene K2CO3+TTAB 3-3.5 70 
24 MDC K2CO3+TTAB 3-4 74 
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Table 2: Synthesis of highly substituted thiophenes by using various 
acetoacetanilide. 
 
Entry R R1 Yield % Time h. 
VBA -1 C6H5 -COOEt 70 2.2 
VBA-2 4-ClC6H4 -COOEt 75 2.5 
VBA-3 3-ClC6H4 -COOEt 72 2.5 
VBA-4 3,4Cl2C6H3 -COOEt 82 2.2 
VBA-5 3-Cl,4-F,C6H3 -COOEt 78 2.6 
VBA-6 4-BrC6H4 -COOEt 85 2.5 
VBA-7 4-FC6H4 -COOEt 74 2.5 
VBA-8 4-CH3C6H4 -COOEt 65 2.4 
VBA-9 4-OCH3C6H4 -COOEt 70 2.5 
VBA-10 2,3-(CH3)2C6H3 -COOEt 63 2.3 
VBA-11 3,4-(CH3)2C6H3 -COOEt 72 2.1 
VBA-12 3-BrC6H4 -COOEt 72 2.2 
VBA-13 C6H5 4-NO2C6H4 92 3.0 
VBA-14 4-OCH3C6H4 4-NO2C6H4 88 1.8 
VBA-15 4-CH3C6H4 4-NO2C6H4 84 1.8 
VBA-16 2,3-(CH3)2C6H3 4-NO2C6H4 92 1.5 
VBA-17 4-ClC6H4 4-NO2C6H4 86 2.7 
VBA-18 3-ClC6H4 4-NO2C6H4 92 2.3 
VBA-19 4-BrC6H4 4-NO2C6H4 90 2.3 
VBA-20 4-FC6H4 4-NO2C6H4 92 2.5 
VBA-21 3,4Cl2C6H3 4-NO2C6H4 88 2.5 
VBA-22 3-Cl,4-F,C6H3 4-NO2C6H4 84 2.6 
VBA-23 3-BrC6H4 4-NO2C6H4 90 2.5 
VBA-24 3,4-(CH3)2C6H3 4-NO2C6H4 92 1.7 
VBA-25 C6H5 (CH3)2-CH-CH2- 88 4.5 
VBA-26 4-ClC6H4 (CH3)2-CH-CH2- 74 4.8 
VBA-27 3-ClC6H4 (CH3)2-CH-CH2- 76 4.7 
VBA-28 3,4Cl2C6H3 (CH3)2-CH-CH2- 78 4.6 
VBA-29 3-Cl,4-F,C6H3 (CH3)2-CH-CH2- 84 4.6 
VBA-30 4-BrC6H4 (CH3)2-CH-CH2- 82 4.7 
VBA-31 4-FC6H4 (CH3)2-CH-CH2- 86 4.8 
VBA-32 4-CH3C6H4 (CH3)2-CH-CH2- 70 4.5 
VBA-33 4-OCH3C6H4 (CH3)2-CH-CH2- 72 4.5 
VBA-34 2,3-(CH3)2C6H3 (CH3)2-CH-CH2- 70 4.9 
VBA-35 3,4-(CH3)2C6H3 (CH3)2-CH-CH2- 75 4.6 
VBA-36 3-BrC6H4 (CH3)2-CH-CH2- 80 4.5 
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? Brief Spectral Analysis Discussion Compounds VBA 1-36 
The structure of VBA- 1 was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 1 revealed a 
molecular formula C21H25NO5S2 (m/z 435). The 1H NMR spectrum revealed one 
singlet at δH= 1.23-1.28 assigned to 3 protons of (–CH3) groups, δH= 1.31-1.39of 
isopropyl, a multiplet assigned to 9 protons of (3x –CH3) groups of isopropyl and 
alkyl, one singlet at δH= 3.76ppm assigned to the (–SCH2) protons of methylene, a 
multiplet at δH= 4.00-4.03ppm assigned to the –CH protons of isopropyl, one 
multiplet at δH= 4.17-4.22ppm assigned to the –SCH2COOCH2CH3 protons of 
methylene, one multiplet at δH= 4.30-4.35ppm assigned to the –COOCH2CH3 protons 
of methylene, one multiplet at δH= 7.13-7.16ppm assigned to Ar-H (1H),one doublet 
at δH= 7.26-7.39ppm assigned to Ar-H(2H), one doublet at δH= 7.71-7.73ppm 
assigned to Ar-H (2H), one singlet at δH= 9.18ppm assigned to –ArCONH groups . 
 
The structure of VBA-15 was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 15 revealed 
a molecular formula C28H25N3O5S2 (m/z547). The 1H NMR spectrum revealed singlet 
at δH= 1.23-1.27ppm assigned to 6 protons of (2x -CH3) groups of isopropyl, singlet at 
δH= 2.32ppm assigned to -ArCH3, a multiplet at δH= 3.10-3.14ppm assigned to the–
CH protons of isopropyl, one singlet at δH= 4.21ppm assigned to the –CH2 protons of 
methylene, one doublet at δH= 7.13-7.15ppm assigned to Ar-H (2H), one mutiplet at 
δH= 7.48-7.55ppm assigned to Ar-H(2H), Ar-NO2(2H),one doublet at δH= 7.60-
7.63ppm assigned to Ar-H (2H), one doublet at δH= 8.07 -8.10ppm assigned to Ar-
NO2 (2H), one doublet at δH= 8.26 -8.29ppm assigned to Ar-NO2 (2H), one singlet at 
δH= 10.34ppm assigned to –ArCONH group. 
 
The structure of VBA- 25 was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 25 revealed 
a molecular formula C23H33NOS2 (m/z403). The 1H NMR spectrum revealed a doublet 
at δH= 0.83-0.89 ppm assigned to 6 protons of (2x –CH3) groups of isopropyl, singlet 
at δH= 0.91-0.92 ppm assigned to 6 protons of (2x –CH3) groups of isopropyl, one 
singlet at δH= 1.08-1.10 ppm assigned to 6 protons of (2x –CH3) groups of isopropyl, 
a multiplet at δH=1.44-1.49 ppm assigned to the –CH protons of isopropyl, one singlet 
at δH= 2.01 ppm assigned to the –CH2 protons of methylene, one singlet at δH= 
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2.52ppm assigned to the –CH2 protons of methylene, a multiplet at δH=2.85-2.95 ppm 
assigned to the –CH protons of isopropyl, a multiplet at δH=3.02-3.09 ppm assigned to 
the –CH protons of isopropyl, one singlet at δH=3.37 ppm assigned to the –SCH2 
protons of methylene, one triplet at δH= 7.03-7.07 ppm assigned to Ar-H (1H) , one 
triplet at δH= 7.26-7.30 ppm assigned to Ar-H (2H) , one doublet at δH= 7.64-7.66ppm 
assigned to (d, 2H J=8.0 Hz,–ArH(2H), one singlet at δH= 10.27 ppm assigned to –
ArCONH groups .  
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Figure: 35 A proposed mechanism for the preparation of highly 
substituted thiophenes (HST) (VBA 1-36) from 1,3-dicarbonyl compounds 
in water 
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1.6  Biological activity  
EXPERIMENTAL: 
The solvent DMSO was also purified before use by standard method (37). All 
the synthesized compounds were recrystallized prior to use. For all the compounds, 
agar well diffusion method was used. 
Test Microorganisms: 
The synthesized compounds were tested for its antimicrobial susceptibility 
activity against two Gram positive bacteria Micrococcus luteus MTCC 106 and 
Bacillus circulans MTCC1197 and two Gram negative bacteria Escherichia coli 
MTCC729 and pseudomonas aeruginosa MTCC 4676. Microorganisms were 
obtained from Microbial Type Culture Collection and Gene Bank, Chandigarh, India 
and were maintained at 37°C on nutrient agar slants. 
Preparation of test compounds: 
The solutions were prepared at a concentration of 1 mg/mL (Stock Solution) 
and further diluted to 0.1 mg/mL and 0.05 mg/mL for all the compounds. 
Preparation of the plates and microbiological assay: 
The antibacterial evaluation was done by agar well diffusion method (38, 39) 
using Mueller Hinton Agar No.2 as the nutrient medium. The agar well diffusion 
method was preferred to be used in this study because it was found to be better than 
the disc diffusion method (39). The bacterial strains were activated by inoculating a 
loop full of test strain in 25 mL of N-broth and the same was incubated for 24 h in an 
incubator at 37ºC. 0.2 mL of the activated strain was inoculated in Mueller Hinton 
Agar. Mueller Hinton Agar kept at 45ºC was then poured in the Petri dishes and 
allowed to solidify. After solidification of the media, 0.85 cm ditch was made in the 
plates using a sterile cork borer and these were completely filled with the test 
solution. The plates were incubated for 24 h at 37ºC. The mean value obtained for the 
three wells was used to calculate the zone of growth inhibition of each sample. The 
controls were maintained for each bacterial strain and each solvent. The inhibition 
zone formed by these compounds against the particular test bacterial strain 
determined the antibacterial activities of these synthesized compounds. 
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Table 3: Biological Activity Result for Active compounds as following. 
Compound 
Code 
Bacterial strain  
E. coli P. aurogenosa B. Circulans M. Luteus 
50 
µ/ 
gm 
100 
µ/ 
gm 
1000 
µ/ 
gm 
50  
µ/ 
gm 
100 
µ/ 
gm 
1000 
µ/ 
gm 
50  
µ/ 
gm 
100 
µ/ 
gm 
1000 
µ/ 
gm 
50  
µ/ 
gm 
100 
µ/ 
gm 
1000 
µ/ 
gm 
VBA 11 - - - - - - - 2 4 - - - 
VBA 13 - - - - - 6 - 3 6 - - - 
VBA 14 - - - - 7   - 3 6 - - - 
VBA 15 - - - - 5 9 2 4 6 - - - 
VBA 16 - - - - - - - -   - - - 
VBA 17 - - - - - 9 - 4 6 - - - 
VBA 18 - - - - - 10 -   10 - - - 
VBA 21 - - - - - 4 - - - - 6   
VBA 24 - - - - - 3 - - - - - - 
VBA 25 - - - - -   - - 2 - 4 6 
VBA 26 - - -   - - - - - - - - 
VBA 27 - - - 6 - - - - - - - - 
VBA 28 - - - - - 3 - - - - - 6 
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1.7 CONCLUSION 
 
In summary, a facile and convenient route of synthesis for highly substituted 
thiophenes (VBA1-36) based on the reactions of 1,3-dicarbonylcompounds 3a-k with 
carbon disulfide and alkyl bromide catalyzed by TEAB/TBAB (Table 1) in the 
presence of K2CO3 in water has been developed. The main advantage of the reaction 
is simple procedure, mild conditions and high yields observed at room temperature. 
The present methodology will be beneficiary in organic synthesis for the synthesis of 
highly substituted thiophenes in easy way. Out of 36 compounds were Screened for 
anti microbial susceptibility assay 12 compounds shown positive activity against 
microbs and result shown in table 3.No compounds have shown activity against E-coli 
MTCC 729. 
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1.8 EXPERIMENTAL SECTION 
 
Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZU FTIR 8400 
instrument by using DRS prob. 1H (400 MHz) and 13C(100 MHz) NMR spectra were 
recorded on a Bruker AVANCE II spectrometer in CDCl3 and DMSO. 13C NMR were 
recorded on 100 MHz spectrometer, referred to the internal solvent signals (77.0for 
CDCl3 or 40.0 for DMSO). Chemical shifts are expressed in δ ppm downfield from 
TMS as an internal standard. Mass spectra were determined using direct inlet probe 
on a SHIMADZUGCMS-QP 2010 mass spectrometer. Solvents were evaporated with 
a BUCHI rotary evaporator. Melting points were measured in open capillaries and are 
uncorrected. The chemicals used in this work were purchased from Merck, 
Spectrochem and Sisco Chemical Companies. 
 
? General Representative Procedure for synthesis of 4-methyl-3-oxo-N- 
arylpentan -amide 2a-t. 
 A mixture containing the primary amine (10 mmol), acetate (10 mmol), and 
catalytic amount of sodium or potassium hydroxide (10 %) was reflux at 110oC for 
the approximately 15-20 hrs. The reaction was monitored by TLC. After completion 
of reaction, the solvent was removed under vaccuo when the reaction was completed. 
The solid or oil was crystallized from methanol to give pure product 2a-t. 
 
? General procedure for the synthesis of substituted thiophene (VBA 1-36). 
To a solution of 4-methyl-3-oxo-N-phenylpentanamide(2, 1.0 mmol) and 
K2CO3 (4.0mmol) with various PTC used such as TBAB, TEAB, CTAB (2.0mmol) in 
DMF (5mL) and solvent describe in (table-1) was added CS2 (1.1 mmol) at 0-5°C and 
after 10-15 min alkyl bromide (2.0 mmol)such as (ethyl 2-bromoacetate,p-nitrobenzyl 
bromide, isopentyl bromide) (2.0 mmol) was added slowly. The reaction was 
vigorously shaken at room temperature for appropriate time given in (table-1), the 
reaction was monitored by TLC. After complication of reaction, mixture poured into 
crushed ice. The precipitate of crude product was purified by (hexane/Et2O). When 
crude product was not obtained than acidified with HCl and further purified by 
(hexanes/Et2O). 
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? Spectral data of the synthesized compounds VBA 1-36 
 
Ethyl5-((ethoxycarbonyl)methylthio)-4-(phenylcarbamoyl)-3-isopropylthiophene 
-2-carboxylate (VBA-1): White solid; Rf0.70 (8:2H-E.A); mp 99-101°C; IR (KBr): 
3142, 3022, 2983, 2842, 1741, 1720, 1651, 1641, 1600, 1543, 1487, 1460,1392, 1298, 
1207, 1165, 749, 667, cm-1; 1H NMR:(400 MHz, CDCl3): δH 1.23-1.28 (m, 3H, -CH3), 
1.31-1.39 (m, 9H, -iprCH3,CH3), 3.76 (s, 2H, -SCH2), 4.00-4.03 (m, 1H, -iprCH), 
4.17-4.22 (dd, 2H J=7.12 Hz, -CH2), 4.30-4.35(dd, 2H J=7.16 Hz, -CH2), 7.13-7.16 (t, 
1H, Ar-H), 7.35-7.39 (t, 2H, Ar-H), 7.71-7.73 (d, 2H J=7.64 Hz, Ar-H), 9.18(S, 1H, -
ArCONH); 13C NMR: (100 MHz, CDCl3): δC 14.03, 14.25, 21.06, 28.66, 39.91, 
61.37, 62.57, 119.96, 124.47, 129.02, 130.25, 136.53, 138.36, 144.24, 155.20, 161.26, 
163.25, 170.02; MS m/z: 435.56(M+); Anal. Calcd. for C21H25NO5S2: C, 57.91; H, 
5.79; N, 3.22%. Found: C, 57.88; H, 5.71; N, 3.23%. 
 
Ethyl 4-(4-chloro phenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-isopropyl 
thiophene-2-carboxylate (VBA-2): Yellow solid; Rf0.68 (8:2 H-E.A); mp 105-
107°C; IR (KBr): 3144, 3020, 2985, 2840, 1741, 1720, 1651, 1641, 1600, 1543, 1489, 
1464, 1386, 1298, 1210, 1165, 804, 784, cm-1; MS m/z: 470(M+); Anal. Calcd. for 
C21H24ClNO5S2: C, 53.66; H, 5.15; N, 2.98%.Found: C, 53.61; H, 5.08; N, 2.93%. 
 
Ethyl4-(3-chlorophenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-isopropyl 
thiophene-2-carboxylate (VBA-3): Yellowsolid; Rf0.67 (8:2 H-E.A); mp 102-105°C; 
IR (KBr): 3147,  3024,  2982,  2836, 1741, 1720, 1651, 1641, 1603, 1543, 1484, 
1462, 1382, 1290, 1212, 1167, 854, cm-1; MS m/z: 470(M+); Anal. Calcd. for 
C21H24ClNO5S2: C, 53.66; H, 5.15; N, 2.98%. Found: C, 53.64; H, 5.12; N, 2.88%. 
 
Ethyl4-(3,4-dichlorophenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-
isopropylthiophene-2-carboxylate (VBA-4): Lemon yellow solid; Rf0.66 (8:2 H-
E.A); mp 108-110°C; IR (KBr): 3140, 3018, 2972, 2842, 1741, 1720, 1651, 1641, 
1610, 1545, 1486, 1468, 1378, 1288, 1218, 1169, 772, cm-1; MS m/z: 504.45(M+); 
Anal. Calcd. for C21H23Cl2NO5S2: C, 50.00; H, 4.60; N, 2.78%. Found: C, 50.07; H, 
4.58; N, 2.73%. 
 
Ethyl4-(3-chloro-4-fluorophenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-
isopropylthiophene-2-carboxylate (VBA-5): White solid; Rf0.64 (8:2 H-E.A); mp 
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112-115°C; IR (KBr): 3152, 3035, 2962, 2852, 1741, 1720, 1651, 1641, 1615, 1550, 
1490, 1462, 1384, 1284, 1202, 1158, 784, cm-1; MS m/z: 487.99(M+); Anal. Calcd. for 
C21H23ClFNO5S2: C, 51.69; H, 4.75; N, 2.87%. Found: C, 51.69; H, 4.65; N, 2.79%. 
 
Ethyl 4-(4-bromo phenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-isopropyl 
thiophene-2-carboxylate (VBA-6): Yellow solid; Rf0.66 (8:2 hexane-EtOAc); mp 
102-104°C; IR (KBr): 3158, 3020, 2972, 2860, 1741, 1720, 1651, 1641, 1615, 1555, 
1494, 1470, 1372, 1288, 1228, 1165, 845, 792, cm-1; MS m/z: 514.5(M+); Anal. 
Calcd. for C21H24BrNO5S2: C, 49.03; H, 4.70; N, 2.72% Found: C, 49.05; H, 4.68; N, 
2.65%. 
 
Ethyl 4-(4-fluoro phenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-isopropyl 
thiophene-2-carboxylate (VBA-7): Yellow solid;  Rf0.62 (8:2 hexane-EtOAc); mp 
97-99°C; IR (KBr): 3135, 3010, 2962, 2828, 1741, 1720, 1651, 1641, 1612, 1558, 
1488, 1472, 1364, 1276, 1212, 1176, 824, 798, cm-1; MS m/z: 453.55(M+); Anal. 
Calcd. for C21H24FNO5S2: C, 55.61; H, 5.33; N, 3.09%. Found: C, 54.79; H, 5.67; N, 
3.16% 
 
Ethyl4-(p-tolylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-isopropylthiophene-
2-carboxylate (VBA-8): White solid; Rf0.70 (8:2 H-E.A); mp 110-115°C; IR (KBr): 
3421, 3230, 3124, 3034, 2987, 2937, 2821, 1768, 1741, 1718, 1639, 1604, 1545, 
1508, 1460, 1402, 1332, 1298, 1244, 1203, 1093, 1028, 815, 773, 667, cm-1; 1H 
NMR: (400 MHz, CDCl3): δH 1.23-1.26 (m, 3H, -CH3), 1.30-1.38 (m, 9H, -iprCH3,-
CH3), 2.31-2.33 (s, 3H, Ar-CH3), 3.74 -3.76 (s, 2H, -SCH2-), 3.99-4.00 (m, 1H, -
iprCH-), 4.16-4.21 (dd, 2H J=7.16Hz,-CH2-), 4.29-4.35 (dd, 2H J=7.08Hz,–CH2-), 
7.16-7.18 (dd, 2H J=8.24Hz, Ar-H), 7.59- 7.61 (dd, 2H  J=8.36Hz, Ar-H), 9.06 (s, 1H, 
-CONH); MS m/z: 449.58(M+); 13CNMR: (100 MHz, CDCl3): δC 14.02, 14.25, 20.94, 
21.07, 28.66, 39.85, 61.36, 62.53, 120.02, 129.52, 130.15, 134.18, 135.72, 136.54, 
144.26, 155.16, 161.28, 163.19, 169.96; Anal. Calcd. for C22H27NO5S2: C, 58.77; H, 
6.05; N, 3.12%. Found: C, 58.45; H, 6.89; N, 3.84% 
 
Ethyl4-(4-methoxyphenylcarbamoyl)-5-((ethoxycarbonyl)methylthio)-3-
isopropylthiophene-2-carboxylate (VBA-9): White solid; Rf0.72 (8:2 H-E.A); mp 
105-107°C; IR (KBr): 3174, 3054, 2982, 2862, 1741, 1720, 1651, 1641, 1618, 1554, 
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1496, 1474, 1364, 1278, 1236, 1172, 828, 785, cm-1; 1H NMR: (400 MHz, CDCl3): δH 
1.23-1.31 (m, 3H, -CH3), 1.31-1.40 (m, 9H,- iprCH3, -CH3), 3.75-3.78 (m, 2H, -
SCH2), 3.81 (s, 3H, -OCH3), 4.00-4.03 (m, 1H, -iprCH-), 4.15-4.21 (dd, 2H, 
J=6.96Hz, -CH2-), 4.29-4.35 (dd, 2H J=7.12Hz, -CH2-), 6.89-6.91 (d, 2H J=8.92 Hz, –
Ar-H-), 7.62-7.64 (d, 2H J=8.92 Hz, –Ar-H), 9.03 (s, 1H, -ArCONH); 13C NMR (100 
MHz, CDCl3): δC 14.02, 14.25, 21.06, 28.67, 29.70, 39.91, 55.54, 61.35, 62.52, 
114.19, 121.63, 130.16, 131.51, 136.48, 144.29, 155.17, 156.55, 161.28, 163.02, 
169.99; MS m/z: 465.58(M+); Anal. Calcd. for C22H27NO6S2: C, 56.75; H, 5.85; N, 
3.01%. Found: C, 56.84; H, 5.98; N, 3.76%. 
 
Ethyl4-((2,3-dimethylphenyl)carbomayl)-5-((2-ethoxy-2-oxoethyl)thio)-3-
isopropyl thiophene-2-carboxylate (VBA-10): Yellow solid; Rf0.68 (8:2 H-E.A); 
mp 115-118°C; IR (KBr): 3184, 3064, 2965, 2820, 1741, 1720, 1651, 1641, 1614, 
1552, 1486, 1462, 1365, 1275, 1232, 1173, 757, 804, cm-1; MS m/z: 463.61(M+); 
Anal. Calcd. for C23H29NO5S2: C, 59.59; H, 6.30; N, 3.02%. Found: C, 59.89; H, 
6.28; N, 3.95%. 
 
Ethyl4-(3,4-dimethylphenylcarbamoyl)-5-((ethoxycarbonyl)methylthio-3-
isopropyl  thiophene-2-carboxylate (VBA-11): Yellow solid; Rf0.68 (8:2 H-E.A); 
mp 115-118°C; IR (KBr): 3184, 3064, 2965, 2820, 1741, 1720, 1651, 1641, 1614, 
1552, 1486, 1462, 1365, 1275, 1232, 1173, 792, 778, cm-1; MS m/z: 463.61(M+); 
Anal. Calcd. for C23H29NO5S2: C, 59.59; H, 6.30; N, 3.02%. Found:C, 59.89; H, 6.97; 
N, 3.89%. 
 
 
Ethyl4-((3-bromophenyl)carbamoyl)-5-((2-ethoxy-2-oxoethyl)thio)-3-isopropyl 
thiophene-2-carboxylate (VBA-12): Yellow solid; Rf0.64 (8:2 H-E.A); mp 70-74°C; 
IR (KBr): 3138, 3054, 2985, 2847, 1741, 1720, 1651, 1641, 1624, 1564, 1474, 1477, 
1373, 1279, 1235, 1182, 778, cm-1; MS m/z: 514.5(M+); Anal. Calcd. for 
C21H24BrNO5S2: C, 49.03; H, 4.70; N, 2.72%. FoundC, 49.14; H, 4.88; N, 2.67%. 
 
2-(4-nitrobenzylthio)-4-isopropyl-5-(4-nitrophenyl)-N-phenylthiophene-3-
carboxamide (VBA-13): Yellow solid; Rf0.80 (8:2 H-E.A); mp 144-147°C; IR 
(KBr): 3267, 3027, 2945, 2885, 1643, 1595, 1508, 1516, 1467, 1415, 1348, 1239, 
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1029, 844, 833, 814, 702, cm-1; MS m/z: 533.62(M+); Anal. Calcd. for C27H23N3O5S2: 
C, 60.77; H, 4.34; N, 7.87%. Found: C, 60.66; H, 4.47; N, 7.65%. 
 
2-(4-nitrobenzylthio)-4-isopropyl-N-(4-methoxyphenyl)-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-14): Yellow solid; Rf0.82 (8:2 H-E.A); mp 142-
144°C; IR (KBr): 3259, 3057, 2965, 2895, 1643, 1595, 1508, 1516, 1465, 1411, 1346, 
1236, 1039, 854, 833, 804, 696, cm-1; 1H NMR:(400 MHz, DMSO) δH 1.23-1.29 (d, 
6H J=7.08Hz, -iprCH3), 3.12-3.13 (m, 1H, -iprCH), 3.80 (s, 3H, -OCH3), 4.19(s, 2H, -
SCH2), 6.87-6.90 (dd, 2H J=3.28Hz, -ArH), 7.46-7.51 (m, 4H, -ArHNO2), 7.63-7.66 
(d, 2H J=3.2Hz, -ArH), 7.88-8.10 (d, 2H J=3.2Hz, -ArH), 8.24-8.28 (d, 2H J=8.68Hz, 
-ArHNO2), 10.18 (s, 1H, -ArCONH); 13CNMR (100 MHz, DMSO) δC 22.13, 28.25, 
41.24, 54.97, 99.49, 113.51, 121.29, 123.06, 123.42, 129.75, 130.26, 131.67, 138.49, 
139.89, 144.09, 144.73, 145.30, 146.56, 146.86, 155.73, 163.36; MS m/z: 563.6(M+); 
Anal. Calcd. for C28H25N3O6S2: C, 59.67; H, 4.47; N, 7.46%. Found C, 59.78; H, 
4.35; N, 7.36%. 
 
2-(4-nitrobenzylthio)-4-isopropyl-5-(4-nitrophenyl)-N-p-tolylthiophene-3-carbox- 
Amide (VBA-15): Yellow solid; Rf0.78 (8:2 H-E.A); mp 147-149°C; IR (KBr): 3437, 
3250, 3078, 2960, 2870, 2839, 1643, 1597, 1525, 1516, 1464, 1406, 1313, 1238, 
1178, 1109, 1039, 856, 833, 802, 744, 700, cm-1; 1H NMR:(400 MHz, DMSO) δH 
1.23-1.27 (d, 6H J=7.08Hz, 2X-iprCH3), 2.32 (s, 3H, -ArCH3), 3.10-3.14 (m, 1H, -
iprCH), 4.21 (s, 2H, -SCH2), 7.13-7.15 (d, 2H J=8.32Hz, -ArH), 7.48-7.55 (m, 4H, -
ArHNO2), 7.60-7.63 (d, 2H J=8.4Hz, -ArH), 8.07-8.10 (dd, 2H J=1.8Hz, -ArHNO2), 
8.26-8.29 (dd, 2H, -ArHNO2), 10.34 (s, 1H, -ArCONH); 13CNMR (100MHz,DMSO) 
δC 20.50, 22.16, 28.24, 41.09, 119.71, 123.14, 123.55, 128.87, 129.88, 130.34, 130.41, 
132.85, 136.16, 138.47, 139.85, 143.94, 144.96, 145.22, 146.58, 146.92, 163.49; MS 
m/z: 547.65(M+); Anal. Calcd. for C28H25N3O5S2: C, 61.41; H, 4.60; N, 7.67%. 
Found: C, 61.35; H, 4.48; N, 7.87%. 
 
N-(2,3-dimethylphenyl)-4-isopropyl-2-((4-nitrobenzyl)thio)-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-16): Yellow solid; Rf0.76 (8:2 H-E.A); mp 153-
155°C; IR (KBr): 3254, 3054, 2978, 2875, 1643, 1595, 1516, 1508, 1465, 1411, 1346, 
1256, 1044, 854, 833, 804, 798, cm-1; MS m/z: 561.67(M+); Anal. Calcd. for 
C29H27N3O5S2: C, 62.01; H, 4.85; N, 7.48%. Found: C, 62.25; H, 4.65; N, 7.63%. 
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2-(4-nitrobenzylthio)-N-(4-chlorophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-17): Lemon yellow solid; Rf0.72 (8:2 H-E.A); mp 
151-154°C; IR (KBr): 3264, 3065, 2960, 2822, 1643, 1595, 1508, 1516, 1465, 1411, 
1358, 1318, 1239, 854, 833, 804, 775, cm-1; MS m/z: 568.06(M+); Anal. Calcd. for 
C27H22ClN3O5S2: C, 57.09; H, 3.90; N, 7.40%. Found: C, 57.45; H, 3.78; N, 7.31%. 
 
2-(4-nitrobenzylthio)-N-(3-chlorophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-18): white solid; Rf0.72 (8:2 H-E.A); mp 155-
158°C; IR (KBr): 3248, 3052, 2965, 2842, 1643, 1595, 1516, 1508, 1465, 1411,1358, 
1318, 1248, 858, 839, 818, 804, cm-1; MS m/z: 568.06(M+); Anal. Calcd. for 
C27H22ClN3O5S2: C, 57.09; H, 3.90; N, 7.40%. Found: C, 57.07; H, 3.98; N, 7.67%. 
 
2-(4-nitrobenzylthio)-N-(4-bromophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-19): white solid; Rf0.70 (8:2 H-E.A); mp 154-
157°C; IR(KBr): 3252, 3064, 2972, 2855, 1643, 1595, 1528, 1508, 1465, 1411, 1346, 
1318, 1262, 866, 842, 818, 718, 696, cm-1; MS m/z: 612.5(M+); Anal. Calcd. for 
C27H22BrN3O5S2: C, 52.94; H, 3.62; N, 6.86%. Found: C, 52.97; H, 3.69; N,6.94%. 
 
2-(4-nitrobenzylthio)-N-(4-fluorophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-20): Yellow solid; Rf0.74 (8:2 H-E.A); mp 148-
151°C; IR (KBr): 3254, 3097, 3003, 2929, 2816, 1643, 1595, 1540, 1516, 1465, 1346, 
1256, 854, 833, 804, 796, 623, 599, cm-1; MS m/z: 551.61(M+); Anal. Calcd. For 
C27H22FN3O5S2: C, 58.79; H, 4.02; N, 7.62%. Found: C, 58.65; H, 4.68; N,7.87%. 
 
2-(4-nitrobenzylthio)-N-(3,4-dichlorophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA-21): Lemon white solid; Rf0.74 (8:2 H-E.A); mp 
156-159°C; IR (KBr): 3239, 3046, 2968, 2832, 1643, 1595, 1532, 1508, 1472, 1411, 
1352, 1318, 1218, 848, 836, 818, 718, 696, cm-1; MS m/z: 602.5(M+); Anal. Calcd. for 
C27H21Cl2N3O5S2: C, 53.82; H, 3.51; N, 6.97%. Found: C, 53.78; H, 3.95; N, 6.67%. 
 
2-(4-nitrobenzylthio)-N-(3-chloro-4-fluorophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA -22): Lemon yellow solid; Rf0.72 (8:2 H-E.A); mp 
162-164°C; IR (KBr): 3246, 3042, 2964, 2865, 1643, 1595, 1532, 1508, 1482, 1411, 
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1352, 1322, 1224, 858, 828, 812, 726, cm-1; MS m/z: 586.5(M+); Anal. Calcd. for 
C27H21ClFN3O5S2: C, 55.33; H, 3.61; N, 7.17%. Found: C, 55.47; H, 3.44; N, 7.28%. 
 
2-(4-nitrobenzylthio)-N-(3-bromophenyl)-4-isopropyl-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA -23): Lemon yellow solid; Rf0.72 (8:2 H-E.A); mp 
139-141°C; IR (KBr): 3264, 3052, 2928, 2873, 1643, 1595, 1532, 1508, 1482, 1411, 
1345, 1322, 1219, 864, 816, 812, 715, cm-1; MS m/z: 612.5(M+); Anal. Calcd. for 
C27H22BrN3O5S2: C, 52.94; H, 3.62; N, 6.86%. Found: C, 52.98; H, 3.58; N, 6.78%. 
 
2-(4-nitrobenzylthio)-4-isopropyl-N-(3,4-dimethylphenyl)-5-(4-nitrophenyl) 
thiophene-3-carboxamide (VBA -24): Lemon yellow solid; Rf0.72 (8:2 H-E.A); mp 
164-166°C; IR (KBr): 3245, 3063, 2972, 2862, 1643, 1595, 1532, 1508, 1482, 1411, 
1352, 1318, 1215, 872, 814, 812, 712, cm-1; 1H NMR:(400 MHz, CDCl3) δH 1.29 (s, 
6H, -iprCH3), 3.12-3.15 (m, 1H, -iprCH), 3.76 (s, 3H, -CH3), 3.83 (s, 3H, -CH3), 4.09 
(s, 2H, -SCH2), 6.93-6.95 (d, 2H J=8.88Hz, -ArH), 7.26 (s, 1H, -ArH), 7.44-7.46 (d, 
2H J=8.6Hz, -ArHNO2), 7.49-7.51 (d, 2H J=8.8Hz, -ArHNO2), 8.06-8.08 (d, 2H 
J=8.6Hz, -ArHNO2), 8.25-8.27 (d, 2H, -ArHNO2), 8.36 (s, 1H, -CONH). 13CNMR 
(100MHz, CDCl3) : δC 22.57, 22.68, 28.91, 29.71,  42.07, 55.42, 55.59, 114.18, 
114.43, 121.91, 123.72, 123.80, 129.93, 130.45, 130.73, 130.81, 139.78, 140.17, 
144.30, 144.47, 145.26, 147.29, 147.58, 157.10, 163.61; MS m/z: 561.67(M+); Anal. 
Calcd. for C29H27N3O5S2: C, 62.01; H, 4.85; N, 7.48%. Found: C, 62.27; H, 4.85; N, 
7.56%. 
 
5-isobutyl-2-(isopentylthio)-4-isopropyl-N-phenylthiophene-3-carboxamide 
(VBA-25): Lemon yellow solid; Rf0.86 (8:2 H-E.A); mp 110-112°C; IR (KBr): 3354, 
3038, 2988, 2836, 1741, 1720, 1651, 1641, 1628, 1548, 1492, 1466, 1354, 1282, 
1218, 1188, 746, 694, cm-1; 1H NMR:(400 MHz, DMSO) δH 0.83-0.87 (d, 6H 
J=16Hz, - iprCH3), 0.91-0.92 (s, 6H, -iprCH3), 1.08-1.10 (s, 6H, -iprCH3), 1.44-1.49 
(s, 1H, -iprCH), 2.01 (s, 2H, -CH2), 2.52 (s, 2H,  -CH2), 2.85-2.95 (s, 1H, -iprCH), 
3.02-3.09 (m, 1H, -iprCH), 3.37 (s, 2H, -SCH2), 7.03-7.07 (t, 1H, -ArH), 7.26-7.30 (t, 
2H, -ArH), 7.64-7.66 (d, 2H J=8.0Hz, -ArH), 10.27 (s, 1H, Ar-CONH). 13CNMR (100 
MHz, DMSO): δC 18.64, 21.90, 21.95, 26.75, 26.97, 30.51, 31.49, 33.29, 37.88, 
38.04,  119.48, 123.47, 128.38, 138.79, 141.64, 148.02, 163.87, 200.98; MS m/z: 
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403.64(M+); Anal. Calcd. for C23H33NOS2: C, 68.44; H, 8.24; N, 3.47%. Found: C, 
68.86; H, 8.49; N, 3.69%. 
 
N-(4-chlorophenyl)-5-isobutyl-2-(isopentylthio)-4-isopropylthiophene-3-
carboxamide (VBA -26): Lemon yellow solid; Rf0.80 (8:2 H-E.A); mp 104-106°C; 
IR (KBr): 3327, 3017, 2972, 2852, 1741, 1720, 1651, 1641, 1628, 1548, 1492, 1466, 
1354, 1282, 1218, 1188, 872, 788, cm-1; MS m/z: 438.09(M+); Anal. Calcd. for 
C23H32ClNOS2: C, 63.06; H, 7.36; N, 3.20%. Found: C, 63.48; H, 7.29; N, 3.18%. 
 
N-(3-chlorophenyl)-5-isobutyl-2-(isopentylthio)-4-isopropylthiophene-3-
carboxamide (VBA -27): Lemon yellow solid; Rf0.76 (8:2 H-E.A); mp 105-107°C; 
IR (KBr): 3308, 3005, 2979, 2845, 1745, 1723, 1651, 1641, 1628, 1548, 1492, 1466, 
1354, 1272, 1227, 1192, 872, 824, cm-1; 1H NMR: (400 MHz, DMSO) δH 0.83-0.87 
(d, 6H J=16 Hz, - iprCH3), 0.91-0.99 (s, 6H, -iprCH3), 1.07-1.09 (s, 6H, -iprCH3), 
1.46-1.47(s, 1H, -iprCH), 1.53-1.67 (s, 2H, -CH2), 2.10 (s, 2H, -CH2), 2.52-2.54 (s, 
2H, -SCH2), 2.87-2.93 (m, 1H, -iprCH), 3.00-3.07 (m, 1H, -iprCH), 7.06-7.09 (dd, 1H 
J=4.0Hz, -ArH), 7.27-7.31 (t, 1H, -ArH), 7.49-7.52 (d, 1H J=16.0Hz, -ArH), 7.84 (t, 
1H, -ArH), 10.48 (s, 1H, -ArCONH); 13CNMR (100 MHz, DMSO): δC 18.62, 21.92, 
26.72, 26.96, 31.52, 33.36, 37.86, 38.01, 117.65, 118.98, 123.22, 129.91, 133.22, 
140.17, 141.14, 148.84, 164.21, 200.73; MS m/z: 438.09(M+); Anal. Calcd. for 
C23H32ClNOS2: C, 63.06; H, 7.36; N, 3.20%. Found: C, 63.79; H, 7.87; N, 3.82%. 
 
N-(3,4-dichlorophenyl)-2-(isopentylthio)-4-isopropyl-5-propylthiophene-3-
carboxamide (VBA -28): Yellow solid; Rf0.82 (8:2 H-E.A); mp 107-110°C; IR 
(KBr): 3308, 3005, 2979, 2845, 1745, 1723, 1651, 1641, 1628, 1548, 1492, 1466, 
1354, 1272, 1227, 1192, 872, 824, cm-1; MS m/z: 472.53(M+); Anal. Calcd. for 
C23H31Cl2NOS2: C, 58.46; H, 6.61; N, 2.96%. Found: C, 58.52; H, 6.72; N, 2.92%. 
 
N-(3-chloro-4-fluorophenyl)-2-(isopentylthio)-4-isopropyl-5-propylthiophene-3-
carboxamide (VBA -29): Lemon yellow solid; Rf0.78 (8:2 H-E.A); mp103-105°C; 
IR (KBr): 3315, 3016, 2962, 2838, 1745, 1723, 1653, 1641, 1628, 1548, 1494, 1472, 
1354, 1262, 1218, 1192, 804, 762, cm-1; MS m/z: 456.08(M+); Anal. Calcd. for 
C23H31ClFNOS2: C, 60.57; H, 6.85; N, 3.07%. Found: C, 60.25; H, 6.89; N, 3.67%. 
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N-(4-bromophenyl)-2-(isopentylthio)-4-isopropyl-5-propylthiophene-3-
carboxamide (VBA -30): Yellow solid; Rf0.76 (8:2 H-E.A); mp 113-115°C; IR 
(KBr): 3328, 3026, 2972, 2842, 1734, 1723, 1658, 1641, 1628, 1539, 1494, 1476, 
1354, 1274, 1214, 1188, 834, 782, cm-1; MS m/z: 482.54(M+); Anal. Calcd. for 
C23H32BrNOS2: C, 57.25; H, 6.68; N, 2.90%. Found: C, 57.06; H, 6.75; N, 2.99%. 
 
N-(4-fluorophenyl)-5-isobutyl-2-(isopentylthio)-4-isopropylthiophene-3-
carboxamide (VBA-31): Lemon yellow solid; Rf0.78 (8:2 H-E.A); mp 103-106°C; 
IR (KBr): 3352, 3008, 2956, 2834, 1742, 1727, 1654, 1641, 1628, 1539, 1497, 1468, 
1346, 1262, 1212, 1182, 834, 802, cm-1; MS m/z: 421.63(M+); Anal. Calcd. for 
C23H32FNOS2: C, 57.25; H, 6.68; N, 2.90%. Found: C, 57.25; H, 6.68; N, 2.94%. 
 
5-isobutyl-2-(isopentylthio)-4-isopropyl-N-p-tolylthiophene-3-carboxamide 
(VBA-32): Lemon yellow solid; Rf0.82 (8:2 H-E.A); mp 92-94°C; IR (KBr): 3361, 
3029, 2962, 2822, 1747, 1724, 1659, 1641, 1623, 1539, 1497, 1468, 1346, 1262, 
1208, 1186, 867, 788, cm-1; 1H NMR: (400 MHz, DMSO) δH 0.88-0.91 (d, 12H 
J=12Hz, 4X-iprCH3), 1.07-1.12 (s, 6H, 2X-iprCH3), 1.49 (s, 1H, -iprCH), 1.65 (s, 2H, 
-CH2), 2.13 (s, 2H, -CH2), 2.29 (s, 1H, -iprCH),  2.57 (s, 3H, -CH3), 2.90 (s, 2H, -
SCH2), 3.05-3.12 (m, 1H, -iprCH), 7.08-7.10 (d, 2H J=8.0Hz, -ArH), 7.51-7.53 (d, 2H 
J=8.0Hz, -ArH), 10.02 (s, 1H, -ArCONH);  13CNMR (100 MHz, DMSO): δC 18.55, 
20.44, 21.83, 26.87, 31.61, 33.33, 37.88, 119.57, 128.75, 132.78, 135.90, 135.90, 
141.38, 148.37, 163.65, 201.64; MS m/z: 417.67(M+); Anal. Calcd. for C24H35NOS2: 
C, 69.02; H, 8.45; N, 3.35%. Found: C, 69.45; H, 8.96; N, 3.66%. 
 
5-isobutyl-2-(isopentylthio)-4-isopropyl-N-(4-methoxyphenyl)thiophene-3-
carboxamide (VBA -33): Lemon yellow solid; Rf0.80 (8:2 H-E.A); mp 94-96°C; IR 
(KBr): 3345, 3063, 2971, 2862, 1744, 1643, 1575, 1532, 1518, 1482, 1352, 1318, 
1215, 872, 812, cm-1; MS m/z: 433.67(M+); Anal. Calcd. for C24H35NO2S2: C, 66.47; 
H, 8.13; N, 3.23%. Found: C, 66.52; H, 8.18; N, 3.31%. 
 
5-isobutyl-2-(isopentylthio)-4-isopropyl-N-(2,3-dimethylphenyl)thiophene-3-
carboxamide (VBA -34): Yellow solid; Rf0.74 (8:2 H-E.A); mp 90-92°C; IR (KBr): 
3318, 3048,  2938, 2872, 1756, 1639, 1563, 1529, 1518, 1482, 1354, 1318, 1218, 872, 
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792, cm-1; MS m/z: 431.7(M+); Anal. Calcd. for C25H37NOS2: C, 69.56; H, 8.64; N, 
3.24%. Found: C, 69.79; H, 8.97; N, 3.16%. 
 
5-isobutyl-2-(isopentylthio)-4-isopropyl-N-(3,4-dimethylphenyl)thiophene-3-
carboxamide (VBA -35): Yellow solid; Rf0.76 (8:2 H-E.A); mp 97-99°C; IR (KBr): 
3337, 3082, 2958, 2845, 1752, 1653, 1578, 1542, 1507, 1492, 1358, 1307, 1215, 892, 
775, cm-1; MS m/z: 431.7(M+); Anal. Calcd. for C25H37NOS2: C, 69.56; H, 8.64; N, 
3.24%. Found: C, 69.89; H, 8.58; N, 3.48%. 
 
N-(3-bromophenyl)-2-(isopentylthio)-4-isopropyl-5-propylthiophene-3-
carboxamide (VBA -36): Lemon yellow solid; Rf0.69 (8:2 H-E.A); mp 82-84°C; IR 
(KBr): 3319, 3027, 2935, 2835, 1739, 1669, 1582, 1538, 1504, 1478, 1344, 1309, 
1202, 803,754, cm-1; MS m/z: 482.54(M+); Anal. Calcd. for C23H32BrNOS2: C, 57.25; 
H, 6.68; N, 2.90%. Found: C, 57.18; H, 6.73; N, 2.97%. 
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1H NMR spectrum of VBA- 27 
 
 
 
13C NMR spectrum of VBA- 27 
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13C NMR spectrum of VBA-32 
 
 
 
 
13C DEPT NMR spectrum of VBA-32 
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Chemical purity of VBA- 8 
Column: phenomenox (250X4.6),5µ, 
Injection volume:20 µL,                          
Mobile phase:H2O: Acetonitrile (30:70) premix, Diluent: Methanol 
Column Temp-30 C;Flow-1mL/min 
 
 
Pk # Retention Time Area Area % 
1 1.749 2629 0.060 
2 3.061 4376139 99.055 
3 3.403 35549 0.805 
4 5.099 3581 0.081 
Totals  4417898 100.000 
 
Chemical purity of VBA- 15 
Column: phenomenox (250X4.6), 5µ,     
Injection volume: 20 µL,                          
Mobile phase: H2O: Acetonitrile (30:70) premix; 
Diluent: Methanol , Column Temp-30 C; Flow-1mL/min. 
 
 
Pk # Retention Time Area Area % 
1 3.787 46544 0.824 
2 17.120 5525657 97.793 
3 17.920 78138 1.383 
Totals  5650339 100.000 
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CHAPTER 2 
 
SYNTHESIS AND CHARACTERIZATION OF NOVEL 
POLY SUBSTITUTED PYRAZOLES USING VARIOUS 
KETENE DITHIOACETALS. 
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                             Where R1= Aryl,                                                                                                                             
                                                 R2= Benzyl, p‐nitro benzyl. 
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2.1 INTRODUCTION   
 
 Pyrazoles are well known five member heterocyclic compounds and several 
procedures for its synthesis have been extensively studied (Figure-1). Such studies 
have been stimulated by various promising applications, especially in the case of 
highly substituted pyrazole derivatives. In fact, certain substituted pyrazoles are used 
as analgesic, anti-inflammatory, antipyretic, agrochemicals where as some others are 
being studied for their medicinal interest. The pyrazole ring system consists of a 
doubly unsaturated five member ring containing two adjacent nitrogen atoms. The 
knowledge of such applications has pointed out that trisubstituted pyrazole are 
important target to be prepared to our interest on synthesis and molecular structure 
determination of some types of pyrazole.  
 
N
H
N
 
 
Figure-1 
 
The discovery of pyrazole derivatives as antipyretic agents dates back to 1884, 
when the German chemist Ludwig Knorr1 attempted to synthesize quinoline 
derivatives with antipyretic activity and accidentally obtained antipyrine (2,3-
dimethyl-1-phenyl-3-pyrazolin-5-one), which has analgesic, antipyretic and 
antirheumatic activity. Pyrazoles is widely found as the core structure in a large 
variety of compounds that possess important agrochemical and pharmaceutical 
activities.2,3 Classical methods for the synthesis of substituted pyrazoles involve 
approaches based either on the condensations of hydrazines with 1,3-dicarbonyl 
compounds and their 1,3-dielectrophile equivalents, or on intermolecular [3+2] 
cycloadditions of 1,3-dipoles to alkynes.4,5 
 
2.2 Synthesis of functionalized pyrazole derivatives using various 
synthetic approaches.  
 
S. Cacchi, et al.6 devlopment of  strategy based on the concept of palladium-
catalyzed coupling/annulation was applied to the one-pot synthesis of a large number 
of 3-(5)aryl/vinyl-1H-pyrazole derivatives 3 from the readily available N-tosyl-N-
propargylhydrazine 1 and aryl iodides or vinyl triflates 2.5 This process allows the 
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introduction of a variety of aryl groups bearing electron-donating and electron-
withdrawing substituents (Figure-2). 
N
Ts NH2
Rx N
N
H
R
1. Pd(OAC)2 (PPh3)4,
   Et3N,THF,rt
2. PdCl2,MeCN,reflux
3. KOBut,DMF,rt
X=I,R=4-MeCOC6H4
1
2 3
 
 
Figure-2 
A [1+4] approach was developed by Santagostino et al.7 to prepare 3-(5)-
substituted pyrazoles 7 from diethoxyphosphorylacetaldehyde tosylhydrazone 4 and 
aldehydes 5 via α,β-unsaturated tosylhydrazones 6. This method is quite general in 
that the reaction conditions leave a number of functional groups unscathed; in 
addition, it can be applied to enolizable as well as unsaturated or aromatic aldehydes 
(Figure-3). 
P
OEtO
N
EtO
H
N
Ts
4 5
R H
O 2 eq NaH
THF 0 oC, rt R N
N
Ts
6
Na THF,reflux
p-TolSO2Na
N
N
H
R
7R=propenyl,styryl R=2-thienyl,4-BrC6H4
      
Figure-3 
 
The oxidation of pyrazolines is a suitable method for obtaining pyrazoles. One 
of the  most common synthetic procedures for the preparation of pyrazolines is based 
on the cycloaddition of diazoalkanes to α,β-unsaturated ketones. Silva et al.8 applied 
this approach to the synthesis of 3-benzoyl-4-styryl-2-pyrazolines 12 by treatment of 
(E,E)-cinnamylideneacetophenones 11 with diazomethane. Subsequent oxidation with 
chloranil afforded 3-(5)benzoyl-4-styrylpyrazoles 13 in good yields Figure-4. 
 
R1 R2
O
R3 R1
O
CH2N2,
CH2Cl2
(C2H5)2O N
H
N
R3R2
Chloranil,
Toluene,
reflux
R1
O
N
H
N
R3R2
R1=4CH3C6H4 R2=4CH3C6H4 R3=4CH3C6H4
11 12 13
 
 
Figure-4 
 
V. K. Aggarwal et al.9 The 1,3-dipolar cycloaddition of diazo compounds to 
triple bonds is an important [3+2] method for the preparation of pyrazoles. Thus, 
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diazo compounds 9 generated in situ from tosylhydrazones of aldehydes 8 react with 
N-vinylimidazole–an acetylene equivalent bearing a leaving group–to afford 
pyrazoles 10 in moderate yields Figure-5 
R
O
H
1.TsNHNH2,
   MeCN, rt, 3 h
2. 5M NaOH R
N
H
N N
N
50 0C, 48h
N
N
H
R
8 9 10R=Ph, 2-MeC6H4  
 
Figure-5 
 
 Junjappa H. et al.10 have demonstrated that 1-bis(methoxy)-4-bis(methylthio)-
3-buten-2-one has been to a useful three carbon synthon for efficient regiospecific 
synthesis of a variety pyrazoles with mask or unmask aldehyde functionality by 
cyclocondensation with hydrazine hydrate in alcohol (Figure-6). 
 
MeO OMe
CHO
MeS SMe Δ  / 2 h
N
N
H
SMe
OMe
MeO
EtOH,
N2H4 .H2O
 
 
Figure-6 
 
In 2005, Sakya S. M. et al.11 have offered fluoride-mediated nucleophilic 
substitution reactions of 1-(4-methylsulfonyl (or  sulfonamido)-2-pyridyl)-5-chloro-4- 
cyano pyrazoles (Figure-7) with various amines and alcohols under mild conditions. 
The further reaction of novel pyrazoles provides the 5-alkyl amino and ether 
pyrazoles in moderate to high yields. 
 
N
S O
O
HN
NH2
CF2R1
O
OEt
O
2steps N
S O
O
N
N
CF2R1R
Cl
 
 
Figure-7 
 
Junjappa H. et al.12 have developed highly efficient and regioselective 
synthesis of 1-aryl-3,4-substituted/annulated-5-(methylthio)-pyrazoles and 1-aryl-3-
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(methylthio)-4,5-substituted/ annulated pyrazoles via cyclocondensation of 
arylhydrazines with either α-oxoketene dithioacetals or α-oxodithioesters (Figure-8). 
 
R1
OR2
SMeMeS
N
N
R1 R2
SMe
Ar
a N
N
MeS R2
R1
Ar
b
MeS S
R2 O
R1
a, ArNHNH2 / t-BuOK/t-BuOH;                    b, ArNHNH2/EtOH  
 
Figure-8 
 
A novel approach to the synthesis of pyrazole derivatives from 
tosylhydrazones of α,β-unsaturated carbonyl compounds possessing a β-hydrogen was 
proposed by Rosa R. and coworkers (Figure-9),13 exploiting microwave (MW) 
activation coupled with solvent free reaction conditions. The cycloaddition was 
studied on three ketones (trans-4-phenyl-3-buten-2-one, β-ionone and trans-
chalcone). The corresponding 3,5-disubstitued-1H-pyrazoles were obtained in high 
yields and short reaction times. 
N
H
N S
Ar
O O
N N S
Ar
O O
Base
N N
N
N
HN
NH
 
 
Figure-9 
 
Tang L. et al.14 have synthesized the pyrazole analogs (Figure-10) from a 
common aryl isocyanide intermediate. The cyclization of isocyanide with the oxime 
or BOC-protected hydrazones of ethyl bromopyruvate furnished the pyrazole carboxy 
esters. 
 
N
C
N
H
Br
CO2Et
NH
a = Na2CO3, CH2Cl2, 
      rt, 24 h,
b = TFA, 1 h, HN N
HN
CO2Et
 
 
Figure-10 
 
Kim J. N. et al.15 have reported the regio-selective synthesis of 1,3,4,5-
tetrasubstituted pyrazole derivatives from the reaction of Baylis-Hillman adducts of 
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alkyl vinyl ketone and hydrazine derivatives (Figure-11). During the continuous 
studies on the chemical transformations of Baylis-Hillman adducts including the 
synthesis of pyrazole. 
 
O
Ph
O
COOMe PhNHNH2•HCl
ClCH2CH2Cl
 reflux, 48 h N
N
Ph
PhMeOOC
 
 
Figure-11 
 
Elgemeie G. H. et al.16 were readily prepared novel ketene N,S-acetals by the 
reaction of cyanoacetamide or cyanothioacetamide with phenylisothiocyanate in the 
presence of potassium hydroxide, followed by alkylation of the produced salts with 
methyl iodide. Further, the reaction of ketene N,S-acetals with hydrazine afforded 
different substituted pyrazoles in excellent yields (Figure-12). 
 
NH2
X
CN
NHH3CS
Ph
NH2NHR
N
N
R
HN PhH2N
X
H2N
R= Me, Ph
X= O, S
EtOH
 
 
Figure-12 
 
Kuettel S. et al.17 have synthesized 4-(3-phenylisoxazol-5-yl)morpholine 
derrivatives (Figure-13) using ketene dithioacetals. The reaction of substituted 
acetophenones with carbon disulfide in the presence of base and followed by 
alkylation with methyl iodide afforded 4-phenoxyphenyl-2,2- bis(methylthio) ketones 
vinyl, which were further reacts with hydrazine hydrate to give substituted pyrazoles 
through in situ cyclization of the resulting N,S-acetals. 
 
Ph
O
S S XHN
X=O
X= N-Boc
Ph
N
H
NN
X
N2H4H2O
 
 
Figure-13 
 
Recently, Dong D. and coworkers18 have developed an efficient and divergent 
synthesis of fully substituted 1H-pyrazoles using cyclopropyl oximes (Figure-14). 
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Under Vilsmeier conditions (POCl3/DMF), substituted 1H-pyrazoles were synthesized 
from 1-carbamoyl, 1-oximyl cyclopropanes via sequential ring-opening, 
chlorovinylation, and intramolecular aza-cyclization. 
 
Ar
N
N
RClH2CH2C
Cl
POCl3/DMF
38-56 %
R
N O
NHAr
OH
 
 
Figure-14 
 
? Reported synthetic approaches pyrazoles 
Kurz T. et al.19 have synthesized novel fluorinated ketene N,S-acetals by the 
reaction of fluoro substituted cyanoacetamide derivatives with aryl isothiocyanate in 
the presence of potassium hydroxide, followed by the alkylation with methyl iodide. 
The reaction of fluorinated ketene N,S-acetals with hydrazine afforded different fluoro 
substituted pyrazole derivatives in good yield (Figure-15). 
HN
O
N
H
N
HN
H2N
NH2NH2H
N NH
SCH3O
CN
F
F
X
X
X= H, 2-F, 4-F, 4-Cl
EtOH
 
 
Figure-15 
 
Elgemeie G. H. et al.20 synthesized  variety of novel α-cyanoketene S,S-
acetals, readily prepared by the reaction of cyanoacetanilide or cyanothioacetamide 
with carbon disulfide, followed by alkylation, react smoothly with nucleophile to 
afford variously substituted methylthio derivatives of pyrazole (Figure-16). 
 
NC
SMeMeS
S
NH2 RNHNH2, 
EtOH
N
N
SMe
O
H2N
H2N
RR= H, Ph  
 
Figure-16 
 
? Synthesis of functionalized pyrazoles using combinatorial chemistry 
approach. 
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In recent decades, combinatorial chemistry tools have enabled the rapid 
synthesis of a large number of heterocyclic small molecule libraries and it is 
recognized now as a key element of early drug discovery21. The main advantage of 
the combinatorial technique is the speed at which diverse types of organic compounds 
can be synthesized, formulated, and tested for a particular application. Moreover, in 
combinatorial study the quantity of required material is less in comparison to 
conventional methods, which makes it more suitable when the materials are 
expensive22. 
Organ M. G. et al.23 have developed a library of 4-(5-Iodo-3-Methyl 
pyrazolyl) Phenyl- sulfonamide derivatives (Figure-17) via solution-phase Suzuki 
coupling using Pd/C as a solid-supported catalyst. 
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Figure-17 
Ivachtchenko A. V. et al.24 have reported the parallel solution-phase approach 
of more than 2200 7-trifluoromethyl-substituted pyrazole[1,5-a]pyrimidine (Figure-
18) and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine carboxamides on a 50-100-mg 
scale. The reactions were include assembly of the pyrazole[1,5-a]pyrimidine ring by 
condensation of 5-aminopyrazole derivatives with the corresponding trifluoromethyl-
α-diketones. libraries were then obtained in good yields and purities using solution-
phase acylation and reduction methodologies. Simple manual techniques for parallel 
reactions using special CombiSyn synthesizers were coupled with easy purification 
procedures (crystallization from the reaction mixtures) to give high-purity final 
products.  
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Figure-18 
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Yang H. Z. et al.25 have developed a small combinatorial library containing 
pyrazolyl- pyrazoles and pyrazole[1,5-a]pyrimidines (Figure-19) by traditional 
organic synthesis and parallel-liquid-phase combinatorial synthesis using α-S,S-acetal 
of ethyl cyanoacetate as key synthon and hydrazine hydrate. 
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Figure-19 
 
Recently, Laufer, S. et al.26 have synthesized structurally diverse and 
medicinally interesting series of 1, 4-dihydropyrano[2,3-c]pyrazoles via a three-
component reaction using solution phase synthesis in excellent yields (Figure-20). 
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Figure-20 
 
In 2009, Laborde E. et al.27 have developed an efficient three-component, two-
step “catch and release” solid-phase synthesis of 3,4,5-trisubstituted pyrazoles 
(Figure-21). The reaction involves a base-promoted condensation of a 2-sulfonyl 
acetonitrile derivative 1 with an isothiocyanate 2 and in situ immobilization of the 
resulting thiolate anion 3 on Merrifield resin. Reaction of the resin-bound sulfonyl 
intermediate 4 with hydrazine, followed by release from the resin and intramoleculer 
cyclization, afforded 3,5-diamino-4-(arylsulfonyl)-1H-pyrazoles 5. However, this 
methodology has some drawback such as; long reaction time, isolation of product and 
high reaction temperature.  
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Taddei M. et al.28 have developed the libraries of substituted pyrazole through 
in situ generation of polymer-bound enaminones (Figure-22). The synthetic protocol 
makes use of commercially available aniline cellulose, a low-cost and versatile 
biopolymer, under very mild conditions. This new support allowed carrying out 
reactions in polar solvents under both conventional heating and MW irradiation 
without degradation of the polymer. The reaction between cellulose-bound 
enaminones and hydrazine to afford the target heterocycles in high yields directly in 
solution is the key step. The support can be conveniently recycled. 
 
R
O
H
N
N
O
Et
Et NH2NHPh
NH2
N
N
H
N
O
Et
Et
iPrOH, 1 h, reflux R
R= Me, iPr, PhCH2  
 
Figure-22 
 
? Various N-substituted Pyrazoles synthetic approach 
Stephen R. Grahams. et al.29 have described and scalable process for the 
preparation of 4-amino-1,3-dimethylpyrazole hydrochloride 1. Compound 1 was a 
useful starting material; its preparation is achieved via a three-step sequence from 
methyl hydrazine and technical grade acetaldehyde dimethylacetal. The target 
molecule is isolated in high chemical and isomeric purity (>99.0% with respect to 4-
amino-1,5-dimethylpyrazole) (Figure-23). 
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Figure-23 
 
Xiao-Ling Ding et al.30 have developed a series of novel 3-aryl-1-arylmethyl-
1H-pyrazole-5-carboxamide derivatives 3a–i, by the reaction of 3-aryl-1-arylmethyl-
1H-pyrazole-5-carbonyl chloride with substituted amine in excellent yields. The 
compounds 3e–h could suppress A549 lung cancer cell growth. More interestingly, 
compounds 3e and 3f might inhibit the A549 cell growth by inducing apoptosis; 
whereas compounds 3g and 3h with fluorine group might inhibit the A549 cell growth 
by inducing autophagy (Figure-24). 
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Anumula Raghupathi Reddy et al.31 have an improved, scalable and 
commercially viable process developed for an active pharmaceutical ingredient, 
celecoxib (Figure-25). 
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Figure-25 
Christina Despotopoulou, Lydia Klier, and Paul Knochel.32 have reported full 
functionalization of the pyrazole ring  achieved by successive regioselective 
metalations using  MPMgCl·LiCl33 and TMP2Mg·2LiCl. Trapping with various 
electrophiles led to trisubstituted pyrazoles. An application to the synthesis of the 
acaricide Tebufenpyrad was reported (figure-26) 
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Figure-26 
Hee Jeong Seo et al.34 have been engaged in searching for novel CB1 receptor 
antagonists, since SR141716A (rimonabant), a CB1 receptor antagonist, proved to be 
efficacious in human for the treatment of obesity. In the present study, a series of 
1,2,4-triazole-containing diarylpyrazolyl carboxamides based on the 1,5-
diarylpyrazole template of rimonabant, was synthesized and tested for CB1 receptor 
binding affinity. The structure–activity relationship studies demonstrated that 
incorporation of 1,2,4-triazole ring onto the pyrazole scaffold via a methylene linker 
led to a significant improvement for CB1 receptor binding affinity. Importantly, these 
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analogues also exhibited excellent selectivity for CB1 receptor over CB2 receptor 
(Figure-27).  
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Figure-27 
 
 
2.3 Biological activity of various substituted pyrazoles.  
 Pyrazole derivatives possessed diverse biological activities such as 
antihyperglycemic, analgesic, anti-inflammatory, antipyretic, antibacterial, and 
sedative-hypnotic activity, cyclooxygenase-2 (Cox-2) inhibitors, IL-1 synthesis 
inhibitors, protein kinase inhibitors, as well as useful activities in conditions like 
schizophrenia, hypertension, and Alzheimer’s disease.35 In addition, they also have 
agrochemical properties including herbicidal and soil fungicidal activity; thus, they 
have been used as pesticides and insecticides36 which are described briefly as follows.  
 
        Anti-inflammatory preparations are widely used in the modern clinic, as 
pathogenetic agents in the treatment of many illnesses and pathological processes, 
alone or more frequently in combination with other drugs. However many of the 
known anti-inflammatory agents cause a range of side phenomena and complications 
in addition to the main effect. Consequently the search for and study of new more 
active anti-inflammatory agents37 of low toxicity is one of the urgent problems of 
contemporary science (Figure-28). 
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Figure-28 
 
Tanitame A. et al.38 have synthesized pyrazole derivatives possesses 
antibacterial activity and inhibitory activity against DNA gyrase and topoisomerase 
IV. They have synthesized new pyrazole derivatives and found that 5-[(E)-2-(5-
chloroindol-3-yl)vinyl]pyrazole (Figure-29) possesses potent antibacterial activity 
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and selective inhibitory activity against bacterial topoisomerases. Many of the 
synthesized pyrazole derivatives were potent against clinically isolated quinolone 
coumarin-resistant Gram-positive strains and had minimal inhibitory concentration 
values against these strains equivalent to those against susceptible strains. 
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Figure-29 
 
In 2004, Edwards P. J. et al.39 have synthesized numerous highly 
functionalized pyrazole derivatives (Figure-30) using various diketone and 
substituted hydrazine hydrate and screened for HIV mediated diseases. Among them 
such compounds were found to useful in the treatment of a variety of disorders 
including those in which the inhibition of reverse transcriptase is implicated. 
Disorders of interest include those caused by HIV and genetically related retroviruses, 
such as AIDS. 
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Figure-30 
 
Bagley M. C. and co workers40 have synthesized substituted N-pyrazole urea 
under the microwave irradiation. The reaction of substituted hydrazines and β-
ketoesters afforded 5-aminopyrazoles in excellent yield, which can be transformed to 
the corresponding N-carbonyl derivatives by treatment with an isocyanate or 
chloroformate. Derivatization of 4-nitronaphth-1-ol using predominantly microwave 
heating methods and reaction with an N-pyrazole carbamate provides a rapid route to 
the N-pyrazole urea BIRB 796 (Figure-31) in high purity, as a potent and selective 
inhibitor of p38a mitogen-activated protein kinase for the study of accelerated ageing 
in Werner syndrome cells. 
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Piscitelli et al.41 new 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 
were synthesized as cannabinoid (CB) receptor ligands. Compound 11 (CB1 Ki¼ 2.3 
nM, CB1 SI ¼ 163.6) showed CB1 receptor affinity and selectivity superior to 
Rimonabant and AM251. Acute administration of 2 mg/kg 11 reduced sucrose, but 
not regular food, intake in rats. On the other hand, compound 23 (CB2 Ki¼ 0.51 nM, 
CB2 SI ¼ 30.0) showed significant affinity and selectivity for the CB2 receptor. The 
results presented here show that the1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-
carboxamide may serve as an effective scaffold for the design of either CB1 or CB2 
receptor ligands. This partial divergence between the in vitro data (suggesting that 11 
has more affinity than 1 at the CB1 receptor binding) and the in vivo data (in which 1 
appears to be more potent and effective than 11) may be due to presently unexplored 
differences in the pharmacokinetic profile (e.g., rate and extend of absorption, 
distribution, passage through the elucidation of the structural determinants for the 
CB1 versusCB2 selectivity and the pharmacological characterization of this class of 
CB receptor ligand are warranted (Figure-32). 
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? Biologically active molecules containing alkyl and carboxamide functional 
groups  
Pyrazoles bearing sulfones and carboxamide moieties demonstrated to have 
significant pharmacological applications which are discussed as under. 
 
The role of the cyclooxygenase-2 isoform in inflammation42 and the 
attractiveness of COX-2 as a therapeutic target for the development of anti-
inflammatory drugs are very well recognized.43 COX-2 selective inhibitors have 
proven to be effective anti-inflammatory and analgesic medicines with lower chronic 
gastrointestinal (GI) toxicity than traditional non-steroidal anti-inflammatory drugs 
(NSAIDs), which non-selectively inhibit COX-2 and COX-1. Prostaglandin (PG)-
dependent and PG-independent factors are responsible for NSAID induced GI 
toxicity. Decreased PG production due to COX-1 inhibition may adversely affect 
mucus-bicarbonate secretion, acid secretion, and mucosal blood flow. COX inhibition 
may also elicit an increase in 5-lipoxygenase activity that would potentiate production 
of leukotriene-B4 and vasoconstrictor peptido-leukotrienes by the lipoxygenase 
pathway, and this may also contribute to the vascular and other mucosal damage 
induced by NSAIDs44 Celecoxib (Figure-33) is one of the COX-2 selective inhibitors 
and are currently prescribed for the treatment of arthritis and inflammatory diseases. 
They show anti-inflammatory activity with reduced GI side effects. 
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Figure-33 
 
The identification of several potent pyrazole-based inhibitors of bacterial 
dihydroorotate dehydrogenase (DHODase) via a directed parallel synthetic approach 
is described below (Figure-34). The initial pyrazole-containing lead compounds were 
optimized for potency against Helicobacter pylori DHODase.45 Using three successive 
focused libraries, inhibitors were rapidly identified with the following characteristics: 
Ki<10 µM against H. pylori DHODase, sub-µg/mL H. pylori minimum inhibitory 
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concentration activity, low molecular weight, and >10 000-fold selectivity over 
human DHODase. DHODase is an enzyme that catalyzes the fourth step in the de 
novo biosynthesis of pyrimidine. It converts dihydroorotate to orotate. The anti-
inflammatory drug leflunomide has been shown to inhibit DHODH. 
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Figure-34 
 
P. K. Sasmal et al.46 describes the synthesis and biological evaluation of novel 
pyrazole-3-carboxamide derivatives as CB1 antagonists (Figure-35). As a part of 
eastern amide SAR, various chemically diverse motifs were introduced. In general, a 
range of modifications were well tolerated. Several molecules with high polar surface 
area were also indentified as potent CB1 receptor antagonists. The in vivo proof of 
principle for weight loss is exemplified with a lead compound from this series. 
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Figure-35 
 
In addition, Bonacorso H. G. et al.47 have synthesized some novel N-
substituted pyrazoles containing sulfone and trifluoromethyl groups at N and C5 
position of pyrazole ring (Figure-36) and evaluated for antimicrobial activity. All the 
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synthesized compounds were shown promising antimicrobial activity. The best 
activity was obtained when the structure possessed a 4-fluorophenyl substituent linked 
at the carbon-3 of the pyrazoline ring. 
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Figure-36 
 
R.V. Ragavan et al.48 have synthesized novel 1,5-diaryl pyrazole derivatives 
viz. 5-(4-chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazole-3-carboxamides,2-(5-(4-
chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazole-3-yl)thiazoles by varying the active 
part (amide group) of pyrazole, characterized using IR, 1H NMR, mass spectral data 
and screened for their antibacterial activity against Escherichia coli (ATTC- 25922), 
Staphylococcus aureus (ATTC-25923), Pseudomonas aeruginosa (ATTC-27853), 
Klebsiella pneumonia. Similarly all these compounds were screened for their 
antifungal activity against Aspergillus flavus (NCIM No. 524), Aspergillus fumigates 
(NCIM No. 902), Penicillium marneffei and Trichophyton mentagrophytes (Figure-
37).  
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Figure-37 
 
Stephen Brand et al.49 have  repoted N-Myristoyltransferase (NMT) represents 
a promising drug target for human African trypanosomiasis (HAT),which was caused 
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  76 
by the parasitic protozoa Trypanosoma brucei. We report the optimization of a high 
throughput screening hit (1) to give a lead molecule DDD85646 (63), which has 
potent activity against the enzyme (IC50 = 2 µM) and T. brucei (EC50 =2 µM) in 
culture. The compound has good oral pharmacokinetics and cures rodent models of 
peripheral HAT infection. Thiscompound provides an excellent tool for validation of 
T. brucei NMT as a drug target for HAT as well as a valuable lead for further 
optimization (Figure-38). 
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Helicobacter pylori is a Gram-negative microaerophilic bacterium that infects 
up to 50% of the world’s human population.50 H. pylori resides in the acidic 
surroundings of the stomach, utilizing a high urease enzyme activity to provide a 
locally alkaline environment. H. pylori has been implicated in numerous 
gastrointestinal disorders and is associated with gastric ulcers, gastritis, and gastric 
cancer.51 The current treatment of H. pylori infections typically utilizes a multiple 
drug therapy involving at least one broad spectrum antibiotic (antimicrobial therapy) 
and a proton pump inhibitor (antisecretory therapy). However, a H. pylori specific 
antimicrobial would be very desirable; a specific agent should avoid many of the 
negative gastrointestinal side effects associated with a broad spectrum antibacterial 
resulting from eradication of the normal gastrointestinal flora. 
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2.4 Aim of Current research work 
 
 The pyrazole nucleus is present in a wide variety of biologically  interesting 
compounds, which exhibit antihyperglycemic, analgesic, anti-inflammatory, 
antipyretic, antibacterial, hypoglycemic, sedative-hypnotic activities42-46. As described 
above, the tremendous biological potential of the sulfone group and carboxamide 
group bearing pyrazole scaffolds have attracted many chemists to synthesize this class 
of molecules. Thus, continuous efforts have been devoted to the development of more 
general and versatile synthetic methodologies to this class of compounds. Many 
research groups have been synthesized pyrazole derivatives using various methods. 
However, the existing methods suffered with some drawbacks such as; long reaction 
time, product isolation, etc. Thus, the practical synthesis of structurally diverse 
pyrazole based small molecules is of great significance. 
 
Nowadays, a great deal of effort has been focused on the field of green 
chemistry in adopting methods and processes. As a part of this “green” concept, toxic 
and/or flammable organic solvents are replaced by alternative non-toxic and 
nonflammable media. In this context, many efforts have been made to use aqueous 
media. Among alternative green solvents, water has been the solvent of choice for a 
variety of transformations. On the other hand; functionalized ketene dithioacetals are 
versatile intermediates in organic synthesis for the construction of substituted 
heterocycles. Given the importance of N-substituted and carboxamide group 
containing pyrazoles and our ongoing interest on the synthesis various bioactive 
heterocycles using novel ketene dithioacetals starting from starting from 
acetoacetanilides encouraged us to utilized these ketene dithioacetals for the 
construction of small molecule library of 3-methyl-5-(methylthio)-N-benzyl-1H-
pyrazole-4-carboxamidederivatives in aqueous medium. The newly synthesized 
compounds were characterized by IR, Mass, 1H NMR, 13C NMR spectroscopy and 
elemental analysis. The antiviral screening of the synthesized compounds are under 
process.  
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2.5 Results and discussion 
Route of Synthesis for novel substituted Pyrazoles derivatives using versatile 
intermediate as ketene dithioacetals. 
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Where R= -CH3,-OCH3, -Cl, -Br, -F and R1= -H, -NO2 
 
  
Preparation of the target compounds was initiated by the reaction of (1) with 
aryl amines (2) in toluene at reflux temperature to afford the acetoacetanilide (3) in 
85-90% yields (Scheme-1). This product undergoes reaction with carbon disulfide in 
the presence of base in DMF followed by methylation to afford corresponding 2-
(bis(methylthio)methylene)-3-oxo-N-phenylbutanamide (4). Which on reaction with 
hydrazine hydrate undergoes cyclization to form 3-methyl-5-(methylthio)-N-aryl-1H-
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  79 
pyrazole-4-carboxamide (6). Eleven different acetoacetanilide were synthesized 
bearing various electron donating and electron withdrawing groups such as 2,3-
diCH3; 3,4-diCH3; 4-CH3; H; 2,5-diCH3; 2,4-diCH3; 3-Cl-4-F; 4-F; 4-Cl; 2-Cl; 2-F; 4-
OCH3; 2,5-diCl and 3-NO2 on the phenyl ring. Thus, it has been found that reaction of 
substituted acetoacetanilide 3a-k derivatives with carbon disulfide in the presence of 
potassium carbonate followed by the Hydrazine hydrate (99%), (80-20%) with 
alkyl/aryl halide (7-9) (Scheme-2-5) gave the novel Pyrazoles 8a-k and 10a-k. 
 
The structures of compound VBA-10a were established on the basis of their 
elemental analysis and spectral data (MS, IR, and 1H NMR (400 MHz, CDCl3)). The 
analytical data for 10a revealed a molecular formula C19H18N4O3S (m/z 382). The 1H 
NMR spectrum revealed one singlet at δH= 2.25ppm assigned to 3 protons of (-CH3) 
group of methyl, a singlet at δH= 2.59-2.61ppm assigned to 3 protons of (-SCH3) 
group of methyl, a singlet at δH= 5.43ppm  assigned to 1 protons of (-ArCH2-) group 
of methylene, a singlet at δH= 5.62ppm  assigned to 1 protons of (-ArCH2) group of 
methylene, a triplet at δH= 7.13-7.30ppm  assigned to 3 proton of (-Ar-H) group, one 
doublet at δH = 7.36-7.39ppm assigned to Ar-NO2(2H),one doublet at δH= 7.64-
7.66ppm assigned to Ar-H (2H),one doublet at δH= 8.21-8.23ppm assigned to 
ArHNO2 (2H) one singlet at δH= 9.33-9.37ppm assigned to –ArCONH groups . 
 
The structures of compound VBA-10i were established on the basis of their 
elemental analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 
10i revealed a molecular formula C20H20N4O4S (m/z 412). The 1H NMR spectrum 
revealed one singlet at δH= 2.25 ppm assigned to 3 protons of (-CH3,-) one triplet at 
δH= 2.57-2.61 ppm assigned to 3 protons of (-SCH3) group of methyl, a singlet at δH= 
3.85ppm  assigned to 3 protons of (-CH3) group of methyl, a singlet at δH= 5.43ppm  
assigned to 1 protons of (-ArCH2-) group of methylene, a singlet at δH= 5.62ppm  
assigned to 1 protons of (-ArCH2) group of methylene, a doublet at δH= 6.89-6.93ppm  
assigned to 2 proton of   (-Ar-H) group, one multiplet at δH = 7.37-7.40ppm assigned 
to Ar-HNO2 (2H), one doublet at δH=7.53-7.57ppm assigned to 2 proton of   Ar-H 
(2H), one doublet at δH=8.21-8.24ppm assigned to 2 proton of   Ar-H (2H), one singlet 
at δH= 9.32-9.38 ppm assigned to –ArCONH groups .  
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Table:1- benzyl-3-methyl-5-(methylthio)4-carboxamide functionalized library of 
N-substituted-1H-pyrazole. 
Entry R R1 Yield % Time h. 
VBA -8a C6H5 C6H5CH2- 90 10-12 
VBA-8b 4-ClC6H4 C6H5CH2- 88 8-9 
VBA-8c 3-ClC6H4 C6H5CH2- 84 8-10 
VBA-8d 4-BrC6H4 C6H5CH2- 88 6-8 
VBA-8e 4-FC6H4 C6H5CH2- 86 6-8 
VBA-8f 3,4Cl2C6H3 C6H5CH2- 88 6-8 
VBA-8g 3-Cl,4-F,C6H3 C6H5CH2- 88 6-8 
VBA-8h 4-CH3-C6H4 C6H5CH2- 82 5-7 
VBA-8i 4-OCH3-C6H4 C6H5CH2- 82 5-7 
VBA-8j 3,4-(CH3)2C6H3 C6H5CH2- 84 5-7 
VBA-8k 3-CH3C6H3 C6H5CH2- 80 4-6 
VBA-10a C6H5 4-NO2C6H4CH2- 82 10-12 
VBA-10b 4-ClC6H4 4-NO2C6H4CH2- 84 6-8 
VBA-10c 3-ClC6H4 4-NO2C6H4CH2- 80 6-8 
VBA-10d 4-BrC6H4 4-NO2C6H4CH2- 82 6-8 
VBA-10e 4-FC6H4 4-NO2C6H4CH2- 80 6-8 
VBA-10f 3,4Cl2C6H3 4-NO2C6H4CH2- 78 4-6 
VBA-10g 3-Cl,4-F,C6H3 4-NO2C6H4CH2- 80 4-6 
VBA-10h 4-CH3-C6H4 4-NO2C6H4CH2- 78 5-7 
VBA-10i 4-OCH3-C6H4 4-NO2C6H4CH2- 76 5-7 
VBA-10j 3,4-(CH3)2C6H3 4-NO2C6H4CH2- 74 4-6 
VBA-10k 3-CH3C6H3 4-NO2C6H4CH2- 72 5-7 
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Figure 39: Proposed mechanism for the formation of pyrazole. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  82 
2.6  Biological activity 
 
EXPERIMENTAL 
The solvent DMSO was also purified before use by standard method (37). All 
the synthesized compounds were recrystallized prior to use. For all the compounds, 
agar well diffusion method was used. 
Test Microorganisms: 
The synthesized compounds were tested for its antimicrobial susceptibility 
activity against two Gram positive bacteria Micrococcus luteus MTCC 106 and 
Bacillus circulans MTCC1197 and two Gram negative bacteria Escharichia coli 
MTCC729 and pseudomonas aeruginosa MTCC 4676. Microorganisms were 
obtained from Microbial Type Culture Collection and Gene Bank, Chandigarh, India 
and were maintained at 37°C on nutrient agar slants. 
Preparation of test compounds: 
The solutions were prepared at a concentration of 1 mg/mL (Stock Solution) 
and further diluted to 0.1 mg/mL and 0.05 mg/mL for all the compounds. 
Preparation of the plates and microbiological assay: 
The antibacterial evaluation was done by agar well diffusion method (38, 39) 
using Mueller Hinton Agar No.2 as the nutrient medium. The agar well diffusion 
method was preferred to be used in this study because it was found to be better than 
the disc diffusion method (39). The bacterial strains were activated by inoculating a 
loop full of test strain in 25 mL of N-broth and the same was incubated for 24 h in an 
incubator at 37ºC. 0.2 mL of the activated strain was inoculated in Mueller Hinton 
Agar. Mueller Hinton Agar kept at 45ºC was then poured in the Petri dishes and 
allowed to solidify. After solidification of the media, 0.85 cm ditch was made in the 
plates using a sterile cork borer and these were completely filled with the test 
solution. The plates were incubated for 24 h at 37ºC. The mean value obtained for the 
three wells was used to calculate the zone of growth inhibition of each sample. The 
controls were maintained for each bacterial strain and each solvent. The inhibition 
zone formed by these compounds against the particular test bacterial strain 
determined the antibacterial activities of these synthesized compounds. 
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Table 3: Biological Activity Result for Active compounds as following. 
 
Compound 
Code 
Bacterial strain  
E. coli P aurogenosa B. Circulance M Luteus 
50 µ 
/gm 
100    
µ 
/gm 
1000 
µ 
/gm 
50 µ 
/gm 
100    
µ 
/gm 
1000 
µ /gm 
50 µ 
/gm 
100    
µ 
/gm 
1000 
µ /gm 
50 µ 
/gm 
100    
µ 
/gm 
1000 
µ /gm 
VBA 8a - - - - - 4 - - - - 6   
VBA8d - - - - - 3 - - - - - - 
VBA 8e - - - - -   - - 2 - 4 6 
VBA 8g - - - 6 - - - - - - - - 
VBA 8h - - - - - 3 - - - - - 6 
VBA 10a - - - - 2 4 - 3 6 - 2 4 
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2.7 CONCLUSION 
 
In summary, we reported a facile synthesis of highly substituted pyrazoles 
VBA 8a-k and 10a-k having N-alkylated with benzyl chloride/p-nitro benzyl bromide 
was first investigated under a variety of reaction conditions. Best results were 
obtained when the reaction was conducted in the presence of K2CO3, KI, 
TBAB/TEAB in H2O DMF and acetonitrile furnishing only one N-phenyl-1H-
pyrazole VBA 8a-k and 10a-k in high yield (Table 1, entry 1). The structure of VBA 
8a-k and 10a-k was established on the basis of its reported physical and spectral data. 
Out of 22 compounds screened for antimicrobial susceptibility assay 6 compounds 
shown positive activity against microbs and result shown in table 3. No compounds 
have shown activity against E-coli MTCC 729. 
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2.8 EXPERIMENTAL SECTION 
 
Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZU FTIR 8400 
instrument by using DRS prob. 1H (400 MHz) and 13C(100 MHz) NMR spectra were 
recorded on a Bruker AVANCE II spectrometer in CDCl3and DMSO.13C NMR were 
recorded on 100 MHz spectrometer, referred to the internal solvent signals (77.0 for 
CDCl3 or 40.0 for DMSO). Chemical shifts are expressed in δ ppm downfield from 
TMS as an internal standard. Mass spectra were determined using direct inlet probe 
on a SHIMADZUGCMS-QP 2010 mass spectrometer. Solvents were evaporated with 
a BUCHI rotary evaporator. Melting points were measured in open capillaries and are 
uncorrected. The chemicals used in this work were purchased from Merck, 
Spectrochem and sisco Chemical Companies. 
 
? General synthesis of 3-oxo-N-arylbutanamide 2a-t. 
            A mixture containing the primary amine (10 mmol), Ethyl acetoacetate (10 
mmol), and catalytic amount of sodium or potassium hydroxide (10 %) was refluxed 
at 110oC for the approximately 15-20 h. The reaction was monitored by TLC. After 
completion of reaction, the solvent was removed under vaccuo when the reaction was 
completed. The solid or oil was crystallized from methanol to give pure product 2a-t. 
 
? General synthesis of ketene dithioacetals 3a-t. 
           A 100mL conical flask equipped with magnetic stirrer and septum was charged 
with a solution of 3-oxo-N-p-tolylbutanamide 2a-t, (10 mmol) in DMF (10 ml). Dried 
K2CO3 (10 mmol) was added and the mixture was stirred for 2 h at room temperature. 
Then CS2 (30 mmol) was added and stirred for 2 h at room temperature. Then Methyl 
iodide (20 mmol) was added dropwise at 0-5oC during 30 min and the mixtures was 
stirred for 1 h at 0-5oC and allow to come at room temperature and stirred for 4 h. 
After completion of the reaction, the reaction mix was poured it in to ice cold water. 
The precipitated crude product was purified by filtration followed by crystallization 
from EtOH. In case of crude obtained as oil, the product was extracted with Et2O. The 
combined organic extracts were washed with H2O (2 × 10 mL), dried (MgSO4), and 
concentrated in vaccuo to afford ketene dithioacetals directly used for the next step. 
 
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  86 
? General procedure for the synthesis of trisubstituted pyrazoles 6a-w. 
To a suspension of various α-acylketenedithioacetals 1a-w (10 mmol) in water 
(25 mL), hydrazine hydrate 80% (20 mmol) was added and the reaction mixture was 
refluxed for appropriate time (Table 2) with constant stirring. After completion of the 
reaction, the reaction mixtures were cooled to room temperature and add cold water 
(50 mL). The separated solid was filtered, washed with water (2 × 50 mL), dried and 
crystallized from methanol to afford analytically pure products which were used for 
next step without further purification. 
 
? General procedure for the synthesis of N-substituted pyrazoles VBA 8a-k and 
10a-k 
To a solution of (0.006mol) trisubstitutedpyrazoles6 dissolved in 30mL 
acetonitrile/ DMF was added (0.012 mol) of potassium carbonate and (0.0006 mol) 
potassium iodide, (0.0006 mol) TBAB/ TEAB and the mixture was stirred at room 
temperature for 30 min. To this mixture was then added (0.006 mol) of 4-nitro benzyl 
bromide dissolved in 20mL acetonitrile or benzyl chloride dissolved in 20mL DMF, 
in a dropwise manner over a period of 15 min and the mixture was stirred at room 
temperature for 12-14 h. The reaction was monitored by TLC. The reaction was 
completed than poured into crushed ice or solvent was evaporate. The product was 
obtained as white/yellow amorphous powder. The product was purified by 
Hexane/ether. The structures of compounds synthesized by this method are given in 
Table 2. 
 
? Spectral data of the synthesized compounds VBA 8a-j and VBA 10a-j 
 
1-benzyl-3-methyl-5-(methylthio)-N-phenyl-1H-pyrazole-4-carboxamide (VBA-
8a): 
White solid; Rf  0.46 (7:3 H-E.A); mp 241-243°C; IR (KBr): 3315, 2982, 2854, 1651, 
1645, 1589, 1545, 1532, 1510, 1477, 1385, 1253, 744, 651, cm-1; 1H NMR: (400 
MHz, DMSO)  δH2.27 (s, 3H, -CH3), 2.47 (s, 3H, -SCH3,), 5.34 (s, 1H, -ArCH2-), 
5.46 (s, 1H, -ArCH2-), 7.02-7.08 (dd, 1H J=24.0Hz, Ar-H), 7.20-7.22 (t, 3H, Ar-H), 
7.24-7.30 (m, 2H, Ar-H), 7.33-7.37 (m, 2H, Ar-H), 7.62-7.64 (d, 1H J=8.0Hz, Ar-H), 
7.67-7.69 (d, 1H J=8.0Hz, Ar-H), 9.56 (s, 1H, -ArCONH); 13C NMR: (100MHz, 
DMSO) δC 10.67, 13.20, 14.91, 19.47, 52.23, 52.33, 115.14, 119.40, 119.50, 119.99, 
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123.14, 123.28, 126.98, 127.32, 127.50, 128.40, 128.43,  128.50, 134.22, 136.42, 
136.89, 138.93, 141.48, 144.73, 147.91, 161.45; MS m/z: 337.4(M+); Anal. Calcd. for 
C19H19N3OS: C, 67.63; H, 5.68; N, 12.45%. Found: C, 66.58; H, 5.62; N, 12.47%. 
 
1-benzyl-N-(4-chlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8b): White solid; Rf0.52 (7:3 H-E.A); mp 220-222°C; IR (KBr): 
3306, 2975, 2845, 1651, 1645, 1589, 1554, 1536, 1514, 1477, 1385, 1253, 815, 749, 
665, cm-1; MS m/z: 371.9(M+); Anal. Calcd. for C19H18ClN3OS: C, 61.36; H, 4.88; N, 
11.30%. Found: C, 61.29; H, 4.79; N, 11.25%. 
 
1-benzyl-N-(3-chlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8c): White solid; Rf 0.50 (7:3 H-E.A); mp 255-257°C; IR (KBr): 
3312, 2992, 2862, 1651, 1647, 1589, 1550, 1530, 1514, 1477, 1375, 1255, 754, 641, 
cm-1; MS m/z: 371.9(M+); Anal. Calcd. for C19H18ClN3OS: C, 61.36; H, 4.88; N, 
11.30%. Found: C, 61.39; H, 4.86; N, 11.29%. 
 
1-benzyl-N-(4-bromophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8d): White solid; Rf 0.53 (7:3 H-E.A); mp 268-270°C; IR (KBr): 
3309, 2978, 2864, 1651, 1643, 1589, 1545, 1529, 1510, 1477, 1383, 1253, 813, 762, 
644, cm-1; MS m/z: 416.3(M+); Anal. Calcd. for C19H18BrN3OS: C, 54.81; H, 4.36; N, 
10.09%. Found: C, 54.77; H, 4.27; N, 10.05%. 
 
1-benzyl-N-(4-fluorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8e): White solid; Rf 0.54 (7:3 H-E.A); mp 200-202°C; IR (KBr): 
3305, 2954, 2858, 1651, 1643, 1592, 1547, 1524, 1510, 1477, 1387, 1249, 815, 744, 
667, cm-1; 1H NMR: (400 MHz, DMSO) δH 2.26 (s, 3H, -CH3), 2.48 (s, 3H, -SCH3), 
5.33 (s, 1H, -ArCH2-), 5.46 (s, 1H, -ArCH2-), 7.03-7.09 (dd, 2H J=24.0Hz, Ar-H), 
7.20-7.22(t, 1H, Ar-H), 7.21-7.30 (m, 2H, Ar-H), 7.33-7.36 (m, 2H, Ar-H), 7.63-7.72 
(m, 2H, Ar-H), 9.56 (s, 1H, -ArCONH); 13C NMR: (100MHz, DMSO) δC 10.66, 
13.18, 14.93, 19.47, 52.25, 52.38, 114.78, 114.86, 115.00, 115.08, 119.87, 121.11, 
121.19, 121.21, 121.29, 126.95, 127.31, 127.49, 128.37, 128.46,  134.24, 135.16, 
135.19, 136.32, 136.81, 141.46, 144.74, 147.93, 156.90, 156.96, 159.29, 159.35, 
161.38, 161.41; MS m/z: 355.4(M+); Anal. Calcd. for C19H18FN3OS; C, 64.21; H, 
5.10; N, 11.82%. Found: C, 64.25; H, 5.06; N, 11.83%. 
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1-benzyl-N-(3,4-dichlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8f): White solid; Rf 0.54 (7:3 H-E.A); mp 262-264°C; IR (KBr): 
3299, 2962, 2863, 1653, 1648, 1588, 1544, 1521, 1508, 1487, 1379, 1253, 751, 655, 
cm-1; MS m/z: 406.3(M+); Anal. Calcd. for C19H17Cl2N3OS: C, 56.16; H, 4.22; N, 
10.34%. Found: C, 55.56; H, 4.34; N, 10.27%. 
 
1-benzyl-N-(3-chloro-4-fluorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8g): White solid; Rf 0.52 (7:3 H-E.A); mp 262-264°C; IR (KBr): 
3309, 2973, 2842, 1656, 1649, 1588, 1544, 1534, 1521, 1474, 1368, 1249, 758, 642, 
cm-1; MS m/z: 389.9(M+); Anal. Calcd. for C19H17ClFN3OS: C, 58.53; H, 4.40; N, 
10.78%. Found:C, 58.64; H, 4.73; N, 10.36%. 
 
1-benzyl-3-methyl-5-(methylthio)-N-p-tolyl-1H-pyrazole-4-carboxamide (VBA-
8h):  
white solid; Rf 0.48 (7:3 H-E.A); mp 214-216°C; IR (KBr): 3318, 2978, 2854, 1652, 
1644, 1588, 1544, 1536, 1521, 1468, 1362, 1249, 809, 748, 638, cm-1; MS m/z: 
336.4(M+); Anal. Calcd. for C19H18N3OS: C, 67.83; H, 5.39; N, 12.49%. Found: C, 
67.86; H, 5.28; N, 12.58%. 
 
1-benzyl-N-(4-methoxyphenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8i): White solid; Rf 0.50 (7:3 H-E.A); mp 224-240°C; IR (KBr): 
3315, 2963, 2856, 1662, 1642, 1588, 1544, 1532, 1521, 1478, 1366, 1252, 814, 745, 
658, cm-1; 1H NMR: (400 MHz, CDCl3) δH  2.14 (s, 3H, -CH3), 2.57(s, 3H, -SCH3,), 
3.82 (s, 3H, -OCH3), 5.33 (s, 1H, -ArCH2-), 5.53 (s, 1H, -ArCH2-), 6.90-6.92 (d, 2H 
J=8.0Hz, Ar-H), 7.23-7.37 (m, 5H, Ar-H), 7.55-7.57 (d, 2H J=8.0Hz, Ar-H), 9.32-
9.38 (d, 1H, -ArCONH); 13C NMR:(100 MHz, CDCl3) δC 11.50, 14.68, 18.49, 19.95, 
53.38, 55.53, 114.18, 114.21, 114.75, 121.63, 121.78, 126.86, 127.28, 128.04, 128.84, 
128.91, 131.34, 135.62, 136.59, 142.34, 145.15, 152.24, 156.27, 161.23; MS m/z: 
367.5(M+); Anal. Calcd. for C20H21N3O2S: C, 65.37; H, 5.76; N, 11.44%. Found: C, 
65.32; H, 5.67; N, 11.57%. 
 
1-benzyl-3-methyl-N-(3,4-dimethylphenyl)-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-8j): White solid; Rf 0.54 (7:3 H-E.A); mp 250-252°C; IR (KBr): 
3307, 2986, 2836, 1662, 1642, 1588, 1548, 1528, 1519, 1472, 1362, 1249, 759, 643, 
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cm-1; MS m/z: 365.5(M+); Anal. Calcd. for C21H23N3OS: C, 69.01; H, 6.34; N, 
11.50%. Found: C, 69.09; H, 6.28; N, 11.43%. 
 
1-benzyl-3-methyl-5-(methylthio)-N-m-tolyl-1H-pyrazole-4-carboxamide (VBA-
8k):  Lemon white solid; Rf 0.51 (7:3 H-E.A); mp 278-280°C; IR (KBr): 3311, 2971, 
2848, 1662, 1642, 1588, 1557, 1534, 1517, 1466, 1354, 1254, 749, 658, cm-1; MS 
m/z: 351.5 (M+);  Anal. Calcd. for C20H21N3OS: C, 68.35; H, 6.02; N, 11.96%. Found: 
C, 68.32; H, 6.08; N, 11.78%. 
 
1-(4-nitrobenzyl)-3-methyl-5-(methylthio)-N-phenyl-1H-pyrazole-4-carboxamide 
(VBA-10a): Yellow solid; Rf 0.42 (7:3 H-E.A); mp 155-157°C; IR (KBr): 3292, 3064, 
2988, 2845, 1664, 1645, 1608, 1555, 1526, 1372, 1262, 1214, 833, 812, 754, 717, 
632, cm-1; 1H NMR (400 MHz, CDCl3): δH 2.25 (s, 3H, -CH3), 2.59-2.61 (s, 3H, -
SCH3), 5.43 (s, 1H, -ArCH2-), 5.62 (s, 1H, -ArCH2-), 7.13-7.30 (m, 3H, ArH), 7.36-
7.39(d, 2H J=12.0Hz, ArHNO2), 7.64-7.66 (d, 2H J=8.0Hz, ArH), 8.21-8.23 (d, 2H 
J=8.0Hz, ArHNO2),  9.33-9.37 (d, 1H, -ArCONH); 13C NMR (100MHz, CDCl3):δC 
11.44, 14.64, 18.13, 20.24, 52.37, 114.97, 119.89, 120.02, 124.14, 124.23, 124.33, 
127.66, 128.08, 129.08, 129.13, 138.07, 142.73, 143.45, 145.45, 147.72, 153.01, 
160.64, 161.07; MS m/z: 382.4(M+); Anal. Calcd. for C19H18N4O3S: C, 59.67; H, 
4.74; N, 14.65%.Found: C, 59.62; H, 4.68; N, 14.59%. 
 
1-(4-nitrobenzyl)-N-(4-chlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-10b): white solid; Rf 0.44 (7:3 H-E.A); mp 176-178°C; IR 
(KBr): 3282, 3072, 2994, 2827, 1664, 1645, 1608, 1555, 1528, 1362, 1268, 1214, 
833, 812, 758, 709, 632, cm-1; MS m/z: 416.9(M+); Anal. Calcd. for C19H17ClN4O3S: 
C, 54.74; H, 4.11; N, 13.44%.  Found: C, 54.62; H, 4.01; N, 13.32%. 
 
1-(4-nitrobenzyl)-N-(3-chlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-10c): Yellow solid; Rf 0.44 (7:3 H-E.A); mp 162-164°C; IR 
(KBr): 3278, 3084, 2982, 2838, 1664, 1645, 1608, 1555, 1532, 1368, 1274, 1222, 
833, 812, 762, 709, 632, cm-1; MS m/z: 416.9(M+); Anal. Calcd. for C19H17ClN4O3S: 
C, 54.74; H, 4.11; N, 13.44%. Found: C, 54.77; H, 4.08; N, 13.69%. 
 
1-(4-nitrobenzyl)-N-(4-bromophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-10d):Yellow solid; Rf 0.46 (7:3 H-E.A); mp 148-150°C; IR 
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(KBr): 3282, 3072, 2989, 2844, 1664, 1645, 1608, 1565, 1522, 1378, 1245, 1216,  
833, 808, 754, 709, 632, cm-1; MS m/z: 461.3(M+); Anal. Calcd. for C19H17BrN4O3S 
C, 49.47; H, 3.71; N, 12.14%. Found: C, 49.53; H, 3.98; N, 12.58%. 
 
1-(4-nitrobenzyl)-N-(4-fluorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-10e): Yellow solid; Rf 0.47 (7:3 H-E.A); mp 237-239°C; IR 
(KBr): 3437, 3286, 3064, 2999, 2828, 1734, 1664, 1645, 1608, 1550, 1446, 1429, 
1365, 1352 1226, 1203, 1157, 1012, 979, 763, 709 cm-1; MS m/z: 400.4(M+); Anal. 
Calcd. for C19H17FN4O3S: C, 56.99; H, 4.28; N, 13.99%. Found: C, 56.83; H, 4.34; N, 
13.78%. 
 
1-(4-nitrobenzyl)-N-(3,4-dichlorophenyl)-3-methyl-5-(methylthio)-1H-pyrazole-
4-carboxamide (VBA-10f): Lemon Yellow solid; Rf 0.46 (7:3 H-E.A); mp 281-
284°C; IR (KBr): 3324,  3015, 2953, 2838, 1637, 1599, 1521, 1438, 1350, 1238, 
1034, 817, 761, 744, 707, 630, cm-1; MS m/z: 451.3(M+); Anal. Calcd. for 
C19H16Cl2N4O3S:C, 50.56; H, 3.57; N, 12.41%. Found: C, 50.78; H, 3.65; N, 12.28% 
 
1-(4-nitrobenzyl)-N-(3-chloro-4-fluorophenyl)-3-methyl-5-(methylthio)-1H-
pyrazole-4-carboxamide (VBA-10g): Lemon Yellow solid; Rf 0.46 (7:3 H-E.A); mp 
256-258°C; IR (KBr): 3318, 3022, 2964, 2848, 1628, 1599, 1521, 1428, 1356, 1238, 
1038, 821, 758, 742, 707, 630, cm-1; MS m/z:434.90(M+); Anal. Calcd. 
forC19H16ClFN4O3S: C, 52.48; H, 3.71; N, 12.88%. Found: C, 52.54; H, 3.85; N, 
12.64% 
 
1-(4-nitrobenzyl)-3-methyl-5-(methylthio)-N-p-tolyl-1H-pyrazole-4-carboxamide 
(VBA-10h): Yellow solid; Rf 0.44 (7:3 H-E.A); mp 275-278°C; IR (KBr): 3349, 3015, 
2978, 2858, 1628, 1599, 1521, 1428, 1358, 1232, 1024, 812, 748, 732, 709, 630 cm-1; 
1H NMR(400 MHz, CDCl3): δH 2.25-2.35 (s, 6H-CH3, - SCH3), 2.58-2.60 (s, 3H, -
CH3), 5.43 (s, 1H, -ArCH2-), 5.62 (s, 1H, -ArCH2), 7.17-7.19 (s, 2H, Ar-H), 7.28-7.39 
(s, 2H, Ar-HNO2), 7.52-7.60 (d,2H J=32.0Hz, Ar-H), 8.22-7.23 (d, 2H J=4.0Hz, Ar-
HNO2), 9.30-9.36 (d, 1H, -ArCONH); 13C NMR (100MHz, CDCl3): δC 11.46, 20.17, 
20.93, 52.47, 119.88, 120.03, 124.15, 124.24, 127.64, 128.06, 129.62; MS m/z: 
396.5(M+); Anal. Calcd. for C20H20N4O3S: C, 60.59; H, 5.08; N, 14.13%. Found: C, 
60.64; H, 5.27; N, 14.27%. 
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1-(4-nitrobenzyl)-N-(4-methoxyphenyl)-3-methyl-5-(methylthio)-1H-pyrazole-4-
carboxamide (VBA-10i): Lemon Yellow solid; Rf 0.43 (7:3 H-E.A); mp 262-264°C; 
IR (KBr): 3406, 3271, 3001, 2933, 2835, 1741, 1637, 1599, 1521, 1460, 1438, 1350, 
1228, 1107, 1030, 839, 817, 740, 707, cm-1; 1H NMR (400 MHz, CDCl3): δH 2.25 (s, 
3H, -CH3), 2.57-2.61 (t, 3H, -SCH3), 3.85 (s, 3H, -OCH3), 5.43 (s, 1H, ArCH2-), 5.62 
(s, 1H, ArCH2-), 6.89-6.93 (d, 2H J=16.0Hz, Ar-H), 7.37-7.40 (d, 2H, Ar-HNO2), 
7.53-7.57 (d, 2H J=8.0Hz, Ar-H), 8.21-8.24 (d, 2H J=12.0Hz,  Ar-HNO2), 9.20-9.24 
(d, 1H, -ArCONH); 13C NMR (100 MHz, CDCl3):δC 11.42, 14.64, 18.11, 20.21, 
52.35, 55.54, 114.20, 114.24, 121.70, 121.85, 124.13, 124.22, 127.64, 128.06, 133.08, 
142.82, 143.67, 145.26, 147.68, 152.86, 156.39, 160.97; MS m/z: 412.5(M+); Anal. 
Calcd. for C20H20N4O4S: C, 58.24; H, 4.89; N, 13.58%. Found: C, 58.33; H, 4.94; N, 
13.18%. 
 
1-(4-nitrobenzyl)-3-methyl-N-(3,4-dimethylphenyl)-5-(methylthio)-1H-pyrazole-
4-carboxamide (VBA10j): Yellow solid; Rf 0.45 (7:3 H-E.A); mp 248-250°C; IR 
(KBr): 3358,  3009,  2964 , 2828, 1634, 1599, 1521, 1428, 1352, 1236, 1028, 824, 
764, 742, 709, 630, cm-1; MS m/z: 410.5(M+); Anal. Calcd. for C21H22N4O3S: C, 
61.44; H, 5.40; N, 13.65%. Found: C, 61.57; H, 5.37; N, 13.48%. 
 
1-(4-nitrobenzyl)-3-methyl-5-(methylthio)-N-m-tolyl-1H-pyrazole-4-carboxamide 
(VBA-10k): Lemon yellow solid; Rf 0.44 (7:3 H-E.A); mp 258-260°C; IR (KBr): 
3346, 3008, 2972, 2846, 1632, 1599, 1521, 1428, 1354, 1232, 1024, 812, 758, 742, 
707, 630, cm-1; MS m/z: 396.5(M+); Anal. Calcd. for C20H20N4O3S: C, 60.59; H, 5.08; 
N, 14.13%. Found: C, 60.64; H, 5.12; N, 14.27%. 
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2.9 Spectral representation of synthesized compounds: 
1H NMR spectrum of VBA 6 (intermediate) 
 
1H NMR spectrum of VBA- 8a 
 
H
N NH
N
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F
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1H NMR Expanded spectrum of VBA 8a 
 
13C NMR spectrum of VBA 8a 
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DEPT NMR spectrum of VBA 8a 
 
13C NMR spectrum of VBA 8e 
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1H NMR spectrum of VBA- 8e 
 
DEPT NMR spectrum of VBA 8e 
 
H
N N
N
O S
F
H
N N
N
O S
F
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  96 
 
1H NMR spectrum of VBA 8i 
 
13C NMR spectrum of VBA 8i 
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1H NMR spectrum of VBA 10a 
 
13C NMR spectrum of VBA 10a 
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1H NMR spectrum of VBA 10i 
 
13C NMR spectrum of VBA 10i 
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Mass spectrum of VBA 8i 
  
 
 
Mass spectrum of VBA 10a 
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Mass spectrum of VBA 10h 
 
 
 
Mass spectrum of VBA 10i 
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IR spectrum of VBA 10e 
 
 
IR spectrum of VBA 10i 
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Chemical purity of VBA-6a 
 
Chemical purity of VBA-8i 
 
Column: phenomenox (250X4.6), 5µ,  Column Temp-30°C  
Injection volume: 20 µL,                Flow-1mL/min 
Mobile phase: H2O: Acetonitrile (30:70) premix; Diluent: Methanol 
 
Pk # Retention Time Area Area % 
1 17.632 9931909 98.839 
2 18.443 116706 1.161 
Totals  10048615 100.000 
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Chemical purity of VBA-10i 
Column: phenomenox (250X4.6), 5µ,     
Injection volume: 20 µL,                          
Mobile phase: H2O: Acetonitrile (30:70) premix; 
Diluent: Methanol 
Column Temp-30°C 
Flow-1mL/min 
 
 
Pk # Retention Time Area Area %
1 1.899 25370 0.097 
2 2.955 26028842 99.723 
3 5.131 47015 0.180 
Totals  26101227 100.000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H
N N
N
O S
O
NO2
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  104 
2.10 REFERENCES 
 
1. Knorr, L. J. Ann. Chem., 1894, 379, 236. 
2. D. N. Gandhale, A. S. Patil, B. G. Awate and L. M. Naik, Pesticides, 1982, 16, 27  
3. J. Elguero, P. Goya, N. Jagerovic and A. M. S. Silva, Targets in Heterocyclic Systems–
Chemistryand Properties 2002, 6, 52.  
4. J. Elguero, “Comprehensive Heterocyclic Chemistry”, 1984, Vol. 5, p. 167, A. R. Katritzky 
and C.W.Rees, Pergamon Press, Oxford. 
5. J. Elguero, “Comprehensive Heterocyclic Chemistry II”, 1996, Vol. 3, p. 1, A. R. Katritzky, C. 
W.Rees and E. F. Scriven, Pergamon Press, Oxford. 
6. S. Cacchi, G. Fabrizi and A. Carangio, Synlett, 1997, 959.  
7. N. Almirante, A. Cerri, G. Fedrizzi, G. Marazzi and M. Santagostino, Tetrahedron Lett., 1998, 
39, 3287.  
8. D. C. G. A. Pinto, A. M. S. Silva, A. L´evai, J. A. S. Cavaleiro, T. Patonay and J. Elguero, 
Eur.J. Org. Chem., 2593 (2000) and references cited therein.   
9. V. K. Aggarwal, J. de Vicente and R. V. Bonnert, J. Org. Chem., 2003, 68, 5381. 
10. Mahata, P. K.; SyamKumar, U. K.; Sriram, V.; Ila, H.; Junjappa, H. Tetra. 2003, 59, 2631. 
11. Shavnya, A.; Sakya, S. M.; Minich, M. L.; Rast, B.; DeMello, K. L.; Jaynes B. H. Tet. Lett. 
2005, 46, 6887. 
12. Peruncheralathan, S.; Khan, T. A.; Ila, H.; Junjappa, H. J. Org. Chem. 2005, 70, 10030. 
13. Wang, X.; Xu, F.; Xu, Q.; Mahmud, H.; Houze, J.; Zhu, L.; Akerman, M.; Tonn, G.; Tang, L. 
Bioorg. Med. Chem. Lett. 2006, 16, 2800. 
14. Kim, H. S.; Kim, J. N. Bull. Korean Chem. Soc. 2007, 28, 1841. 
15. Elgemeie, G. H.; Elghandour, A. H.; Elaziz, G. W. Synth. Comm. 2007, 37, 2827. 
16. Wang, K.; Xiang, D.; Liu, J.; Pan, W.; Dong, D. Org. Lett., 2008, 10, 1691. 
17. Kuettel, S.; Zambon, A.; Kaiser, M.; Brun, R.; Scapozza, L.; Perozzo, R. J. Med. Chem. 2007, 
50, 5833. 
18. Corradi, A.; Leonelli, C.; Rizzuti, A.; Rosa, R.; Veronesi, P.; Grandi, R.; Baldassari, S.; Villa, 
C. Molecules, 2007, 12, 1482. 
19. Kurz, T.; Widyan, K.; Elgemeie, G. H. Phosphorus Sulfur and Silicon 2006, 181, 299. 
20. Elgemeie, G. H.; Elghandour, A. H; Elaziz, G. W.; Ahmed, S. A. J. Chem. Soc. Perkin Trans. 
1997, 1, 3285.  
21. (a) Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996, 96, 555. (b) Booth, S.; Hermkens, P. H. 
H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron 1998, 54, 15385.  
22. (a) Devlin, J. P. High Throughput Screening: The Discovery of Bioactive Substances; Marcel 
Dekker: New York, 1997.(b) Gordon, E. M.; Kerwin, J. F., Jr. Combinatorial Chemistry and 
Molecular Diversity in Drug Discovery; Wiley: New York, 1998. 
23. Organ, M. G.; Mayer, S. J. Comb. Chem. 2003, 5, 118. 
24. Dalinger, I. L.; Vatsadse, I. A.; Shevelev, S. A.; Ivachtchenko, A. V. J. Comb. Chem. 2005, 7, 
236. 
25. Rena, X. L.; Lib, H. B.; Wub, C.; Yang, H. Z. Arkivoc, 2005, 15, 59. 
26. Lehmann, F.; Holm, M.; Laufer, S. J. Comb. Chem. 2008, 10, 364. 
27. Wenli, M.; Peterson, B.; Kelson, A.; Laborde, E. J. Comb. Chem. 2009, 11, 697. 
28. Luca, L. D.; Giacomelli, G.; Porcheddu, A.; Salaris, M.; Taddei, M. J. Comb. Chem. 2003, 5, 
465. 
29. Stephen R. Graham, Peter J. Brown, and J. Gair Ford, Org. Process Res. Dev., 2010, 14, 1, pp 
242. 
30. Xiao-Ling Ding, Hai-Yan Zhang , Lei Qi ,Bao-Xiang Zhao ,Song Lian, Hong-Shui Lv,Jun-
Ying Miao, Bioorganic & Medicinal Chemistry Letters 2009, 19 , 5325. 
31. Anumula Raghupathi Reddy, Alla Sampath, Gilla Goverdhan, Bojja Yakambaram, Kagga 
Mukkanti,‡ and Padi Pratap Reddy Organic Process Research & Development 2009, 13, 98. 
32. Christina Despotopoulou, Lydia Klier, and Paul Knochel Org. Lett., 2009,Vol. 11, No. 15,  
33. (a) Krasovskiy, A.; Krasovskaya, V.; Knochel, P. Angew. Chem., Int. Ed. 2006, 45, 2958. (b) 
Lin, W.; Baron, O.; Knochel, P. Org. Lett.2006, 8, 5673. (c) Garcia-Alvarez, P.; Graham, D. 
V.; Hevia, E.; Kennedy,A. R.; Klett, J.; Mulvey, R. E.; O’Hara, C. T.; Weatherstone, S. 
Angew.Chem., Int. Ed. 2008, 47, 8079. (d) Mulvey, R. E. Organometallics 2006,25, 1060. (e) 
Mulvey, R. E. Chem. Commun. 2001, 1049. (f) Westerhausen,M. Dalton Trans. 2006, 4755. 
(g) Mulvey, R. E.; Mongin, F.; Uchiyama,M.; Kondo, Y. Angew. Chem., Int. Ed. 2007, 46, 
3802. (h) Mosrin, M.; Knochel, P. Org. Lett. 2008, 10, 2497. (i) Mosrin, M.; Boudet, N.; 
Knochel,P. Org. Biomol. Chem. 2008, 6, 3237. 
Chapter 2                                                                            Synthesis of Novel Poly-substituted Pyrazoles 
Department of Chemistry, Saurashtra University, Rajkot-360005  105 
34. Hee Jeong Seo, Min Ju Kim, Suk Ho Lee, Sung-Han Lee, Myung Eun Jung, Mi-Soon Kim, 
Kwangwoo Ahn, Jeongmin Kim, Jinhwa Lee Bioorganic & Medicinal Chemistry 2010, 18  
1149. 
35. (a) Rowley, M.; Broughton, H. B.; Collins, I.; Baker, R.; Emms, F.; Marwood, R.; Patel, S.; 
Ragan, C. I.; Freedman, S. B.; Leeson, P. D. J. Med. Chem. 1996, 39, 1943. (b) Wittenberger, 
S. J. J. Org. Chem. 1996, 61, 356. (c) Dannhardt, G.; Dominiak, P.; Laufer, S. Arznei-
Forschung. 1993, 43, 441. 
36.  (a) Pinho, E. M.; Teresa, M. V. D. Curr. Org. Chem. 2005, 9, 925. (b) Colliot, F.; 
Kukorowski, K. A.; Hawkins, D. W.; Roberts, D. A. Brighton Crop Prot. Conf. Pests Dis. 
1992, 1, 29. (c) Chen, H. S.; Li, Z. M.; Han, Y. F. J. Agric. Food.Chem. 2000, 48, 5312. (d) 
Vicentini, C. B.; Romagnoli, C.; Reotti, E.; Mares, D. J. Agric. Food Chem. 2007, 55, 10331. 
(e) Vicentini, C. B.; Mares, D.; Tartari, A.; Manfrini, M.; Forlani, G. J. Agric. Food Chem. 
2004, 52, 1898. 
37. Makhsumov, A. G.; Dzhuraev, A. D.; Kilichov, G.; Nikbaev, A. T.; Tashkent Medical 
institute. Translated from Khim. Farm. Zh., 1986, Vol. 20, No. 3, pp. 289. 
38. Tanitame, A.; Oyamada, Y.; Ofuji, K.; Fujimoto, M.; Iwai, N.; Hiyama, Y.; Suzuki, K.; Ito, 
H.; Terauchi, H.; Kawasaki, M.; Nagai, K. J. Med. Chem. 2004,   47, 3693. 
39. Edwards, P. J.; Jones, L. H.; Mowbray, C. E.; Stupple, P. A.; Tran, I. Pfizer limited, US, New 
York, WO2004031156 A1. 
40. Bagley, M. C.; Davis, T.; Dix, M. C.; Widdowson, C. S; Kipling, D. Org. Biomol. Chem., 
2006, 4, 4158. 
41. Francesco Piscitelli, Alessia Ligresti b, Giuseppe La Regina, Valerio Gatti, Antonella Brizzi 
,Serena Pasquini, Marco Allarà, Mauro Antonio Maria Carai, Ettore Novellino,Giancarlo 
Colombo, Vincenzo Di Marzo, Federico Corelli, Romano Silvestri,  European Journal of 
Medicinal Chemistry 2011, 46  5641. 
42. Xie, W.; Chipman, J. G.; Robertson, D. L.; Erickson, R. L.; Simmons, D. L. Proceedings of 
the National Academy of Sciences U. S. A. 1991, 88, 2692. 
43. (a) Turini, M. E.; DuBois, R. N. Annual Reviews in Medicine 2002, 53, 35. (b) Vane, J. R.; 
Botting, R. M. Therapeutic roles of selective COX-2 inhibitors; William Harvey Press: 
London, UK, 2001. 
44. (a) Dubois, A. Prostaglandins & Other Lipid Mediators 2000, Special Issue: Guest Editor, A. 
Dubois, 1-174. (b) Khanapure, S. P.; Letts, L. G. In The Eicosanoids ; Curtis-Prior, P. B., Ed.; 
John Wiely & Sons: London, 2003, p 131. 
45. Haque, T. S.; Tadesse, S.; Marcinkeviciene, J.; Rogers, M. J.; Kopcho, L. M.; Amsler, K. J. 
Med. Chem. 2002, 45, 4669. 
46. Pradip K. Sasmal, D. Srinivasa Reddy, Rashmi Talwar, B. Venkatesham, D. 
Balasubrahmanyam, M. Kannan,P. Srinivas, K. Shiva Kumar, B. Neelima Devi, Vikram P. 
Jadhav, Sanjoy K. Khan, Priya Mohan,Hira Chaudhury, Debnath Bhuniya, Javed Iqbal, 
Ranjan Chakrabarti. Bioorg. & Med. Chem. 2006, 14, 4657. 
47. Bonacorso, H. G.; Wentz, A. P.; Lourega, R. V.; Cechinel, C. A.; Moraes, T. S.; Coelho, H. 
S.; Zanatta, N.; Martins, A. P.; Hoerner, M.; Alves, S. H. J. Fluorine Chem. 2006, 127, 1066. 
48. R. Venkat Ragavan V. Vijayakumar N. Suchetha Kumari European Journal of Medicinal 
Chemistry 2010 45, 1173. 
49. Stephen Brand, Laura A. T. Cleghorn, Stuart P. McElroy, David A. Robinson, Victoria C. 
Smith, Irene Hallyburton, Justin R. Harrison, Neil R. Norcross, Daniel Spinks, Tracy Bayliss, 
Suzanne Norval, Laste Stojanovski, Leah S. Torrie, Julie A. Frearson, Ruth Brenk, Alan H. 
Fairlamb, Michael A. J. Ferguson,Kevin D. Read, Paul G. Wyatt, and Ian H. Gilbert J. Med. 
Chem. XXXX, XXX, XXX−XXX dx.doi.org/10.1021/jm201091t (article in press). 
50. Covacci, A.; Telford, J. L.; Giudice, G. D.; Parsonnet, J.; Rappuoli, R.; Helicobacter pylori 
Virulence and Genetic Geography. Science, 1999, 284, 1328. 
51. McGowan, C. C.; Cover, T. L.; Blaser, M. J.; Helicobacter pylori and Gastric Acid: Biological 
and Therapeutic Implications. Gastroenterology, 1996, 110, 426. 
 
 
 
 
  
CHAPTER 3 
 
A NOVEL PROCESS FOR THE PREPARATION OF 2-
AMINO-4-METHOXY-6-METHYL-N- PHENYL-
PYRIMIDINE-5-CARBOXAMIDE DERIVATIVES. 
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3.1 Introduction 
 
 The pyrimidine fragment is present in the molecules of a series of biologically 
active compounds, many of which have found use in medical practice (soporific, anti-
inflammatory, antitumor, and other products).1,2 In this connection, great attention has 
recently been paid to the derivatives of pyrimidine, including their hydrogenation 
products. The first investigation into the synthesis of pyrimidine nucleus appeared 
more than a hundred years ago and subsequently several methods for the synthesis of 
dihydropyrimidine were reported and their physicochemical properties has been 
studied (e.g., the Biginelli reaction).3Further, the high reactivity and wide range of 
biological activity associated with these scaffolds have been demonstrated in the 
literature. For example, 2-substituted 5-alkoxycarbonyl-4-aryl-l,4-dihydropyrimidines 
(structural analogs of Hantzsch esters) are modulators of the transport of calcium 
through membranes.4-7 Many hydrogenated pyrimidines exhibit antimicrobial,8 
hypoglemic,9herbicidal,10 and pesticidal11 activity. Publications devoted to these 
problems have been summarized in a number of reviews.9-14 
 Pyrimidines have a long and distinguished history extending from the days of 
their discovery as important constituents of several biological molecules such as 
nucleic acids, cofactors, various toxins, to their current use in the chemotherapy of 
AIDS. All these compounds yield great promise for the treatment of retro virus 
infections in humans. 
 Alloxan (1) is known for its diabetogenic action in a number of animals.15 
Uracil (2), thymine (3) and cytosine (4) are the three important constituents of nucleic 
acids (Figure-1). 
 
 
Figure-1 
 The pyrimidine ring is also found in vitamins such asthiamine (5), riboflavin 
(6) (Figure-2) and folic acid (7).16 Barbitone (8) is the first barbiturate hypnotic, 
sedative and anticonvulsant are pyrimidine derivatives (Figure-3). 
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Figure-2 
 
 
 
Figure-3 
 
3.2 Synthetic strategies for the dihydropyrimidines (DHPMs) 
  
 Having tremendous important of DHPMs in medicinal chemistry, a literature 
survey on the synthetic methods for the biologically active dihydropyrimidines 
(DHPMs) has been carried out and described as follows. Various modifications have 
been applied to Biginelli reaction to get better yield and to synthesize biologically 
active analogs. Different catalysts have been reported to increase the yield of the 
reaction. Microwave synthesis strategies have also been applied to shorten the 
reaction time. Solid phase synthesis and combinatorial chemistry has made possible to 
generate library of DHPM analogs. The various modifications are discussed in the 
following section. 
In 1893 Biginelli reported the first synthesis of dihydropyrimidines of type 4 
by a simple one-pot condensation reaction of ethyl acetoacetate (1), benzaldehyde (2), 
and urea (3a).17 In the following decades the original cyclocondensation reaction has 
been extended widely to include variations in all three components, allowing access to 
a large number of multi functionalized dihydropyrimidine derivatives.18 Largely 
ignored for many years, the Biginelli reaction has recently attracted a great deal of 
attention, and several improved procedures for the preparation of dihydropyrimidines 
of type 4 have been reported within the past few years.19-21 Various solid phase 
modifications of the Biginelli reaction suitable for combinatorial chemistry have also 
been described.22 The present interest in “Biginelli compounds” 4 is mainly due to 
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their close structural relationship to the clinically important dihydropyridine calcium 
channel modulators of the nifedipine-type.23 Properly functional functionalized 
dihydropyrimidines of type 4 show a very similar pharmacological profile to classical 
dihydropyridine drugs and several lead compounds with excellent calcium channel 
modulator activity have been identified.24 In addition, several marine alkaloids with 
interesting biological activities containing the dihydropyrimidine-5- carboxylate core 
have been isolated.24-26 Most notably among these are the crambine24 and batzelladine 
alkaloids25 and the more complex pentacyclic alkaloid ptilomycalin A,26 which was 
recently synthesized employing a “tethered Biginelli condensation” as one of the key 
steps.27  C. Oliver Kappe et al .described by Biginelli produced the expected 6-
methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates28 (Figure-4) . 
 
EtO2C
Me O
NH2
O
NH2Ph
O
H N
H
NH
Ph
O
EtO2C
Me
H+
 
 
Figure-4 
 
Claude pantadosi et al.32 Various 5-Substitued pyrimidine-6-carboxaldehydes 
and derivatives were synthesized and tested for inhibition of growth of the Ehrlich as 
cites carcinoma and inhibition of incorporation of L-phenylalanine-1-14C into 
proteins and orotic acid-5-3H, thymine-2-14C and formate-14C into nucleic acids of 
tumor cells in vitro. The following compounds were found to be particularly active as 
inhibitors 2-mercapto-4-hydroxy-5-(4-chlorobenzyl)pyrimidine-6-carboxaldehyde 
(VII-3),2-mercapto-4-hydroxy-5-(4-bromobenzyl) pyrimidine-6-carboxaldehyde(VII-
6),2-ethylthio-4-hydroxy-5-(4-chlorobenzyl)pyrimidine-6-carboxaldehyde(VII-
16),and2-ethylthio-4-hydroxy-5-(4-bromobenzyl)pyrimidine-6-carboxaldehyde (VII-
17).The best compounds of this series are equally as effective as 5-fluorouracil(FU) in 
inhibiting formate incorporation into DNA and growth of the tumor. They are more 
effective than FU in inhibiting incorporation of formate and orotic acid into RNA 
thymine into DNA, and phenylalanine and glycine into proteins. 2-merecapto-4-
hydroxypyrimidine-6-carboxaldehydes,29 2-phthalimidoaldehdes30,5-fluoropyrimidne-
6-carboxaldehydes31, and their derivatives have been synthesized and tested as 
inhibitors of growth and protein synthesis in Ehrlich as cites carcinoma in mice 
(Figure -5). 
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Figure-5 
? Catalysts 
 Min Yang and coworkers33 have synthesized the different DHPMs by using 
various inorganic salts as a catalyst (Figure-6). They found that the yields of the one-
pot Biginelli reaction can be increased from 20-50% to 81-99%, while the reaction 
time shorted for 18-24 hr to 20-30 min. This modification was developed by using 
Yb(OTf)3 and YbCl3 as a catalyst under solvent free conditions. One additional 
important feature of this protocol is the catalyst can be easily recovered and reused.  
 
 
 
Figure-6 
 Lewis acid such as Indium (III) chloride was emerged as a powerful Lewis 
catalyst imparting high region and chemo selectivity in various chemical 
transformations. B. C. Ranu and co-workers34 have reported indium (III) chloride 
(InCl3) as an efficient catalyst for the synthesis of 3,4-dihydropyrimidn-2(1H)-ones 
(Figure-7). A variety of substituted aromatic, aliphatic and heterocyclic aldehydes 
have been subjected to this condensation very efficiently. Thiourea has been used 
with similar success to provide the corresponding dihydropyrimidin-2(1H)-thiones. 
 
 
 
Figure-7 
 Majid M. Heravi et al.35 has reported a simple, efficient and cost-effective 
method for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones/thiones by one pot 
three-component cyclocondensation reaction of a 1,3-dicarbonyl compound, an 
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aldehyde and urea or thiourea using 12-tungstophosphoric acid35 and 12-
molybdophosphoric acid36 as  recyclable catalyst (Figure-8). 
 
 
 
Figure-8 
 
 Hydroxyapatite doped with ZnCl2, CuCl2, NiCl2 and CoCl2 efficiently 
catalyzes the three components Biginelli reaction between an aldehyde, ethyl 
acetoacetate and urea in refluxing toluene to afford the corresponding 
dihydropyrimidinones in high yields.37 
 
 Sc(III)triflate catalyzes the three-component condensation reaction of an 
aldehyde, a β-ketoester and urea in refluxing acetonitrile to afford the corresponding 
3,4-dihydropyrimidin-2(1H)-ones in excellent yields (Figure-9). The catalyst can be 
recovered and reused, making this method friendly and environmentally acceptable.38 
 
 
 
Figure-9 
 
? Synthetic Methods for the substituted pyrimidines 
 The generation of combinatorial libraries of heterocyclic compounds by solid 
phase synthesis is of great interest for accelerating lead discovery and lead 
optimization in pharmaceutical research. Multi-component reactions (MCRs)39-41 
leading to heterocycles are particularly useful for the creation of diverse chemical 
libraries, since the combination of any 3 small molecular weight building blocks in a 
single operation leads to high combinatorial efficiency. Therefore, solid phase 
modifications of MCRs are rapidly become the cornerstone of combinatorial synthesis 
of small-molecule libraries.  
 The first solid-phase modification of the Biginelli condensation was reported 
by Wipf and Cunningham42 in 1995 (Figure-10). In this sequence, γ-aminobutyric 
acid derived urea was attached to Wang resin using standard procedures. The 
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resulting polymer-bound urea was condensed with excess β-ketoester and aromatic 
aldehydes in THF at 55°C in the presence of a catalytic amount of HCl to afford the 
corresponding immobilized DHPMs. Subsequent cleavage of product from the resin 
by 50 % trifluoroacetic acid (TFA) provided DHPMs in high yields and excellent 
purity. 
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Figure-10 
Li W. and Lam Y.43 have described the synthesis of 3,4-dihydropyrimidin-2- 
(1H)ones/thiones using sodium benzenesulfinate as a traceless linker (Figure-11). 
The key steps involved in the solid-phase synthetic procedure were sulfinate 
acidification, condensation of urea or thiourea with aldehydes and sulfinic acid and 
traceless product release by a one-pot cyclization-dehydration process. Since a variety 
of reagents can be used, the overall strategy appears for library generation. 
 
 
 
Figure-11 
 
? Liquid phase synthesis 
 In the solid phase synthesis there are some disadvantages in compared to 
standard solution-phase synthesis, such as difficulties to monitor reaction progress, 
the large excess of reagents typically used in solid-phase supported synthesis, low 
loading capacity and limited solubility during the reaction progress and the 
heterogeneous reaction condition with solid phase.44 Recently, organic synthesis of 
small molecular compounds on soluble polymers, i.e. liquid phase chemistry has 
increasingly become attractive field.45  
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 Moreover, owing to the homogeneity of liquid-phase reactions, the reaction 
conditions can be readily shifted from solution-phase systems without large changes 
and the amount of excessive reagents is less than that in solid-phase reactions. In the 
recent years, Task Specific room temperature Ionic Liquids (TSILs) has emerged as a 
powerful alternative to conventional molecular organic solvents or catalysts. Liu Z. et 
al.46 have reported cheap and reusable TSILs for the synthesis of 3,4-
dihydropyrimidin-2(1H)-ones via one-pot three component Biginelli reaction. Ionic 
liquid-phase bound acetoacetate reacts with thiourea and various aldehydes with a 
cheap catalyst to afford ionic liquid-phase supported 3,4-dihydropyrimidin-2(1H)-
thiones, which has been reported by Bazureau J. P. and co-workers47 (Figure-12). 
3,4-Dihydropyrimidinones were synthesized in one-pot, by the reaction of aldehydes, 
β-dicarbonyl compounds and urea, catalyzed by non-toxic room temperature ionic 
liquid 1-n-butyl-3-methylimidazolium saccharinate (BMImSac).48 
 
 
 
Figure-12 
 
? Microwave assisted synthesis 
 In general, the standard procedure for the Biginelli condensation involves one 
pot condensation of the three building blocks in a solvent such as ethanol using a 
strongly acidic catalyst that is hydrochloric acid. One major drawback of this 
procedure, apart from the long reaction time involving reflux temperature, is the 
moderate yields frequently observed when using more complex building blocks. 
Microwave irradiation (MW) has become accepted tool in organic synthesis, because 
the rate enhancement, higher yields and often, improved selectivity with respect to 
conventional reaction conditions.49 The publication by Dandia A. et al.50 described 
microwave-enhanced solution-phase Biginelli reactions employing ethyl acetoacetate, 
thiourea and a wide variety of aromatic aldehydes as building blocks (Figure-13). 
Upon irradiation of the individual reaction mixtures (ethanol, catalytic HCl) in an 
open glass beaker inside the cavity of a domestic microwave oven the reaction times 
were reduced from 2–24 hours of conventional heating 80°C, reflux to 3–11 minutes 
under microwave activation (ca. 200 –300 W). At the same time the yields of DHPMs 
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obtained were distinctly improved compared to those reported earlier using 
conventional conditions. 
 
 
Figure-13 
 In recent years, solvent free reactions using either organic or inorganic solid 
supports have received more attention.51 There are several advantages to perform 
synthesis in dry media: (i) short reaction times, (ii) increased safety, (iii) economic 
advantages due to the absence of solvent. In addition, solvent free MW processes are 
also clean and efficient. Gopala krishnan M. and co-workers have reported Biginelli 
reaction under microwave irradiation in solvent-free conditions using activated fly ash 
as catalyst, an industrial waste (pollutant) is an efficient and novel catalyst for some 
selected organic reactions in solvent free conditions under microwave irradiation.52 
 
? Synthetic Methods for the Synthesis of 2-aminopyrimidine Derivatives 
Several methods were reported in the literature for the chlorination of 2-
hydroxypyrimidines, few of them are described herein. 
A. Kumar and V. Agrawal et al.53 have synthesized a novel series of 2-amino-
4-(N-alkyl-N-arylamino)-pyrimidines using polarized ketene S,S-and S,N-acetals 
(Figure-14) by reaction of ketene S,S-acetal 1with aniline 2 in boiling ethanol the 
corresponding S,N-acetal3 was obtained in good yield. Treatment of 3 with guanidine 
nitrarte in the presence of sodium ethoxide followed by refluxing in ethanol, yielded 
2-amino-4-anilino-5-cyno-1,6-dihydro-6-oxopyrimidine 4 in 57% yield. 
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Figure-14 
Junjappa and coworkers54 extended the generality of this strategy by using 
guanidine and thiourea as the nucleophilic reagents. Reaction of α-unsubstituted β, β’-
bis(alkylthio)-α,β-enones with guanidine nitrate in refluxing methanolic sodium 
methoxide affords the 2-amino-4-methoxy pyrimidines(Figure-15,16).While 
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utilization of thiourea affords the corresponding 2-mercapto-4-alkoxy analogs. This 
procedure is particularly useful for the synthesis of the latter compounds, which 
would be difficult to prepare by alkylation of a free hydroxyl group in the presence of 
thiol functionality. These procedures have been extended to α-aryl substituted β,β’-
bis(alkylthio)-α,β-enones and to α-oxo ketene dithioacetals derived from cyclic 
ketones. 
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Figure-16 
 
U. K. Syamkumar et al.55 have reported a hetero annulation of 2-[Bis 
(methylthio) methylene]-1-methyl-3-oxoindole with guanidine nitrate and sodium 
methoxide or ethoxide in 50 mL of the respective alcohol and the reaction mix was 
refluxed for 12-15 h which yielded 2-amino-5-N-methyl-4-(alkoxy)pyrimido[5,4-b] 
indole (Figure-17) in good yield. 
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Figure-17 
 
? Synthesis of substituted pyrimidines by using various ketene dithioacetals. 
H. Ila and H. Junjappa et al.56 have synthesized a novel series of 2-amino-4-
ethoxy dibenz[b,f]oxepino-[4,5-d]pyrimidine(Figure-18). Guanidine nitrate was 
added to a stirred solution of sodium ethoxide then after 5 min ketene dithioacetal was 
added and reflux the reaction mix for 5-12 h which yielded pyrimidine. 
 
O
O
SS
NH .HX
H2N NH2
O
N
NaOEt / EtOH
Reflux 5-12h. NH2NEtO  
 
Figure-18 
 
Signal transducers and activators of transcription 6 (STAT6) is a key regulator 
of the type 2 helper T (Th2) cell immune response and a potential therapeutic target 
for allergic diseases such as asthma and atopic diseases. In search of potent and orally 
bioavailable STAT6 inhibitors, Shinya Nagashima et al.57 have synthesized a series of 
4-benzylaminopyrimidine- 5-carboxamide derivatives and evaluated their STAT6 
inhibitory activities. Among those compounds, 2-[(4-morpholin-4-ylphenyl)amino]-4-
[(2,3,6-trifluorobenzyl)amino]pyrimidine-5-carboxamide (25y,YM-341619, AS1617 
612)  showed potent STAT6 inhibition with an IC50 of 0.70 nM, and also inhibited 
Th2 differentiation in mouse spleen T cells induced by interleukin (IL)-4 with an IC50 
of 0.28 nM without affecting type 1 helper T (Th1) cell differentiation induced by IL-
12 (Figure-19). 
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Figure-19 
 
R. J. Gillespie et al.58 describes the detailed optimization and structure–activity 
relationships of a series of pyrimidine-4-carboxamides. These optimized derivatives 
displayed desirable physiochemical and pharmacokinetic profiles, which have led to 
promising oral activity in clinically relevant models of Parkinson’s disease (Figure-
20). 
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Figure-20 
 
 M. A. Ebraheem et al.59 have reported a novel synthesis of poly substituted 
pyrimidines (2) via the reaction of α,α-oxoketene dithioacetals (1) with urea and 
thiourea in EtOH reflux 3 h which yielded pyrimidine (Figure-21) in good yield. 
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Figure-21 
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Microwave Assisted Organic Synthesis (MAOS) is energy efficient and 
effective tool to speed up the synthesis for drug discovery process. In the present 
study Kishor S. Jain et al.60 report a novel protocol for the rapid, high throughput 
synthesis of mononuclear 2-amino-5-cyano-4,6-disubstituted pyrimidines, adaptable 
to parallel synthesis for compound libraries. The overall reaction time in hrs has been 
reduced to 25 - 50 minutes with improved yields (Figure-22). 
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(Figure-22) 
 
3.3  Biological Activity Associated with 4-Aryl dihydropyrimidine 
derivatives 
 
 Among the dihydropyrimidines,4-Aryl-1,4-dihydropyridines (DHPs, e.g. 
nifedipine) are the most studied class of organic calcium channel modulators. More 
than 30 years after the introduction of nifedipine many DHP analogs have now been 
synthesized and numerous second-generation commercial products have appeared on 
the market.61-62 
 Nowadays, interest has also been focused on aza-analogs such as 
dihydropyrimidines (DHPMs) which showed a very similar pharmacological profile 
to the classical dihydropyridine calcium channel modulators.63-64 Over the past few 
years several lead-compounds were developed (i.e. SQ 32,926) that are superior in 
potency and duration of antihypertensive activity to classical DHP drugs, and 
compare favorably with second-generation analogs such as amlodipine and 
nicardipine (Figure-23). 
 
 
Figure-23 
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 Barrow et al.65 has reported in vitro and in vivo evaluation of 
dihydropyrimidinone C-5 amides as potent and selective r1A receptor antagonists for 
the treatment of benign prostatic hyperplasia (Figure-24). R1 Adrenergic receptors 
mediate both vascular and lower urinary tract tone, and R1 receptor antagonists such 
as terazosin are used to treat both hypertension and benign prostatic hyperplasia 
(BPH). Recently, three different subtypes of this receptor have been identified, with 
the R1A receptor being most prevalent in lower urinary tract tissue. Barrow et al. has 
also reported 4-aryldihydropyrimidinones attached to an aminopropyl-4-
arylpiperidine via a C5 amide as selective R1A receptor subtype antagonists. In 
receptor binding assays, these types of compounds generally display Ki values for the 
R1a receptor subtype <1 nM while being greater than 100-fold selective versus the 
R1b and R1d receptor subtypes. Many of these compounds were also evaluated invivo 
and found to be more potent than terazosin in both a rat model of prostate tone and a 
dog model of intra-urethral pressure without significantly affecting blood pressure. 
While many of the compounds tested displayed poor pharmacokinetics, one 
compound was found to have adequate bioavailability (>20%) and half-life (>6 h) in 
both rats and dogs. Due to its selectivity for the R1a over the R1b and R1d receptors 
as well as its favorable pharmacokinetic profile, it has the potential to relieve the 
symptoms of BPH without eliciting effects on the cardiovascular system.65-66 
N
H
NH
F
F
OR1
N
H
O
N
R3 R2  
 
Figure-24 
 
 The 4-aryldihydropyrimidinone attached to an aminopropyl-4-arylpiperidine 
via a C5 amide has proved to be an excellent template for selective R1A receptor 
subtype antagonists. Those compounds are exceptionally potent in both cloned 
receptor binding studies as well as in vivo pharmacodynamic models of prostatic tone. 
 Atwal et al.66 have examined a series of novel dihydropyrimidine calcium 
channel blockers that contain a basic group attached to either C5 or N3 of the 
heterocyclic ring (Figure-25). Structure-activity studies showed that l-
Chapter 3                                                                                     Synthesis of Functionalized Pyrimidines 
Department of Chemistry, Saurashtra University, Rajkot-360005  119 
(phenylmethyl)-4-piperidinylcarbamate moiety at N3 and sulfur at C2 are optimal for 
vasorelaxantactivity invitro and impart potent and long-acting antihypertensive 
activity invivo. One of these compounds was identified as a lead, and the individual 
enantiomers were synthesized. Two key steps of the synthesis were (1) the efficient 
separation of the diastereomericureido derivatives and (2) the high-yield 
transformation of 2-methoxy intermediate to the (p-methoxybenzyl)thio 
intermediates. Chirality was demonstrated to be a significant determinant of 
biological activity, with the DHP receptor recognizing the enamines ester moiety but 
not the carbamate moiety. DHPM is equipotent to nifidepine and amlodipine invitro. 
In the spontaneously hypertensive rat, DHPM is more potent and longer acting than 
both nifidepine and the long-acting amlodipine (DHP derivative). DHPM has the 
potential advantage of being a single enantiomer.67-68 
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Figure-25 
 
 In order to explain the potent antihypertensive activity of the modestly active 
(ICw = 3.2 pM) DHPM calcium channel blocker, Atwal et al.66 carried out drug 
metabolism studies in the rat and found that two of the metabolites (ICw =16 nM) and 
(ICw = 12 nM), were responsible for antihypertensive activity of compound. Potential 
metabolism invivo precluded interest in pursuing compounds related to it. Structure-
activity studies aimed at identifying additional aryl-substituted analogues led to 
comparable potential in vivo, though these compounds were less potent invitro. To 
investigate the effects of absolute stereochemistry on potency, authors resolved via 
diastereomeric urea, prepared by treatment with (R)-α-methylbenzylamine. The 
results demonstrate that the active R-(-)-enantiomer is more potent and longer acting 
than nifedipine as an antihypertensive agent in the SHR. The invivo potency and 
duration is comparable to the long-acting DHP amlodipine. The superior oral 
antihypertensive activity compared to that of previously described carbamates 
(R2=COOEt) could be explained by its improved oral bioavailability, possibly 
resulting from increased stability of the urea functionality (Figure-26).66 
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Figure-26 
 
 Authors modified the structure of previously described DHPM i.e. 3-
substituted 1,4-dihydropyrimidines. Structure-activity studies using potassium-
depolarized rabbit aorta show that ortho, meta-disubstituted aryl derivatives are more 
potent than either ortho or meta-monosubstituted compounds. While vaso relaxant 
activity was critically dependent on the size of the C5 ester group, isopropyl ester 
being the best, a variety of substituent (carbamate, acyl, sulfonyl, and alkyl) were 
tolerated at N3. The results showed that DHPM’S are significantly more potent than 
corresponding 2- heteroalkyl-l,4-dihydropyrimidinesand only slightly less potent than 
similarly substituted 2-heteroalkyl-1-4-dihydropyridines (Figure-27).Whereas DHP 
enantiomers usually show 10-15-fold difference in activity, the enantiomers of DHPM 
show more than a 1000-fold difference in activity. These results strengthen the 
requirement of an enaminoester for binding to the dihydropyridine receptor and 
indicate a nonspecific role for the N3-substituent. 
 
 
 
Figure-27 
 2-Heterosubstituted-4-aryl-l,4-dihydro-6-methyl-5-pyrimidinecarboxylicesters 
(Figure-28), which lack the potential symmetry of DHP calcium channel blockers, 
were prepared and evaluated for biological activity. Biological assays using 
potassium-depolarized rabbit aorta and radio ligand binding techniques showed that 
some of these compounds are potent mimics of DHP calcium channel blockers.69 
 
Figure-28 
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 Bryzgalov A. O. et al.70 has studied the antiarrhythmic activity of 4,6-
di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones (Figure-29) toward two types 
of experimental rat arrhythmia. With CaCl2 induced arrhythmia model, several agents 
have demonstrated high antiarrhythmic activity and the lack of influence on arterial 
pressure of rats.71 
 
 
Figure-29 
 
 Remennikov G.et al.71 have synthesized some novel 4-aryl-5-nitro substituted 
DHPMs (Figure-30) using nitro acetone and screened as calcium modulators. They 
have studied the pharmacological properties of 6-methyl- and 1,6-dimethyl-4-aryl-5-
nitro-2-oxo-l,2,3,4-tetrahydropyrimidines with different substituent in the aryl 
fragment, i.e. unsubstituted, ortho, meta, para, di, and tri-substituted compounds and 
observed that 5-nitro DHPMs bearing unsubstituted, ortho and tri-substitution on aryl 
moieties at C4 position reduced blood pressure and inhibited myocardial contractile 
activity. The second group consisted meta, para and di-substituted aryl moieties with 
DHPMs increased blood pressure and had positive inotropic effects. The compounds 
with the highest hypotensive activity were containing substituent in the ortho position 
of the phenyl fragment. Thus, compounds having substitution on aryl moieties which 
had pronounced vasodilator and weak cardiodepressive actions, increased cardiac 
pump function (SV). When inhibition of myocardial contractile function 
predominated, there was a reduction in SV. The effect of compounds of the first group 
on heart rate was variable, though most reduced heart rate. In addition, a reflex 
increase in heart rate might be expected because of the reduction in blood pressure. 
The reference preparations for compounds of this group were the calcium antagonist 
nifedipine.  
 
 
Figure-30 
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The pharmacological profile of compounds of the first group was analogous to 
that of nifedipine. This suggests that they share a common mechanism of action - 
blockade of calcium ion influx. 
 Spleen tyrosine kinase (Syk) is a non-receptor-type tyrosine kinase which 
mediates diverse responses in haematopoieticcells. Therefore, Syk is an attractive 
therapeutic target, and in a study of Syk inhibitors as potentially new therapeutic 
agents. In thiscontext, Hiroyuki Hisamichi et al.72 have discovered the 4-
anilinopyrimidine-5-carboxamides (Figure-31). Enzyme screening indicated that an 
aminoethylamino moiety at the 2-positionof the pyrimidine ring was important for 
Syk inhibitory activity, and an investigation of the substituents at the 4-position 
revealed that an anilino moiety substituted at the meta position was preferred. These 
compounds showed high selectivity for Syk, compared to other kinases, such as ZAP-
70, c-Src, and PKC, and exhibited good inhibitory activities against 5-HT release 
from RBL-cells. 
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Figure-31 
 
S. Nagashima et al.73 have synthesized a series of 2-{[2-(4 hydroxyphenyl) 
ethyl]amino}pyrimidine-5-carboxamide derivatives and evaluated their STAT6 
inhibitory activities. Among thesecompounds,4-(benzylamino)-2-{[2-(3-chloro-4-
hydroxyphenyl) ethyl] amino}pyrimidine-5-carboxamide (2t, AS1517499) showed 
potent STAT6 inhibition with an IC50 value of 21 nM, and also inhibited IL-4-induced 
Th2 differentiation of mouse spleen T cells with an IC50 value of 2.3 nM and without 
influencing T-helper cell 1 (Th1) differentiation induced by IL-12.The STAT6 (signal 
transducers and activators of transcription 6) protein is activated by interleukin (IL)-4 
and IL-13, and plays an important role in T-helper cell 2 (Th2) differentiation. STAT6 
might therefore be an excellent therapeutic target for various allergic conditions, 
including asthma and atopic diseases (Figure -32). 
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Figure-32 
 
Brain C. Shook et al.74 has synthesized a novel series of arylindeno- 
pyrimidines (Figure-33) identified as A2A and A1 receptor antagonists. The series was 
optimized for vitro activity by substituting the 8-and-9- positions with methylene 
amine substituents. The compounds show excellent activity in mouse models of 
parkinson’s disease when dosed orally. 
 
 
Figure-33 
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3.4  Current research work 
 
 The highly substituted pyrimidine derivatives have considerable chemical and 
pharmacological importance because of a broad range of biological activities 
displayed by these classes of molecules. As we demonstrated, the tremendous 
biological potential of substituted pyrimidine derivatives encouraged us to synthesize 
some new highly functionalized substituted pyrimidine derivatives. Various 
methodologies have been described for the synthesis of substituted pyrimidine 
derivatives. However, the existing methods are suffer with some drawbacks, such as; 
yield, time, product isolation, purification. The following provides an explanation of 
the compound of the present invention, a novel process for the preparation of 
substituted pyrimidine compound.  
 
 In an exploratory experiment, the reaction of N-alkyl-3-oxobutanamide (3), 
with carbon disulphide and methyl iodide in the presence of K2CO3 was performed in 
dry DMF/THF at ambient temperature and afforded ketene dithioacetals. The progress 
of the reaction was monitored by TLC. Further, the reaction of ketene dithioacetals 
(4) with either guanidine nitrate or guanidine hydrochloride (5) in the presence of 
sodium methoxide as a base was performed in MeOH which affords the desired 
product in good yield. The progress of the reaction was monitored by TLC. 
 
We have shown that the use of a wide diversity of substituent’s in amines (1) 
and guanidine nitrate or guanidine hydrochloride (5) in this multi component reaction 
makes possible the synthesis of libraries under similar circumstances. The results are 
shown in Table 1. As anticipated from our original results, these reactions proceeded 
very cleanly under mild conditions at ambient temperature. All the newly synthesized 
compounds were characterized by spectroscopic technique. 
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3.5  Results and discussion 
 
Route of Synthesis for novel substituted Pyrimidine derivatives using various 
ketene dithioacetals. 
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Where R= -CH3,-OCH3, -Cl, -Br, -F 
 
 Preparation of the target compounds was initiated by the reaction of ethyl 
acetoacetate (2) with aryl amines (1) in toluene at reflux temperature to afford the 
acetoacetanilide (3) in 85-90% yields (Scheme-1). The reaction of 3with carbon 
disulfide in the presence of base in DMF followed by methylation to afforded 
corresponding 2-(bis(methylthio)methylene)-3-oxo-N-phenylbutanamide (4). 
Followed by reaction of 4 with guanidine nitrate undergoes cyclization to form 2-
amino-6-methoxy-5-methyl-N-phenylpyrimidine-4-carboxamide VBA (6a-s). 
 Twenty different acetoacetanilide were synthesized bearing various electron 
donating and electron withdrawing groups such as 2,3-diCH3; 3,4-diCH3; 4-CH3; H; 
2,5-diCH3; 2,4-(CH3)2; 3-Cl-4-F; 4-F; 4-Cl; 2-Cl; 2-F; 4-OCH3; 2,5-diCl and 3-NO2 
on the phenyl ring. Thus, it was found that reaction of substituted acetoacetanilide 
(3a-s) derivatives with carbon disulfide in the presence of potassium carbonate 
followed by the guanidine nitrate with alkyl/aryl halide (Scheme-2) gave the novel 
pyrimidine (6a-s). 
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Table 1: Synthesis of Novel highly substituted pyrimidine using various a ketene 
dithioacetals. 
Entry R Yield % Time h. 
VBA-6a C6H5 72 8-10 
VBA-6b 4-ClC6H4 70 6-8 
VBA-6c 3-ClC6H4 70 6-8 
VBA-6d 4-BrC6H4 68 6-8 
VBA-6e 3,4Cl2C6H3 64 6-8 
VBA-6f 4-FC6H4 66 6-8 
VBA-6g 3-Cl,4-F,C6H3 62 8-10 
VBA-6h 4-CH3-C6H4 66 8-10 
VBA-6i 4-OCH3-C6H4 64 8-10 
VBA-6j 3,4-(CH3)2C6H3 66 8-10 
VBA-6k 2,3-(CH3)2C6H3 66 8-10 
VBA-6l 2,6-(CH3)2C6H3 62 10-12 
VBA-6m 2-CH3C6H4 64 10-12 
VBA-6n 3-CH3C6H4 66 12-14 
VBA-6o 2,5-(CH3)2C6H3 62 12-14 
VBA-6p 2,5-(Cl)2C6H3 60 10-12 
VBA-6q 4-C2H5C6H4 64 10-12 
VBA-6r 4-NO2C6H4 64 10-12 
VBA-6s 3-NO2C6H4 68 8-10 
 
 
? Brief Spectral Analysis Discussion Compounds VBA 6a-s 
The structure of VBA-6a was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 6a revealed 
a molecular formula C13H14N4O2 (m/z 258). The 1H NMR spectrum revealed one 
singlet at δH= 2.31ppm assigned to 3 protons of (-CH3) group of methyl, one singlet at 
δH= 3.89ppm assigned to 3 protons of (-OCH3) group of methyl, one singlet at δH= 
6.22ppm assigned to 2 protons of (-NH2) group of 1o-NH2,a triplet at δH= 7.03-
7.06ppm  assigned to 1 proton of (-Ar-H) group, a doublet at δH= 7.26-7.30ppm 
assigned to Ar-H (2H),one doublet at δH= 7.68-7.69ppm assigned to Ar-H (2H), one 
singlet at δH= 9.87ppm assigned to –ArCONH groups . 
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The structure of VBA-6h was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for VBA-6h 
revealed a molecular formula C14H16N4O2 (m/z 272). The 1H NMR spectrum revealed 
one singlet at δH= 2.29ppm assigned to 6 protons of (-CH3, ArCH3) group of methyl, 
one singlet at δH= 3.88ppm  assigned to 3 protons of (-OCH3) group of methyl, one 
singlet at δH= 6.26ppm  assigned to 2 protons of (-NH2) group of 1o-NH2, a doublet at 
δH = 7.07-7.09ppm assigned to Ar-H (2H) ,a doublet at δH= 7.57-7.95 ppm assigned to 
Ar-H (2H), one singlet at δH= 9.80ppm assigned to –ArCONH groups .  
 The mechanism (Figure-34), in ketene dithioacetal system the carbonyl 
carbon and β-carbon atoms regarded as hard and soft electrophilic centers, since the 
carbonyl carbon is adjacent to the hard-base oxygen while the β-carbon is flanked by 
the soft-basemethylthio group. Thus, the binucleophile guanidine in the presence of 
base attacks oncarbonyl carbon of systems and formed heterocyclic product by 
removal of water molecule followed by methylthio as good leaving group.  
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Figure 34: Proposed mechanism for the formation of substituted Pyrimidine. 
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3.6  Conclusion 
 In summary, various ketene dithioacetals has been identified as a versatile 
intermediate for the reaction of 2-amino-6-methoxy-5-methyl-N-arylpyrimidine-4-
carboxamide (VBA6a-s) in high yields at ambient temperature. The present method is 
concise and efficient. The main advantage of this process is easy work up process and 
high yield of the diversify pyrimidine derivatives for biological interest. 
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3.7  EXPERIMENTAL SECTION 
 
Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZUFTIR-8400 
spectrophotometer using DRS prob. 1H (400 MHz) and 13C(100 MHz) NMR spectra 
were recorded on a BRUKER AVANCE II spectrometer in CDCl3 and DMSO 
respectively 13C NMR were recorded on 100 MHz spectrometer, referred to the 
internal solvent signals (77.0for CDCl3 or 40.0 for DMSO-d6). Chemical shifts are 
expressed in δ ppm downfield from TMS as an internal standard. Mass spectra were 
determined using direct inlet probe on a SHIMADZUGCMS-QP 2010 mass 
spectrometer. Solvents were evaporated with a BUCHI rotary evaporator. Melting 
points were measured in open capillaries and are uncorrected. The chemicals used in 
this work were purchased from Merck, Spectro chem and Sisco Chemical Companies. 
 
? General synthesis of 3-oxo-N-arylbutanamide 2a-s. 
 A mixture containing the primary amine (10 mmol), Ethyl acetoacetate (10 
mmol), and catalytic amount of sodium or potassium hydroxide (10 %) was refluxed 
at 110oC for the approximately 15-20 h. The reaction was monitored by TLC. After 
completion of reaction, the solvent was removed under vaccuo when the reaction was 
completed. The solid or oil was crystallized from methanol to give pure product 2a-s. 
 
? General synthesis of ketene dithioacetals 3a-s. 
 A 100mL conical flask equipped with magnetic stirrer and septum was 
charged with a solution of 3-oxo-N-p-tolylbutanamide 2a-t, (10 mmol) in DMF (10 
ml). Dried K2CO3 (10 mmol) was added and the mixture was stirred for 2 h at room 
temperature. CS2 (30 mmol) was added and the mixture was stirred for an additional 2 
h at room temperature. Methyl iodide (20 mmol) was added at 0-5oCandthe mixture 
was stirred for 4 h.The reaction is being monitored by TLC.The precipitated crude 
product was filtered and purified by crystallization from EtOH. In case of oily 
product, the organic phase was extracted with Et2O (3 ×10 mL). The combined 
organic extracts were washed with H2O (2 ×10 mL), dried over (MgSO4), and 
concentrated in vaccuo to afford ketene dithioacetals directly used for the next step. 
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? General procedure for the synthesis of substituted pyrimidines VBA-5a-s. 
 To a solution of guanidine nitrate (10 mmol) 5 and sodium methoxide in 
methanol was added the solution of ketene dithioacetals 4a-s (10 mmol) in methanol 
within 10-15 min. resulting reaction mixture was further stirred at room temperature 
for 15 min followed by reflux for 8-14h on water bath. After completion of the 
reaction, the reaction mixture was poured onto ice cold water. Thus, the obtained 
solid was filtered, washed with water, dried it and crystallized from EtOH to afforded 
analytically pure products 6a-s. 
 
? Spectral data of the synthesized compounds VBA 6a-s. 
 
2-amino-6-methoxy-5-methyl-N-phenylpyrimidine-4-carboxamide (VBA-6a): 
White solid; Rf 0.38 (8:2 H-E.A); mp 219-221°C; IR (KBr): 3460, 3342, 3286, 3196, 
3171, 3147, 3068, 3026, 1753, 1647, 1575, 1550, 1494, 1447, 1371, 1325, 1265, 
1238, 1203, 1097, 1033 ,977, 891, 829, 796, 785, 692, cm-1 ; 1H NMR 
(400MHz,DMSO): δH 2.31 (S, 3H, -CH3), 3.89 (s, 3H, -OCH3), 6.22 (s, 2H, -NH2), 
7.03-7.06 (m, 1H, Ar-H), 7.26-7.30 (m, 2H, Ar-H), 7.68-7.69 (d, J=8 Hz 2H, Ar-H), 
9.87 (s, 1H, -CONH); 13C NMR (100MHz,DMSO): δC  21.61, 53.14, 107.25, 119.20, 
138.91, 161.81, 164.15, 165.75, 166.68 ; MS m/z: 258(M+); Anal. Calcd. for 
C13H14N4O2: C, 60.45; H, 5.46; N, 21.69 %. Found: C, 60.38; H, 5.36; N, 21.61%. 
 
2-amino-N-(4-chlorophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6b): Yellow solid; Rf 0.34 (8:2 H-E.A); mp 218-220°C; IR (KBr): 3460, 3342, 
3171, 3068, 3026, 2988, 1647, 1575, 1550, 1494, 1444, 1371, 1212, 1033 ,820, 715, 
cm-1; MS m/z:292.7(M+); Anal. Calcd. for C13H13ClN4O2: C, 53.34; H, 4.48; N, 
19.14%. Found: C, 55.42; H, 4.38; N, 19.08%. 
 
2-amino-N-(3-chlorophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6c): Pale yellow solid; Rf 0.32 (8:2 H-E.A); mp 225-227°C; IR (KBr): 3472, 
3354, 3175, 3055, 3026, 2984, 1647,1575, 1550, 1498, 1459, 1371, 1218, 1045 , 896, 
815, cm-1; MS m/z: 292.7(M+); Anal. Calcd. for C13H13ClN4O2: C, 53.34; H, 4.48; N, 
19.14%. Found: C, 53.28; H, 4.41; N, 19.11%. 
 
2-amino-N-(4-bromophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6d): Lemon yellow solid; Rf 0.32(8:2 H-E.A); mp 227-229°C; IR (KBr): 3465, 
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3362, 3098, 3012, 2994, 1647, 1575, 1550, 1494, 1444, 1371, 1209, 1018 , 834, 704, 
cm-1; MS m/z: 337.2(M+); Anal. Calcd. for C13H13BrN4O2: C, 46.31; H, 3.89; N, 
16.62%. Found: C, 46.27; H, 3.78; N, 16.57%. 
 
2-amino-N-(3,4-dichlorophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6e): Yellow solid; Rf 0.34 (8:2 H-E.A); mp 231-233°C; IR (KBr): 3503, 3385, 
3107, 2975, 2910, 2822, 1645, 1585, 1552, 1465, 1410, 1371, 1317, 1249, 1185, 
1029, 875, 792, cm-1; MS m/z: 327.2(M+); Anal. Calcd. for C13H12Cl2N4O2: C, 47.72; 
H, 3.70; N, 17.12; O, 9.78%. Found: C, 47.65; H, 3.62; N, 17.05%. 
 
2-amino-N-(4-fluorophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6f): Pale yellow solid; Rf 0.35 (8:2 H-E.A); mp 200-202°C; IR (KBr): 3603, 
3371, 3122, 2989, 2910, 2843, 1645, 1585, 1552, 1465, 1410, 1371, 1321, 1249, 
1197, 1037, 864, 790, cm-1; 1H NMR (400MHz,CDCl3): δH 2.58 (s, 3H, -CH3), 4.01 
(s, 3H, -OCH3), 5.15 (s, 2H, -NH2), 7.09-7.11 (d, 1H  J=8 Hz, Ar-H), 7.24-7.28 (m, 
1H, Ar-H), 7.42-7.44 (d, 1H  J=8 Hz, Ar-H), 7.73 (s, 1H, Ar-H), 8.34 (s, 1H, -
CONH); 13C NMR (100MHz,CDCl3); δC 20.43, 54.55, 99.99, 124.45, 129.99, 148.53, 
157.27; MS m/z: 276.3(M+); Anal. Calcd. for C13H13FN4O2: C, 56.52; H, 4.74; N, 
20.28%. Found: C, 56.47; H, 4.65; N, 20.11%. 
 
2-amino-N-(3-chloro-4-fluorophenyl)-6-methoxy-5-methylpyrimidine-4-
carboxamide (VBA-6g):Yellow solid; Rf 0.34 (8:2 H-E.A); mp 221-224°C; IR (KBr): 
3456, 3107, 2989, 2843, 1647, 1588, 1557, 1475, 1412, 1375, 1327, 1254, 1191, 
1022, 864, 815, cm-1; MS m/z: 310.7(M+); Anal. Calcd. for: C13H12ClFN4O2; C, 
61.75; H, 5.92; N, 20.58%Found: C, 61.69; H, 5.96; N, 20.65%. 
2-amino-6-methoxy-5-methyl-N-p-tolylpyrimidine-4-carboxamide (VBA-6h): 
Lemon yellow solid; Rf 0.36 (8:2 H-E.A); mp 224-228°C; IR (KBr): 3431, 3290, 
3132, 3039,  2922, 1660, 1539, 1523, 1458, 1408, 1365, 1313, 1255, 1201, 1097, 
1037, 979, 895, 808, 667, cm-1; 1H NMR (400MHz, DMSO): δH 2.29 (s, 3H -CH3,  
Ar-CH3,), 3.88 (s, 3H, -OCH3), 6.26 (s, 2H, -NH2), 7.07-7.09 (d,  J=8 Hz 2H, Ar-H), 
7.55-7.57 (d, J=8 Hz 2H, Ar-H), 9.80 (s, 1H, -CONH); 13C NMR (100MHz,DMSO): 
δC 20.43, 21.58, 29.06, 53.10, 107.30, 119.20, 128.70, 132.27, 136.43, 161.82, 
163.93, 165.62, 166.64; MS m/z: 272.3(M+); Anal. Calcd. for:C14H16N4O2C, 61.75; H, 
5.92; N, 20.58%. Found: C, 61.67; H, 5.84; N, 20.46%. 
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2-amino-6-methoxy-N-(4-methoxyphenyl)-5-methylpyrimidine-4-carboxamide 
(VBA-6i): Lemon yellow solid; Rf 0.28 (8:2 H-E.A); mp 223-225°C; IR (KBr): 3435, 
3297, 3135, 3045, 2945, 1660, 1539, 1523, 1458, 1418, 1365, 1313, 1265, 1211, 
1037, 812, 667, cm-1 ; MS m/z: 288.33(M+); Anal. Calcd. for C14H16N4O3: C, 58.32; 
H, 5.59; N, 19.43%. Found: C, 58.36; H, 5.49; N, 19.38%. 
 
2-amino-6-methoxy-5-methyl-N-(3,4-dimethylphenyl)pyrimidine-4-carboxamide 
(VBA-6j) : Yellow solid; Rf 0.34 (8:2 H-E.A); mp 227-229°C; IR (KBr): 3428, 3288, 
3127, 3045, 2942, 1660, 1539, 1523, 1458, 1412, 1358, 1313, 1258, 1196, 1037, 804, 
711, cm-1; MS m/z: 286.30(M+); Anal. Calcd. for C15H18N4O2: C, 62.92; H, 6.34; N, 
19.57%. Found: C, 62.87; H, 6.28; N, 19.48%. 
 
2-amino-6-methoxy-5-methyl-N-(2,3-dimethylphenyl)pyrimidine-4-carboxamide 
(VBA-6k): Yellow solid; Rf 0.30 (8:2 H-E.A); mp 232-234°C; IR (KBr): 3425, 3296, 
3122, 3052, 2955, 1660, 1539, 1523, 1458, 1410, 1354, 1313, 1254, 1190, 1037, 802, 
771, cm-1; MS m/z: 286.33(M+); Anal. Calcd. for C15H18N4O2: C, 62.92; H, 6.34; N, 
19.57%. Found: C, 62.89; H, 6.28; N, 19.61%. 
 
2-amino-6-methoxy-5-methyl-N-(2,6-dimethylphenyl)pyrimidine-4-carboxamide 
(VBA-6l): Yellow solid; Rf 0.32 (8:2 H-E.A); mp 235-237°C; IR (KBr): 3432, 3298, 
3127, 3044, 2942, 1660, 1539, 1523, 1458, 1406, 1352, 1315, 1246, 1194, 1035,  804,  
751, cm-1; MS m/z: 286.33(M+); Anal. Calcd. for C15H18N4O2: C, 62.92; H, 6.34; N, 
19.57%.Found: C, 62.88; H, 6.26; N, 19.51% 
 
2-amino-6-methoxy-5-methyl-N-o-tolylpyrimidine-4-carboxamide (VBA-6m): 
Lemon yellow solid; Rf 0.34 (8:2 H-E.A); mp 232-226°C; IR (KBr): 3428, 3292, 
3125, 3044, 2942, 1660, 1539, 1523, 1458, 1406, 1352, 1315, 1246, 1194, 1035,  804,  
751, cm-1; MS m/z: 272.3(M+); Anal. Calcd. for C14H16N4O2: C, 61.75; H, 5.92; N, 
20.58%. Found: C, 61.77; H, 5.98; N, 20.51%. 
 
2-amino-6-methoxy-5-methyl-N-m-tolylpyrimidine-4-carboxamide (VBA-6n):        
Lemon yellow solid; Rf 0.34 (8:2 H-E.A); mp 228-230°C; IR (KBr): 3422, 3282, 
3118, 3032, 2957, 1660, 1539, 1523, 1458, 1406, 1352, 1315, 1242, 1192, 1054,  875,  
812, cm-1; MS m/z: 272.3(M+); Anal. Calcd. for C14H16N4O2: C, 61.75; H, 5.92; N, 
20.58%. Found: C, 61.77; H, 5.84; N, 20.61%. 
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2-amino-6-methoxy-5-methyl-N-(2,5-dimethylphenyl)pyrimidine-4-carboxamide 
(VBA-6o): Yellow solid; Rf 0.34 (8:2 H-E.A); mp 237-239°C; IR (KBr): 3432, 3294, 
3126, 3018, 2957, 1660, 1539, 1523, 1458, 1406, 1358, 1315, 1254, 1204, 1058,  795, 
762, cm-1; MS m/z: 286.33(M+); Anal. Calcd. for C15H18N4O2: C, 62.92; H, 6.34; N, 
19.57%. Found: C, 62.85; H, 6.28; N, 19.58%. 
 
2-amino-N-(2,5-dichlorophenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6p): Yellow solid; Rf 0.30 (8:2 H-E.A); mp 242-244°C; IR (KBr): 3416, 3310, 
3129, 3012, 2962, 1660, 1539, 1523, 1458, 1406, 1346, 1309, 1248, 1210, 1078,  785,  
759, cm-1; MS m/z: 327.17(M+); Anal. Calcd. for C13H12Cl2N4O2: C, 47.72; H, 3.70; 
N, 17.12%. Found: C, 47.65; H, 3.62; N, 17.18%. 
 
2-amino-N-(4-ethylphenyl)-6-methoxy-5-methylpyrimidine-4-carboxamide 
(VBA-6q): Yellow solid; Rf 0.36 (8:2 H-E.A); mp 217-219°C; IR (KBr): 3436, 3314, 
3136, 3025, 2958, 2832, 1660, 1539, 1523, 1458, 1406, 1346, 1318, 1242, 1216, 
1082, 817, 692, cm-1; MS m/z: 286.33(M+); Anal. Calcd. for C15H18N4O2: C, 62.92; H, 
6.34; N, 19.57%. Found: C, 62.88; H, 6.28; N, 19.48%. 
 
2-amino-6-methoxy-5-methyl-N-(4-nitrophenyl)pyrimidine-4-carboxamide 
(VBA-6r): Yellow solid; Rf 0.28 (8:2 H-E.A); mp 224-226°C; IR (KBr): 3454, 3308, 
3116, 3015, 2966, 1660, 1539, 1535, 1523, 1458, 1406, 1365, 1346, 1318, 1254, 
1222, 1082, 815, 702, cm-1; MS m/z: 303.27(M+); Anal. Calcd. for C13H13N5O4: C, 
51.48; H, 4.32; N, 23.09%. Found: C, 51.45; H, 4.28; N, 23.01%. 
 
2-amino-6-methoxy-5-methyl-N-(3-nitrophenyl)pyrimidine-4-carboxamide 
(VBA-6s): Yellow solid; Rf 0.26 (8:2 H-E.A); mp 234-236°C; IR (KBr): 3465, 3322, 
3108, 3028, 2958, 1660, 1539, 1535, 1523, 1462, 1418, 1365, 1346, 1322, 1262, 
1228, 1096, 897, 845, cm-1; MS m/z: 303.27(M+); Anal. Calcd. for C13H13N5O4: C, 
51.48; H, 4.32; N, 23.09%. Found: C, 51.39; H, 4.28; N, 23.05%. 
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IR spectrum of VBA-6a 
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Chemical purity of VBA-6h 
 
Column: phenomenox (250X4.6), 5µ,     
Injection volume: 20 µL,                          
Mobile phase: H2O: Acetonitrile (30:70) premix; 
Diluent: Methanol 
Column Temp-30°C 
Flow-1mL/min 
 
 
 
Pk # Retention Time Area Area % 
1 3.467 2190 0.375 
2 11.659 582292 99.625 
Totals  584482 100.000 
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4.1 Introduction 
A pyran, or oxine, is a six-membered heterocyclic, non-aromatic ring, 
consisting of five carbon atoms and one oxygen atom and containing two double 
bonds. The molecular formula is C5H6O. There are two isomers of pyran that differ by 
the location of the double bonds. In 2H-pyran, the saturated carbon is at position 2, 
whereas, in 4H-pyran, the saturated carbon is at position 4. 
Lovastatin is a member of the drug class of statins, used for lowering 
cholesterol (hypolipidemic agent) in those with hypercholesterolemia and so 
preventing cardiovascular disease. Lovastatin is a naturally occurring drug found in 
food such as oyster mushrooms1 and red yeast rice.2 ALTOCOR™ (Lovastatin) 
Extended-Release Tablets contain a cholesterol-lowering agent isolated from a strain 
of Aspergillusterreus. After oral ingestion, lovastatin, which is an inactive lactone, is 
hydrolyzed to the corresponding β-hydroxyacid form. This is a principal metabolite 
and inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. 
This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early 
and rate limiting step in the biosynthesis of cholesterol (Figure-1). 
H
Me
O
OHO
H
H
Me
O
O
Me
Me
 
Figure-1 
Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and 
as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which 
mimics the main ingredient of cannabis (THC). Chemically, nabilone is similar to the 
active ingredient found in naturally occurring Cannabis sativa L3.Cesamet™ 
(nabilone) is a synthetic cannabinoid for oral administration. Nabilone as a raw 
material occurs as a white to off-white polymorphic crystalline powder. In aqueous 
media, the solubility of nabilone is less than 0.5 mg/L, with pH values ranging from 
1.2 to 7.0 (Figure-2). 
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1.2 Synthetic strategies for the pyran derivative. 
Mary anne morgan and Earle van heyningen4  have prepared  of 4,5-dihydro- 
2H-pyran-2,6(3H)-diones (I) appearing in the literature, there is no report of the 
synthesis of the isomeric 2H-pyran-3,5-(4H,6H)-dione(II). Gulland and Farrar5 do 
mention their interest in compounds of this type as possible chemotherapeutic agents; 
they had prepared some substituted cyclotelluropentane - 3,5 - diones which had 
exhibited marked activity and the pyran-3,5-diones are their oxygen analogs. There is, 
however, no subsequent report of their preparation by these authors. The route chosen 
was  indicated in (Figure-3). Initial attempts to make the ketones V from acyloins and 
α-bromoesters via an ether synthesis were unsuccessful for no single, pure product 
could be isolated. But when the acetylenic alcohols III were used in the ether 
formation, acceptable yields of pure acetylenic ether-esters could be obtained. In 
general, the hydration of the acetylene moiety to the methyl ketone proceeded as 
expected. However, in the hydration of 3- carbethoxymethoxy-l- hexyne (IV, R = H, 
R' = C3H6) the solvent used was methanol, and trans esterification occurred during the 
reaction to give as a product an inseparable mixture of methyl and ethyl esters. Since 
the alkoxy1 group is lost in the ring closure, this mixture was as useful as a pure ester 
(Figure-3).  
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Figure-3 
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Nobuyuki Ishibe et al.6 nave developed ultraviolet irradiation of 2, 6-dimethyl-
3, 5-diphenyl-4H-pyran-4-one with a medium-pressure mercury lamp yielded 3, 6-
diphenyl-4,5-dimethyl-2H-pyran-2-one. Photolysis of 2,3,5,6-tetraphenyl-4H-pyran-
4-one afforded 3,4,5,6-tetraphenyl-2H-pyran-2-one afforded 5,6,7,8-dibenzo-2,3-
diphenyl-4-chromen-4-one The photo rearrangement of the hindered 4H-pyran-4-ones 
appears to proceed through two consecutive photoreactions ; the first step is the light-
induced rearrangement of the hindered 4H-pyran-4-ones to the 4,5-epoxycyclopent-2-
en-l-one derivatives and the second is the photo isomerization of the latter to 2H-
pyran-2-ones.  
Under the influence of ultraviolet light 2,6 disubstitued 4H-pyran-ones(Ia, Ib, 
and Ic) undergo dimerization to head to tail dimmers (II)7,8 when the photolysis of Ia 
was carried out under the chosen conduction to reacted dimerization. 4,5-dimethy1-2-
furaldehyde (IIIa) was isolated in very low yield9. Yates and Stills suggested that this 
photoreaction proceeds by rearrangement to 3,4-dimethyl-4,5-epoxycyclopent-2- en- 
1-one (IVa), which is analogous to the photochemical transformation of cyclohexa-
2,5-dienone derivatives10. 
Studies on the photochemistry of 4,5-epoxycyclopent- 2-en- 1-one derivatives 
(IVb and IVc) have revealed that IV undergoes photo isomerization to the 
corresponding 2H-pyran-2-ones (Vb and Vc), 11-14 while furaldehyde derivatives (III) 
were actually formed via the acid catalyzed rearrangement of (IV)11 Padwaand 
Hartman11 have examined the photolysis of 2,6-diphenyl-4H-pyran- 4-one (IC) and 
could not detect the formation of either 3,4-diphenyl-4,5-epoxycyclopent-2-en-1-o ne 
(IVb) or 4,5-diphenyl-2H-pyran-2-one (V b), but obtained only a “head-to-tail’’ cage 
dimer, IIc 8,15 (Figure-4). 
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Figure-4 
Gary A. Molander et al.16 have demonstrated the synthetic utility of the 
cationic lanthanide complex, [(C5Me5)2Ce]-[BPh4], as an effective Lewis acid catalyst 
for the hetero Diels-Alder reaction between Danishefsky’s diene and substituted 
benzaldehydes. The reactions can be performed with as little as 0.1 mol % catalyst, 
although 2 mol % catalyst loading provides for more reasonable reaction times. 
Various functionalities are tolerated in the reaction. Gary A. Molander et al.16 have 
also provided evidence suggesting this reaction follows a concerted pathway. These 
results suggest that cationic organ lanthanides may be useful catalysts in other 
important organic reactions (Figure-5). 
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Figure-5 
Taishi Kawasaki and Yoshinori Yamamoto17 have prepared various kinds of 
6H-dibenzo[b,d]pyran-6-ones 4 were synthesized via a sequential one-pot procedure 
using the Sonogashira coupling-benzannulation reaction of aryl 3-bromopropenoates 
1, in which the ortho-position of aryl group is substituted with enynes or iodine, with 
acetylenes 2 in the presence of palladium and copper catalysts. The Sonogashira 
coupling between the aryl 3-bromopropenoates 1a and 1b, bearing enynes at the 
ortho-position of aryl group, and alkynes 2a-g gave the enyne intermediates 3 in situ, 
which subsequently underwent the palladium-catalyzed benzannulation reaction to 
afford the 6H-dibenzo[b,d]pyran-6-ones 5 (Figure-6). 
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Figure-6 
P. N. Praveen Rao et al.18 have identified the agents with specific 
antiproliferative or cytostatic activity against endothelial cells and also describe novel 
substituted dibenzo[b,d]pyran-6-one scaffold, exemplified by structures 9a and 10, 
and report preliminary in vitro activity data indicating that this scaffold could be a 
promising lead for the development of specific inhibitors of endothelial cell 
proliferation (Figure-7).  
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Figure-7 
Xiang-Shan Wang et al.19 have synthesized series of pyrano[3,2-c]pyran 
derivatives by the reaction of aromatic aldehyde, malononitrile or cyanoacetate and 4-
hydroxy-5-methylpyran-2-one in EtOH at room temperature catalyzed by KF/Al2O3. 
The structures of the products have been characterized by IR, 1H NMR and elemental 
analysis, and 4a was further confirmed by X-ray diffraction analysis (Figure-8). 
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Jun Liu, Mang Wang et al.20 developed a divergent synthesis of functionalized 
unsaturated δ-lactones 2, 3, 4, and 5 has been developed starting from the readily 
available α-alkenoyl-α-carboxyl ketene dithioacetals 1 in high to excellent yields 
under mild reaction conditions. Thus, 6-substituted 3-(1,3-dithiolan/dithian-2-
ylidene)-3H-pyran-2(6H)-ones 2, obtained from a consecutive reduction with NaBH4 
and acidic workup of 1 via a novel vinylogous Pummerer cyclization, can be further 
transformed into R-pyranones 3, 4, and 5 upon a sequential isomerization catalyzed by 
triethylamine (to give 3), followed by dethioacetalization (to give 4) or a formylation 
with Vilsmeier reagent (to give 5) (Figure-9). 
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Figure-9 
? Synthetic Methods for the substituted Pyran 
Nopporn Thasana et al.21 have developed a simple and highly effective C-
Ocarboxylic coupling reaction catalyzed by copper (I) salts to synthesize 
benzopyranones. The reaction of various 2-halobiarylcarboxylic acids has been 
examined using microwave irradiation. A new class of pyrroloisoquinoline alkaloid, 
isolamellarin, was synthesized based on the annulation of dihydroisoquinoline with 
aryl pyruvates under basic condition and Cu-mediated MW-assisted C-
Ocarboxyliclactonization (Figure-10). 
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Figure-10 
 
R. Pratap et al.22 have described innovative and concise synthesis of (7,8-
dihydro-5-benzo[c]chrysene-6-ylidene)acetonitriles through base catalyzed ring 
transformation of 2-oxo-4-piperidin-1-yl-5,6-dihydro-2H-benzo[h]chromene-3-
carbonitriles with 1-tetralone in very good yields (Figure-11). 
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Figure-11 
? Synthetic Methods for the substituted pyran 
R. Pratap et al.23 have developed an efficient and concise de novo synthesis of 
ferrocenyl tethered partially reduced phenanthrenes was described through base-
catalyzed ring transformation of 4-sec-amino-2-oxo-5,6-dihydro-2H-benzo[h] 
chromene-3-carbonitriles with acetylferrocene (Figure-12). 
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Figure-12 
V. Kumar et al.24 have described general, highly efficient synthesis of arylated 
benzenes from simple stitching of α-oxo-ketene-S,S-acetalsand functionalized 
deoxybenzoinsvia a ‘lactone intermediate’. This offers easy access to highly 
functionalized arylated benzenes containing sterically demanding groups in good to 
excellent yields. The advantage of the procedure lies in the fabrication of 
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arylatedbenzenes with desired conformational flexibility along the molecular axis at 
room temperature and in a transition metal-free environment through easily accessible 
precursors (Figure-13). 
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Figure-13 
A. Goel, and F. V. Singh25 exposed the synthesis of unsymmetrical biaryls 
functionalized with electron-withdrawing or -donating substituents is described and 
illustrated by the carbanion-induced ring transformation of 2H-pyran-2-ones with 
malononitrile in excellent yields (Figure-14). 
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Figure-14 
 
? Reported synthetic approaches 
R. Pratap et al.26 have described an efficient and concise synthesis of 17-
amino-6,15-dihydro-7H-11-oxa-15,16-diazacyclopenta[a]phenanthren-12-ones which 
delineated from the reaction of 4-methylsulfanyl/sec-amino-2-oxo-5,6-dihydro-2H-
benzo[h]chromene-3-carbonitriles and hydrazine hydrate (98%) at room temperature 
which gave 6, Regio -selectively, in excellent yield. Reaction at reflux produced 
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different products, characterized as 1-amino-3b,4,5,11-tetrahydro-3H-2,3,10,11-
tetraazanaphtho[2,1-e]azulen-12-ones in moderate yields.Figure-15 
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Figure-15 
A. Goel et al.27 have reported an innovative synthesis of terphenyls 
functionalized with electron-withdrawing or -donating substituents and illustrated by 
carbanion-induced ring transformation of 2H-pyran-2-ones with 2-methoxy 
acetophenone in excellent yields. The existing protocols for the synthesis of 
terphenyls were generally inter- and intramolecular aryl–aryl cross couplings in the 
presence of metal complexes (Figure-16). 
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Figure-16 
Timothy Norris and Kyle Le28 developed Palladium-catalyzed carbon-sulfur 
bond formation using modified Migita reaction conditions was explored and applied 
to the synthesis of a former antiasthma drug candidate, tetrahydro-4- [3-[4-(2-methyl-
1H-imidazol-1-yl)phenyl]thio]phenyl-2H-pyran-4- carboxamide (5) (Figure- 17). The 
reaction was developed into a general method for thioaryl halide cross-coupling, and a 
specific example of its use to synthesize a key intermediate, tetrahydro-4-[3-(4- 
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fluorophenyl)thio]phenyl-2H-pyran-4-carboxamide (6) was demonstrated at large 
scale to provide phase II clinical supplies of 5. Comparison of the multistep phase I 
process and the two-step phase II process showed an overall yield advantage over the 
bond forming steps from common starting material (1) to API 5 of 40%. The ligand 
effect in the modified Migita reaction is described in detail. The second step of the 
scale-up process illustrated formation of carbon-nitrogen bonds without use of 
palladium catalysis, providing a contrast to the first reaction; both reactions were 
developed into efficient single-vessel direct isolation processes.
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Figure-17 
 
AtulGoel et al.29 have demonstrated a general, two-step, highly efficient 
synthesis of 1,2-diaryl-, 1,2,3- triaryl-, and 1,2,3,4-tetraarylbenzenes from simple 
stitching of α-oxo-ketene- S,S-acetals and active methylene compounds via a lactone 
intermediate. This procedure offers easy access to highly functionalized arylated 
benzenes that contain sterically demanding groups in good to excellent yields 
(Figure-18). 
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Figure-18 
 
Yoshinori Tominaga et al.30 have revealed the reaction of various types of 
acetyl compounds with a ketene dithioacetal, methyl2-cyano-3,3-bis(methylthio) 
acrylate, in the presence of potassium hydroxide which gave the correspounding 6-
aryl-and6-styryl-3-cyano-4-methylthio-2H-pyran-2-one derivatives. The methylthio 
group on the pyrone ring reacted readily with nucleophiles such as amines, active 
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methylene compounds and anion to yield the corresponding displacement product in 
good yield (Figure-19). 
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Figure-19 
Akikazu Kakehi et al.31 have synthesized pyrano[2,3-b]indolizine derivatives 
with 18-98% yields by the reactions of 3-[bis(alkylthio)-methylene]-2,3-dihydro 
indolizin-2-ones with various acetates in the presence of alkali.Dihydroindolizines 
were readily obtianed by the alkaline treatment of 1-[2,2-bis(alkylthio)-1-
ethoxycarbonylvinyl]-2-ethylpyridiniumiodides and -2-methylpyridinium iodides or 
bythe S-alkylation of 3-[(alkylthio)mercaptomethylene]-1-phenyl-2,3-dihydro 
indolizin-2-oneswith alkyl- iodides (Figure-20). 
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Figure-20 
 
Hong-Juan Yuanet et al.32 have developed new catalytic C-C bond-forming 
reaction has been developed. Catalyzed by cheap and commercially available 
copper(II) bromide (CuBr2 ; 10 mol%), the reactions of π-electron-withdrawing group 
(EWG)-substituted ketene S,S-acetals with aldehydes or ketones in acetonitrile at 
room temperature gave a variety of densely functionalized coupling products in 
excellent yields (80–98%). Based on this catalytic process, coumarin derivatives have 
been efficiently synthesized when salicylaldehydes were selected as the carbonyl 
components (Figure-21). 
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Figure-21 
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Helge Menz and Stefan F. Kirsch33 have achieved the application of easily 
accessed propargyl vinyl ethers for the synthesis of monocyclic 2H-pyrans. Under the 
reaction conditions, highly substituted heterocycles were obtained in moderate to 
excellent yields. The one-pot sequence proceeds via a Ag(I)-catalyzed propargyl-
Claisen rearrangement, followed by a base-catalyzed isomerization, and 6π-
oxaelectrocyclization, leading to the formation of stable 2Hpyrans (Figure-22) 
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Figure-22 
Boris I. Usachev et al.34 have revealed the expedient synthesis of a series of 2-
pyrones, bearing a CF3 group at the 6-position and aryl group at position 4, from 
readily available aryl-4,4,4-trifluorobutane-1,3-diones, PCl5, and sodium diethyl 
malonate (Figure-23). 
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Franklyn K. MacDonald and D. Jean Burnell35 have synthesized variety of 
R,β-unsaturated 1,3-diketones cyclize to 2,3-dihydro-4H-pyran-4-ones in an acidic 
aqueous medium, with exceptions being R,β-unsaturated 1,3-diketones in which the β 
carbon is substituted by a phenyl group. Addition of 1-butanamine to the reaction 
medium results in the formation of 2,3-dihydro-4-pyridinones, which appear to arise 
via an initial 1,4-addition of the amine to the R,β-unsaturated 1,3-diketones (Figure-
24). 
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Figure-24 
 
Xian Huang and Hongwei Zhou36 have exposed the mixture of 
cyclopropylideneacetic acids (or esters) and CuBr2 (or CuI/I2) in aqueous acetonitrile 
afforded 4-substituted 2(5H)-furanones or 3,4-substituted 5,6-dihydro-2H-pyran-2-
ones in moderate to good yields. The selectivity of the reaction greatly depended on 
the reaction temperature (Figure-25). 
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Mahmoud M. M. Ramiz et al.37 have synthesized a number of new 2,6-
didisubstituted pyrimidine, pyrazoline, and pyran derivatives starting from their 
chalcone derivative. The synthesized compounds displayed different degrees of 
antimicrobialactivity against Bscillussubtilis (Gram-positive), 
Pseudomonasaeruginosa (Gram-negative), and Streptomyces species (Actinomycetes) 
(Figure-26). 
 
Figure-26 
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Wen-Guo Zhao and Ruimao Hua38 have exposed the reaction of 1,3-
dicarbonyl compounds such as acetoacetate, acetylacetone, dibenzoylmethane, and 
benzoylacetate with electron-deficient internal alkynes in the presence of catalytic 
amount of ReBr(CO)5 in toluene under neutral conditions which resulted in the 
formation of 4,5,6-trisubstituted 2H-pyran-2-ones in moderate to high yield. The 
reaction took place via a two-step sequence including the rhenium(I)-catalyzed 
addition of the activated methylenes to alkynes to give enolic 2-alkenyl derivatives, 
and subsequently dealcoholic cyclization to form 2H-pyran-2-one derivatives  
(Figure-27). 
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Figure-27 
A thirupathaiah and G Venkateshwar Rao39 have developed the reaction of 
aldehyde /ketones with homopropargylic alcohols in the presence of bismuyhchloride 
generates the 4-chloro-5,6dihydro-2hpyranderivatives in excellent yield by employing 
microwave irradiation (Figure-28).  
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Figure-28 
Umesh R. Pratap et al.40 have revealed many Baker’s yeast catalyzed one-pot 
three-component cyclocondensation of aryl aldehydes, malononitrile, and b-
dicarbonyls in organic medium has been carried out to obtain polyfunctionalized 4H-
pyrans. The reaction has been carried out at room temperature in organic solvent, 
dimethylacetamide and the products obtained in good to moderate yields with simple 
work up procedure (Figure-29). 
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4.3 Biological Activity Associated with pyran derivatives and its 
synthesis method. 
P. N. Praveen Rao et al.41 have prepared regioisomeric 3,4,6-triphenylpyran-2-
ones with a MeSO2 at the para position of either a C-3 phenyl or a C-4 phenyl 
substituent on the central six-membered pyran-2-one ring and evaluated in vitro for 
their abilities to inhibit the isozymes COX-1 and COX-2. Structure-activity 
relationship (SAR) studies acquired by substituent modification at the para-position 
of the C-6 phenyl ring attached to the central pyranone, showed that 6-(4-
methoxyphenyl)-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-one (12e) was the 
most potent and selective COX-2 inhibitor (COX-2 IC50) 0.02 µM; COX-1 IC50> 100 
íM) with a highCOX-2 selectivity index (SI > 5000) relative to the reference drugs 
celecoxib (COX-2 IC50)0.07 µM; SI > 474) and rofecoxib (COX-2 IC50) 0.50 µM; SI 
> 200). 6-(4-Methoxy phenyl)-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-one 
(12e) was a more potent oral anti-inflammatory agent (ID50) 5.6 mg/kg) then 
celecoxib (ID50) 10.8 mg/kg). In contrast, the corresponding 6-(4-methoxyphenyl)-4-
(4-methane sulfonylphenyl)-3-phenylpyran-2-one regiosiomer (12o) was a less potent 
and selective COX-2 inhibitor (COX-2 IC50) 0.45 µM; SI> 70). A molecular 
modeling study for 12e indicated that the p-OMe substituent on the C-6 phenyl ring 
interacts with the COX-2binding site amino acids Ile345, Val349, Leu359, Leu531, 
and Met535 and that the OMe substituent may be responsible for proper orientation of 
the C-3 p-SO2Me-phenyl ring within the COX-2 secondary pocket (Gln192, Arg513, 
and Phe518). These results show that the COX-2 selectivity and potency of 3,4,6-
triphenylpyranone regioisomers can be modulated by appropriate placement of the p-
SO2Me pharmacophore on either the C-3 or C-4 phenyl moiety. In addition, electronic 
properties at the para-position of a C-6 phenyl substituent on the central pyranone ring 
govern COX-2 inhibitory potency and selectivity by controlling the orientation of the 
p-SO2Me pharmacophore within the COX-2 secondary pocket (Figure-30). 
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Figure-30 
 
Weston R. Judd et al.42 have developed a series of tetrahydropyranyl (THP) 
derivatives as potent inhibitors of isoprenylcysteine carboxyl methyltransferase 
(ICMT) for use as anticancer agents. Structural modification of the compound 3 led to 
the potent 3-methoxy substituted analogue 27.Further SAR development around the 
THP ring guided to increase additional 10-fold potency, exemplified by analogue 75 
with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent 
increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in 
several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 
μM. However, none of the cellular effects observed using ICMT inhibitors were as 
pronounced as those resulting from a farnesyl transferase inhibitor (Figure-31). 
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Susan E. Hagen et al.43 have developed some HIV protease inhibitors. Among 
them, 4-hydroxy-5,6-dihydropyronewas identified as a lead compound (CI-1029, 1) 
which possesses excellent activity against the protease enzyme, good antiviral 
efficacy in cellular assays, and promising bioavailability in several animal species. 
The search for a suitable backup candidate. In general, designed inhibitors displayed 
good activity (in both enzymatic and cellular tests) and low cellular toxicity; 
furthermore, several analogues exhibited improved pharmacokinetic parameters in 
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animal models. The compound with the best combination of high potency, low 
toxicity, and favorable bio availabilty was (S)-3-(2-tertbutyl-4-hydroxymethyl-5-
methyl-phenylsulfanyl)-4-hydroxy-6-isopropyl-6-(2-thiophen-3-ylethyl)-5,6-dihydro-
pyran-2-one (13-(S)) (Figure-32). 
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Figure-32 
 
 
Margherita De Rosa et al.44 have synthesized analogues of two naturally 
occurring antiinflammatory marine compounds, manoalide and cacospongionolide B, 
containing a pyranofuranone moiety which is considered the pharmacophoric group. 
The two series of compounds were tested for their inhibitory effects on secretory 
PLA2 belonging to the groups I, II, and III, and the activities were found to be similar 
in both series, irrespective of the presence or absence of the additional hemiacetal 
function. The most active compounds, FCA and FMA, carry a farnesyl residue linked 
to the pyranofuranone substructure. The most potent PLA2 inhibitor, FMA, was tested 
in the mouse carrageenan paw edema at the oral dose of 10 mg/kg and showed an 
activity similar to the reference antiinflammatory drug, indomethacin (Figure-33). 
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Figure-33 
 
Paul W. Smith et al.45 have designed 4-Amino- and 4-guanidino-4H-pyran-6-
carboxamides 4 and 5 related to zanamivir (GG167) as a inhibitors of influenza virus 
sialidases. Structure-activity studies reveal that, in general, secondary amides are 
weak inhibitors of both influenza A and B viral sialidases. However, tertiary amides, 
which contain one or more small alkyl groups, show much greater inhibitory activity, 
particularly against the influenza A virus enzyme. The sialidase inhibitory activities of 
these compounds correlate well with their in vitro antiviral efficacy, and several of the 
most potent analogues displayed useful antiviral activity in vivo when evaluated in a 
mouse model of influenza A virus infection. Carboxamides were highly active 
sialidase inhibitors in vitro also showed good antiviral activity in the mouse efficacy 
model of influenza A infection when administered intranasally but displayed modest 
activity when delivered by the intraperitoneal route (Figure-34). 
 
 
 
Figure-34 
 
J. V. N. Vara Prasad et al.46 have derived pyran-2-one 1, a series of (4-
hydroxy-6-phenyl- 2-oxo-ω-pyran-3-yl)thiomethane complex with crystal structure of 
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HIV-1 protease (HIV PR) and using molecular modeling study was carried out to 
design and analyzed as novel, non peptidic inhibitors of HIV PR. Structure-activity 
studies led to the discovery of inhibitor 19 having (RS)-1-(cyclopentylthio)-3-
methylbutylfunctionalization at the C-3 position, which exhibited a Kcof 33 nM. AX-
ray crystallographic structure of 19 bound to HIV PR showed that structural water-
301 (inhibitor-flap-bridging water) was displaced by the inhibitor. Some Selected 
compounds were tested for their antiviral activity on H9 cells infected with HIV-lIIIb. 
The best antiviral compound in this series was contained(R,S)-3-
[cyclopentyl(cyclopentyl-thio)methylfunctionalization at the C-3 position of the 
pyran-2-one ring and exhibited a IC50 of 14 µM and TC50 of 70 µM. These studies 
demonstrate that potent enzyme inhibition can be achieved by inhibitors that span 
only three subsites (Figure-35). 
 
Figure-35 
 
Fateh V. Singh et al.47 have synthesized a series of anthranilodinitrile-based 
biaryls and tested against extracellular promastigotes and intracellular amastigotes of 
Leishmaniadonovani. Among various screened compounds, a biaryl with 
trifluoromethyl group 5fshowed 83% inhibition against promastigotes and 70% 
inhibition against amastigotes of L. donovani at 8 and 20, l g/mL concentrations, 
respectively (Figure-36). 
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Figure-36 
A. Sharon et al.48 have synthesized various 6-aryl-3-cyano methoxycarbonyl-
4-methylsulfanyl-2H-pyran-2-ones as a potential substitute of 2,4-thiazolidinedione 
head group to express potent PPAR-c transactivation response. Some of the screened 
compounds have shown promising PPAR-c agonistic activity (Figure-37). 
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Figure-37 
F. V. Singh et al.49 have synthesized various nature-mimicking pyranones such 
as 6-(2,5-dimethylfuran-3-yl)-pyran-2-one and 6-(furan-2-yl)-pyran-2-one derivatives 
and evaluated for their in vivo antihyperglycemic activity in sucrose-loaded 
treptozotocin-induced diabetic rat model. Five of the test compounds showed 
significant lowering of plasma glucose level in STZ-S model (Figure-38). 
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4.4 Current research work 
 The highly substituted pyran derivatives have considerable chemical and 
pharmacological importance because of a broad range of biological activities 
displayed by these classes of molecules. As we demonstrated, the tremendous 
biological potential of substituted pyran derivatives encouraged us to synthesize some 
new highly functionalized substituted pyran derivatives. Various methodologies have 
been described for the synthesis of substituted pyran derivatives. However, the 
existing methods are suffer with some drawbacks, such as; yield, time, product 
isolation, purification, 
 As a part of our ongoing interest on the synthesis of various heterocyclic 
compounds using ketene dithioacetals, we have demonstrated that ketene dithioacetals 
are versatile intermediate for the synthesis of substituted pyran derivatives. Thus, to 
explore further, we sought that the reaction of various ketene dithioacetals with Ethyl 
cyanoacetate in the presence of base in IPA, MeOH, EtOH, t-BuOH, THF, MDC, 
DMF, could be an effective strategy to furnish the novel pyran derivatives. Here we 
describe the novel synthetic methodology for the pyran. A series of compounds 6a–o 
were prepared and evaluated for their agonistic property but none of them displayed 
any significant activity. Oxidation of both the methyl sulfanyl groups in 6a-o to its 
corresponding sulfoxide 7 reduced the activity profile of the compound. Exchange of 
methyl sulfanyl group by highly hydrophobic phenyl sulfanyl substituent in 8 
drastically reduced the activity in future. 
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4.5 Results and discussion 
Route of Synthesis for novel substituted pyran derivatives using various 
actoacetanilides. 
Scheme-01 
H
N
O
O O
NH2
O O
NaOH,Toluene,
Reflux
1 2 3
R R
 
Scheme-02 
H
N
O O
K2CO3,CS2, H
N
O O
SS
3 4
R R
DMF,5-6 hrs
Stirring
 
Scheme-03 
H
N
O O
SS
IPA,IPrONa
CN
COOEt HN
O
O O
S
CN
Stirring and reflux
 6-8 hrs
4 5 6a-o
R R
 
Where R= -CH3,-OCH3, -Cl, -Br, -F 
 
 Preparation of the target compounds was initiated by the reaction of ethyl 
acetoacetate (2) with aryl amines (1) in toluene at reflux temperature to afford the 
acetoacetanilide (3) in 85-90% yields (Scheme-1). This product undergoes reaction 
with carbon disulfide in the presence of base in DMF followed by methylation to 
afford corresponding 2-(bis(methylthio)methylene)-3-oxo-N-phenylbutanamide (4). 
Which on reaction with ethyl cyano acetate undergoes cyclization to form 5-cyano-2-
methyl-4-(methylthio)-6-oxo-N-phenyl-6H-pyran-3-carboxamide (6). 
 Eleven different acetoacetanilide were synthesized bearing various electron 
donating and electron withdrawing groups such as 2,3-diCH3; 3,4-diCH3; 4-CH3; H; 
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2,5-diCH3; 2,4-diCH3; 3-Cl-4-F; 4-F; 4-Cl; 2-Cl; 2-F; 4-OCH3; 2,5-diCl and 3-NO2 on 
the phenyl ring.  
The structure of VBA-6e was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for VBA-6e 
revealed a molecular formula C15H11FN2O3S (m/z 318). The 1H NMR spectrum 
revealed one singlet at δH= 2.38-2.40ppm assigned to 3 protons of (-CH3) groups, 
singlet at δH= 2.65-2.67ppm assigned to 3 protons of (-SCH3) groups of methyl, one 
doublet at δH= 7.03-7.05ppm assigned to Ar-H (2H), one doublet at δH = 7.24-7.26 
ppm assigned to Ar-H(2H), one singlet at δH= 7.97ppm assigned to –ArCONH 
groups. 
The structure of VBA- 6n was established on the basis of their elemental 
analysis and spectral data (MS, IR, and 1H NMR). The analytical data for VBA- 6n 
revealed a molecular formula C18H17N3O4S (m/z 330). The 1H NMR spectrum 
revealed one singlet at δ = 2.87ppm assigned to 3 protons of (-CH3) groups, a singlet 
at δ = 2.91ppm assigned to 3 protons of  (-SCH3) groups of methyl, one singlet at δ = 
3.84ppm assigned to 3 protons of (-OCH3) groups, one doublet at δ = 7.00-7.02ppm 
assigned to Ar-H (2H),one doublet at δ = 7.07-7.10ppm assigned to Ar-H (2H), one 
singlet at δ = 7.26ppm assigned to –ArCONH groups. 
The mechanism for the formation of pyran derivatives may involve the anion 
formed by the reaction of acetoacetate with base. The nucleophile attacks on b carbon 
atom of ketene dithioacetal system and followed by removal of leaving group form 
pyran moiety.  
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Figure: 39 Proposed mechanism for the formation of pyran 
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Table 1:Synthesis of Novel highly substituted pyran by using various a ketene 
dithioacetal. 
Entry R Yield % Time h. 
VBA-6a C6H5 72 8-10 
VBA-6b 4-ClC6H4 70 6-8 
VBA-6c 3-ClC6H4 70 6-8 
VBA-6d 4-BrC6H4 68 6-8 
VBA-6e 4-FC6H4 64 6-8 
VBA-6f 3,4Cl2C6H3 66 6-8 
VBA-6g 3-Cl,4-F,C6H3 62 8-10 
VBA-6h 4-CH3-C6H4 66 8-10 
VBA-6i 3-CH3-C6H4 64 8-10 
VBA-6j 3,4-(CH3)2C6H3 66 8-10 
VBA-6k 2,4-(CH3)2C6H3 66 8-10 
VBA-6l 2,5-(CH3)2C6H3 62 10-12 
VBA-6m 2,6-(CH3)2C6H3 64 10-12 
VBA-6n 4-OCH3-C6H4 66 12-14 
VBA-6o 4-NO2C6H4 62 12-14 
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4.6 Conclusion 
 In summary, we developed a new simple and versatile strategy for the 
synthesis of N-phenyl-6H-pyran-3-carboxamide derivatives by exploiting the reaction 
of ketene dithioacetals with ethyl cyanoacetate of type 1. The method offers several 
advantages including high yields of products and an easy experimental work-up 
procedure. The newly developed process is very useful for the syntheses of N-phenyl-
6H-pyran-3-carboxamide derivatives for biological interest. 
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4.8 EXPERIMENTAL SECTION 
Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZU FTIR-8400 
spectrophotometer using DRS prob. 13C NMR were recorded on 100 MHz 
spectrometer, referred to the internal solvent signals (77.0for CDCl3 or 40.0 for 
DMSO).Chemical shifts are expressed in δ ppm downfield from TMS as an internal 
standard. Mass spectra were determined using direct inlet probe on a SHIMADZU 
GCMS-QP 2010 mass spectrometer. Solvents were evaporated with a BUCHI rotary 
evaporator. Melting points were measured in open capillaries and are uncorrected. 
The chemicals used in this work were purchased from Merck and Spectrochem 
Chemical Companies. 
? General synthesis of 3-oxo-N-arylbutanamide 3a-o. 
 A mixture containing the primary amine (10 mmol), Ethyl acetoacetate (10 
mmol), and catalytic amount of sodium or potassium hydroxide lie (10 %) was reflux 
at 110oC for the approximately 15-20 h. The reaction was monitored by TLC. After 
completion of reaction, the solvent was removed under vaccuo when the reaction was 
completed. The solid or oil was crystallized from methanol to give pure product 2a-t. 
? General synthesis of ketene dithioacetals 4a-o. 
 A 100mL conical flask equipped with magnetic stirrer and septum was 
charged with a solution of 3-oxo-N-arylbutanamide 3a-t, (10 mmol) in DMF (10 ml). 
Dried K2CO3 (10 mmol) was added and the mixture was stirred for 2 h at room 
temperature. CS2 (30 mmol) was added and the mixture was stirred for an additional 2 
h at room temperature. Methyl iodide (20 mmol) was added at 0-5oC and the mixture 
was stirred for 4 h before being poured onto water (40 mL).The precipitated crude 
product was purified by filtration followed by crystallization from EtOH. In case of 
oily product, the organic phase was extracted with Et2O (3 ×10 mL). The combined 
organic extracts were washed with H2O (2 ×10 mL), dried (MgSO4), and concentrated 
in vaccuo to afford ketene dithioacetals directly used for the next step. 
? General procedure for the synthesis of substituted pyranVBA-6a-o. 
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 To a well stirred solution of sodium isopropoxide (12 mmol) in isopropyl 
alcohol (10 ml) was added ethyl cyanoacetate (10 mmol) in isopropyl alcohol within 
15-20 min at 0-5°C. Then the solution of ketene dithioacetals 3a-o (10 mmol) in the 
solvent was added to the reaction mixture within 10-15 min. The resulting reaction 
mixture was further stirred at rt for 15 min then reflux it for 6-8h on water bath. After 
completion of the reaction, the mixture was poured onto ice cold water.After 
completion of reaction, the solvent was removed under vaccuo when the reaction 
was completed. The solid residue was diluted with water. Filtrate this residue and 
acidified with dilute HCl to give a substituted pyran VBA 6a-o. 
 
? Spectral data of the synthesized compounds VBA 6a-o. 
5-cyano-2-methyl-4-(methylthio)-6-oxo-N-phenyl-6H-pyran-3-carboxamide 
(VBA-6a): Lemon yellow solid; Rf 0.20 (5:5 H-E.A); mp 145-147°C; IR (KBr): 3436, 
3358, 3136, 3047, 2955, 2812, 2216, 1684, 1616, 1545, 1509, 1452, 1418, 1311, 
1157, 1109, 854, 747, cm-1; MS m/z: 300.3(M+); Anal. Calcd. for C15H12N2O3S: C, 
59.99; H, 4.03; N, 9.33%. Found: C, 59.45; H, 4.35; N, 9.17%. 
N-(4-chlorophenyl)-5-cyano-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6b): Pale Yellow solid; Rf 0.18 (5:5 H-E.A); mp 132-134°C; IR 
(KBr): 3427, 3328, 3154, 3057, 2968, 2832, 2210, 1678, 1612, 1554, 1518, 1456, 
1418, 1311, 1157, 1097, 837, 754, cm-1; MS m/z: 334.8(M+);  Anal. Calcd. for 
C15H11ClN2O3S: C, 53.82; H, 3.31; N, 8.37%. Found: C, 53.77; H, 3.54; N, 8.09%. 
N-(3-chlorophenyl)-5-cyano-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6c): Pale yellow solid; Rf 0.18 (5:5 H-E.A); mp 216-218°C;IR 
(KBr): 3448, 3307, 3138, 3065, 2974, 2838, 2214, 1682, 1618, 1545, 1521, 1458, 
1418, 1311, 1164, 1097, 848, 769, cm-1; MS m/z: 334.8(M+); Anal. Calcd. for 
C15H11ClN2O3S: C, 53.82; H, 3.31; N, 8.37%. Found: C, 53.75; H, 3.15; N, 8.10%. 
N-(4-bromophenyl)-5-cyano-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6d): Lemon yellow solid; Rf 0.20 (5:5 H-E.A); mp 225-227°C; 
IR (KBr): 3469, 3359, 3107, 3048, 2969, 2817, 2222, 1679, 1609, 1542, 1518, 1449, 
1412, 1311, 1178, 1088, 856, 779, cm-1; MS m/z: 379.2(M+); Anal. Calcd. for 
C15H11BrN2O3S: C, 47.51; H, 2.92; N, 7.39%. Found: C, 47.72; H, 2.82; N, 7.56%. 
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5-cyano-N-(4-fluorophenyl)-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6e): yellow solid; Rf 0.22 (5:5 H-E.A); mp 155-157°C; IR (KBr): 
3435, 3316, 3103, 3087, 2932, 2868, 2228, 1687, 1634, 1555, 1516, 1443, 1408, 
1311, 1178, 1068, 838, 727, cm-1; 1H NMR: (400 MHz, DMSO) δH 2.38 (s, 3H, -
CH3), 2.65-2.67 (d, 3H, -SCH3), 7.00-7.05 (d, 2H, Ar-H), 7.24-7.26 (d, 2H, Ar-H), 
7.97 (s, 1H, -ArCONH) 13C NMR (100 MHz, DMSO): δc 19.59, 20.74, 23.59, 28.60, 
91.61, 108.68, 117.09, 127.77, 127.96, 129.23, 129.48, 132.51, 137.47, 160.39, 
160.66, 165.26, 196.44; MS m/z: 318.3(M+); Anal. Calcd. for C15H11FN2O3S: C, 
56.60; H, 3.48; N, 8.80%. Found: C, 56.69; H, 3.35; N, 8.20%. 
N-(3,4-dichlorophenyl)-5-cyano-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6f): Yellow solid; Rf 0.20 (5:5 H-E.A); mp 262-264°C; IR 
(KBr): 3447, 3352, 3126, 3074, 2952, 2816, 2224, 1672, 1626, 1548, 1524, 1448, 
1412, 1326, 1178, 1068, 856, 719, cm-1; MS m/z: 369.2(M+); Anal. Calcd. for 
C15H10Cl2N2O3S: C, 48.79; H, 2.73; N, 7.59%. Found: C, 48.84; H, 2.71; N, 7.57%. 
N-(3-chloro-4-fluorophenyl)-5-cyano-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6g): Yellow solid; Rf 0.18 (5:5 H-E.A); mp 248-250°C; IR 
(KBr): 3428, 3304, 3138, 3098, 2958, 2846, 2232, 1676, 1634, 1555, 1516, 1449, 
1416, 1315, 1169, 1085, 838, 788, cm-1; MS m/z: 352.8(M+); Anal. Calcd. for 
C15H10ClFN2O3S; C, 51.07; H, 2.86; N, 7.94%. Found: C, 51.37; H, 2.17; N, 7.65%. 
5-cyano-2-methyl-4-(methylthio)-6-oxo-N-p-tolyl-6H-pyran-3-carboxamide 
(VBA-6h): Tameric yellow solid; Rf 0.22 (5:5 H-E.A); mp 147-149°C; IR (KBr): 
3410, 3288, 3161, 3082, 2949, 2816, 2210, 1678, 1612, 1554, 1516, 1442, 1413, 
1311, 1157, 1087, 904, 837, 781, 698, cm-1; 1H NMR: (400 MHz, CDCl3) δH 2.20 (s, 
3H, -CH3),  2.88 (s, 3H, -ArCH3), 3.84 (s, 3H, -SCH3),7.14-7.26 (m, 4H, Ar-H),  8.72 
(s, 1H, -CONH), 13C NMR (100 MHz, CDCl3): δc 21.01, 29.20, 100.73, 103.70, 
114.68, 116.61, 116.83, 128.80, 128.84, 129.81, 129.90, 158.53, 161.61, 163.62, 
164.09, 169.40, 196.53; MS m/z: 314.4(M+); Anal. Calcd. for C16H14N2O3S: C, 61.13; 
H, 4.49; N, 8.91%. FoundC, 61.42; H, 4.08; N, 8.64%. 
5-cyano-2-methyl-4-(methylthio)-6-oxo-N-m-tolyl-6H-pyran-3-carboxamide 
(VBA-6i): Tameric yellow solid; Rf 0.22 (5:5 H-E.A); mp 167-169°C; IR (KBr): 
3418, 3296, 3145, 3072, 2958, 2839, 2215, 1684, 1618, 1569, 1527, 1458, 1427, 
Chapter 4   Highly Functionalized Novel Pyran Derivatives 
Department of Chemistry, Saurashtra University, Rajkot-360005  173 
1308, 1157, 1087, 837, 781, cm-1 ; MS m/z: 314.4(M+); Anal. Calcd. for 
C16H14N2O3S: C, 61.13; H, 4.49; N, 8.91%. Found:61.58; H, 4.17; N, 8.17%. 
5-cyano-2-methyl-N-(3,4-dimethylphenyl)-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6j): Tameric yellow solid; Rf 0.18 (5:5 H-E.A); mp 227-229°C; 
IR (KBr): 3445, 3315, 3163, 3064, 2962, 2836, 2207, 1684, 1618, 1569, 1536, 1458, 
1418, 1308, 1149, 1095, 837, 795, cm-1 ; MS m/z: 328.4(M+); Anal. Calcd. for 
C17H16N2O3S: C, 62.18; H, 4.91; N, 8.53%. Found: C, 62.76; H, 4.54; N, 8.75%. 
5-cyano-2-methyl-N-(2,4-dimethylphenyl)-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6k): Tameric yellow solid; Rf 0.18 (5:5 H-E.A); mp 248-250°C; 
IR (KBr): 3459, 3328, 3172, 3077, 2952, 2825, 2205, 1684, 1618, 1569, 1549, 1465, 
1418, 1326, 1149, 1107, 849, 785, cm-1 ; MS m/z: 328.4(M+); Anal. Calcd. for 
C17H16N2O3SC, 62.18; H, 4.91; N, 8.53%. Found: C, 62.58; H, 4.18; N, 8.85% 
5-cyano-2-methyl-N-(2,5-dimethylphenyl)-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6l): Lemon yellow solid; Rf 0.18 (5:5 H-E.A); mp 262-264°C; IR 
(KBr): 3415, 3305, 3065, 2947, 2836, 1685, 1607, 1547, 1505, 1469, 1418, 1354, 
1235, 1165, 1128, 1057, 859, 798, cm-1; MS m/z: 328.4(M+); Anal. Calcd. for 
C17H16N2O3S: C, 62.18; H, 4.91; N, 8.53%. Found: C, 62.38; H, 4.54; N, 8.44%. 
5-cyano-2-methyl-N-(2,6-dimethylphenyl)-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6m): Lemon yellow solid; Rf 0.18 (5:5 H-E.A); mp 244-246°C; 
IR (KBr): 3422, 3315, 3055, 2968, 2847, 1678, 1610, 1550, 1510, 1485, 1425, 1354, 
1235, 1165, 1109, 1025, 825, 798, cm-1; MS m/z: 328.4(M+); Anal. Calcd. for 
C17H16N2O3S: C, 62.18; H, 4.91; N, 8.53%. Found: C, 62.57; H, 4.54; N, 8.11% 
5-cyano-N-(4-methoxyphenyl)-2-methyl-4-(methylthio)-6-oxo-6H-pyran-3-
carboxamide (VBA-6n): Yellow solid; Rf 0.22 (5:5 H-E.A); mp 264-267°C; IR 
(KBr): 3468, 3350, 3070, 2995, 2837, 1678, 1610, 1550, 1510, 1498, 1438, 1359, 
1246, 1174, 1109, 1039, 877, 817, 781, cm-1; 1H NMR: (400 MHz, CDCl3) δH 2.87 (s, 
3H, -CH3), 2.91(s, 3H, -SCH3), 3.84 (s, 3H, -OCH3), 7.00-7.02 (dd, 2H, Ar-H), 7.07-
7.10 (m, 2H, Ar-H)  8.10 (s, 1H, -CONH), 13C NMR: (100MHz,CDCl3) δc 20.97, 
29.29, 55.54, 103.70, 114.85, 114.91, 125.41, 128.91, 158.75, 160.14, 163.19, 169.63, 
196.72; MS m/z: 330.4(M+); Anal. Calcd. for C16H14N2O4S: C, 58.17; H, 4.27; N, 
8.48%. Found C, 58.65; H, 4.10; N, 8.78% 
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3-cyano-6-methyl-4-(methylthio)-N-(4-nitrophenyl)-2-oxo-2H-pyran-5-
carboxamide (VBA-6o): yellow solid; Rf 0.22 (5:5 H-E.A); mp 272-274°C; IR 
(KBr): 3478, 3369, 3052, 2986, 2816, 1662, 1618, 1564, 1525, 1488, 1426, 1349, 
1246, 1174, 1109, 1042, 898, 812, 758, cm-1; MS m/z: 356(M+); Anal. Calcd. for 
C16H12N4O6: C, 53.94; H, 3.39; N, 15.73%. Found: C, 53.77; H, 3.29; N, 15.58%. 
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5.1     Introduction  
           
Thiazolo[4,5-d]pyrimidine 1 (a guanosine analogue) exhibited in vivo activity 
against a variety of RNA and DNA viruses1 and also had antitumor and antimetastatic 
properties.2 The guanine derivative 2 showed potent in vitro activity against human 
cytomegalovirus (HCMV).3 Thiazolo[4,5-d]pyrimidine-5,7-dione analogues (such as 
for example compound 3) have been reported as having anti-inflammatory activities, 
due to TNF inhibition.4 2-Oxo-3-arylthiazolo[ 4,5-d]pyrimidine analogues (compound 
4) have been synthesized as antagonists of the corticotrophin releasing hormone 
(CRH) R1 receptor.5 2-Thio-3-aryl-thiazolo[4,5-d] pyrimidine derivatives have been 
described as having anticancer6 (compound 6), anti-inflammatory and Anti -microbial 
activity7 (compound 7). 2-Aminothiazolo[4,5-d]pyrimidines (compound 8) which act 
as CXCR2 receptor antagonists are also known.8 Recently, 2,7-substituted-
thiazolo[4,5-d] pyrimidines (compound 5) have been described as ATP-competitive 
inhibitors of protein kinase 9(figure-1). 
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Figure-1 
 
Besides their structural resemblance to purines, thiazolo [5,4-d] pyrimidines 
can also be considered as bioisosteres of a pyrido [3,2-d] pyrimidine skeleton. The 
term bioisosterism has been introduced by Friedman in the early 50s to describe the 
phenomenon that structurally related substances show similar or antagonistic 
biological activities. According to Friedman’s definition, bioisosteres are compounds 
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which fit the definitions of isosteres and which have a similar type of biological 
activity, whether through agonist or antagonist actions.10 Later on, Thornber proposed 
a broadening of the term bioisosteres, defining them as subunits or groups or 
molecules with physicochemical properties of similar biological effects.11 In drug 
design, the purpose of exchanging one bioisostere for another is to enhance the 
desired biological or physicochemical properties of a compound without making 
significant changes in chemical structure. Ring equivalent bioisosteres have been used 
frequently in drug discovery programs.12 Very often this strategy led to the synthesis 
of different heterocyclic core structures, such as phenyl, thiophene, furan and pyridine 
analogues. Examples of ring isosterism in different therapeutic areas are given in 
(figure-2). 
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Figure-2 
Biginelli reported the synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-
ones (DHPMs) via three-component condensation reaction of an aromatic aldehydes, 
urea and ethyl acetoacetate (Figure-3). In the past decade, this multicomponent 
reaction has experienced a remarkable revival, mainly due to the interesting 
pharmacological properties associated with this dihydropyrimidine scaffold.13  
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Figure-3 
Biginelli reaction14 is not only important to synthesize analogs of DHPM ring 
using different building block as potent bioactive heterocycles, but diverse fused and 
non-fused heterocycles can be synthesized by careful applications and various 
scaffolds derived from DHPMs (figure-4).  
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As displayed in above figure, it can be understood that a number of new 
moieties can be generated from DHPM ring15.  
 
5.2 Alternative synthetic routes of DHPM 
 
?   Intramolecular Heck cyclization of DHPM 
The intramolecular Heck reaction can be observed in DHPM skeleton. The 
starting material for the intramolecular Heck reaction, DHPM was prepared by 
selective N3-acylation of 4-(o-bromophenyl)-dihydropyrimidone with acryloyl 
chloride16 (figure-5). 
 
N
H
NH
O
O
O Br
N
H
N
O
O
O Br
O
Cl
O Et3N, MeCN
MW, 180 °C, 20 min+
 
 
Figure-5 
Applying intramolecular Heck reaction, tricyclic ring system can be obtained 
as shown below17 (figure-6). 
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Figure-6 
 
The computational experiments reveal that the formation of a tricyclic ring 
system did not flatten out the overall geometry. On the contrary, the aryl ring was still 
locked in a pseudoaxial position, resembling other non fused 4-aryl-
dihydropyrimidines.18,19 In fact, here, (figure-7) the intramolecular Heck strategy 
allows locking of the aryl ring in the proposed bioactive, that is, the pseudoaxial, 
orientation.20 
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Figure-7 
 
Jiirgen Wichmann et al.21 A series of 5H-thiazolo[3, 2-a]pyrimidine 
derivatives 1 was studied with respect to the inhibition of I S,3R-ACPD (10~tM)-
stimulated GTP y35S binding on rat mGlu2 receptor transfected cell membranes. The 
influence of substituents at position 6 and 7 as well as the substitution pattern of the 
two phenyl-rings in position 2 and 5 on the activity is discussed (figure-8). 
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Figure-8 
? N3-Arylation of DHPMs 
 N3-arylated DHPM analogues cannot be obtained by classical Biginelli 
condensation strategies involving N-arylureas. Here, the corresponding N1-substituted 
derivative will be formed exclusively.22,23  
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Krzysztof Danel24 reported protocol appropriately substituted 2,3-dihydro-7H-
thiazolo[3,2-a]pyrimidin-7-ones 9-12 and 18 were considered as annulated analogues 
of HEPT (1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)- thymine), and some of these 
compounds were also found active against HIV-1, the most active one being 2,3-
dihydro-5-[(3,5-dimethylphenyl)methyl]-3-ethoxy-6-ethyl-7H-thiazolo[3,2-a]pyramid 
-din-7-one (10b). S-Alkylation of 5-alkyl-6-(arylmethyl)-2-thiouracils 1-4 was 
performed with 2-bromoacetaldehyde acetals to furnish the S-[bis(alkoxy)ethyl] 
derivatives 5-8 and with allyl bromide to furnish S-allyl derivatives 17. The target 
compounds 9-12 were obtained by an N1 regioselective intramolecular cyclization 
reaction of silylated 5-8 using trimethylsilyl trifluoromethanesulfonate (TMS triflate) 
as the catalyst. Treatment of the S-allyl derivatives 17 with bromine in dry methylene 
chloride afforded the 3-(bromomethyl) derivatives 18 (figure-9).  
 
 
Figure-9 
 
? Bicyclic systems derived from DHPMs 
  
            Many bicyclic systems can be synthesized from DHPM scaffold. 
Pyrazolo[4,3-d]pyrimidine derivatives synthesized by reacting sodium azide with N-
Me, 6-Br-Me DHPM. The possible mechanism of this transformation is shown in 
below and involves decomposition of the diazide to vinyl diazo derivative, which 
undergoes spontaneous 1,5-electrocyclization to 3H-pyrazole. Subsequent migration 
of the ester substituent from the tetrahedral carbon to N2 (thermal van Alphen-Hüttel 
rearrangement) yields pyrazolo[4,3-d]pyrimidine. The structure confirming the 
position of the ester group at N2 was established by an X-ray analysis.  
 
Use of the 4-chloroacetoacetate building block in a Biginelli-type 
condensation is very useful to get variety of bicyclic systems. The resulting 
functionalized DHPM appeared to be an ideal common chemical template for the 
generation of a variety of interesting bicyclic scaffolds such as (Figure-10,11) 
furo[3,4-d]-pyrimidines, pyrrolo[3,4-d]pyrimidines, and pyrimido[4,5-d]pyridazines.a 
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Figure-11 
   
Solid-phase and solution-phase protocols for the synthesis of furo[3,4-
d]pyrimidines, pyrrolo[3,4-d]-pyrimidines, and pyrimido[4,5-d]pyridazines are 
reported. The multistep solid-phase sequence involves the initial high-speed, 
microwave-promoted acetoacetylation of hydroxymethyl polystyrene resin with 
methyl 4-chloroacetoacetate. The immobilized 4-chloroacetoacetate precursor was 
subsequently subjected to three component Biginelli-type condensations employing 
urea and a variety of aromatic aldehydes. The resulting 6-chloromethyl-functionalized 
resin-bound dihydropyrimidones served as common chemical platforms for the 
generation of the desired heterobicyclic scaffolds using three different traceless 
cyclative cleavage strategies. The corresponding furo[3,4-d]pyrimidines were 
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obtained by microwave flash heating in a rapid, thermally triggered, cyclative release. 
Treatment of the chloromethyl dihydropyrimidone intermediates with a variety of 
primary amines followed by high-temperature microwave heating furnished the 
anticipated pyrrolo[3,4-d]pyrimidine scaffolds via nucleophilic cyclative cleavage. In 
a similar way, reaction with monosubstituted hydrazines resulted in the formation of 
pyrimido[4,5-d]pyridazines. All compounds (Figure-12) were obtained in moderate 
to good overall yields and purities.b  
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Figure-12 
 
Preparation of thiazolo[3,2-a]pyrimidine derivatives was very well reported in 
literature. Two approaches are generally employed for synthesis.  
 
? Azole approach: 
            Various methods for (figure-13) synthesis of thiazolo [3,2-a]pyrimidine 
derivatives using thiazole as starting material.  
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Figure-13 
 
Literature survey on synthetic methodology for thiazolo[3,2-a]pyrimidine 
derivatives can be summarized in chart 1 & 2 where various methods are illustrated 
for synthesis of this class of compounds. Thiazolo [3,2-a]pyrimidine 2 was prepared 
in 30% yield by the reaction of 2-aminothiazole 1 with ethyl cyanoacetate  in a 
sodium ethoxide/ethanol mixture or using polyphosphoric acid or acetic acid. 
However, oxothiazolopyrimidine 3 was obtained upon treatment with phosphorous 
pentoxide and methanesulfonic acid. 
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The reaction of 1 with ethyl acetoacetate at 140-150°C resulted in the 
formation of compound that was then converted to the Z-isomer upon heating at 
250°C and cyclized to give 4. 2-Aminothiazole 5 cyclized with acetyl acetone at 
l00°C, in the presence of methane sulfonic acid-phosphorus pentoxide or formic acid-
phosphorus pentoxide, followed by treatment with 70% perchloric acid, to give the 
thiazolopyrimidin-4-ium salt 5. The ester 6 was obtained from 2-aminothiazole 1 with 
an excess of methyl methane tricarboxylate in 61 % yield. Cyclo condensation of 1 
with diethyl ethoxymethylene malonate in acetic acid followed by hydrolysis of the 
ester gave 7. Similarly, 2-aminothiazole 1 reacted with benzylidine in ethanol to give 
8. Stanovink et al.25-37 131-171 reported the synthesis of a series of thiazolopyrimidine 
derivatives upon reacting 2-aminothiazole with a variety of different reagents. Thus, 
dimethylaminobut-2-enoate (or pentenoate), reacted with 1 to give thiazolo 
pyrimidines 23. 25-37 
 
The reaction of 2-aminothiazole 1 with 2-hydropolyfluoroalk-2-enoate in basic 
medium gave two isomers, 7-oxo 2 and its isomeric 5-oxo 3 (figure-14). The 
structure of both 2 and 3 was established through 1H NMR, 13C NMR and mass 
spectra.38 2-Aminothiazole derivatives, (R' = -H, -CO2Et; R2 = Ph, aryl, -Me), reacted 
with the acetylenic derivative and ester derivative in ethanol and polyphosphoric acid, 
respectively, to give the isomeric oxothiazolopyrimidine derivatives 4 and 5, in 5-
32% and 8-97 % yield, respectively.39 Condensation of 2-aminothiazole 1 in absolute 
ethanol with the sodium salt of ethyl oximinocyanoacetate gave after acidification 
(pH 6) with diluted hydrochloric acid, the nitroso derivative 6 in 92% yield.40 
Treatment of the 2-aminothiazaole derivatives 5 with the hydrazone derivatives gave 
the oxothiazolo [3,2-a] pyrimidine derivatives 7.41 
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Figure-14 
 
? Reported synthetic approaches 
2-Amino-2-thiazoline reacted with 2-acylamino-3-dimethylamino-propenoates 
in acetic acid to yield 6-acylamino-5-oxo-2,3-dihydro-5-thiazolo[3,2-a]pyrimidines in 
73 and 12% yields, respectively42 (figure-15).  
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Figure-15 
 
Moreover, 2-amino-2-thiazoline reacted with an aromatic aldehyde and diethyl 
malonate, to give (figure-16) a mixture of thiazolidino [3,2-a] pyrimidines. 
Furthermore, malononitrile reacted to give following product.43-44 
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Figure-16 
 
2-Amino-2-thiazoline reacted with potassium 2-ethoxycarbonyl-2-fluorovinyl 
alcoholate in a sodium methoxide/methanol mixture to give 6-fluoro-2,3-dihydro-5-
oxothiazolo[3,2-a]pyrimidine.45 (Figure-17)  
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Figure-17 
 
2-(Methylthio)-2-thiazoline reacted with 3-alanine to give a 5-oxothiazolo    
[3, 2-a]-pyrimidine (Figure-18) derivative in 23% yield.46 
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Figure-18 
 
          Pyrmidinethione derivatives were alkylated with monochloroacetic acid or 
chloroacetyl chloride and then cyclized to give thiazolopyrimidine derivatives.47-61 
Thus, pyrimidinethione reacted in DMF47 or in an acetic anhydride/pyridine mixture51 
to give thiazolo-pyrimidines (figure-19).  Alkylation in the presence of an aromatic 
aldehyde gave the yield. Similarly, pyrimidinethione derivatives reacted with 
monochloroacetic acid52-54 in acetic acid/acetic anhydride/sodium acetate mixture or 
with chloroacetyl chloride in dry dioxane to give the corresponding 
thiazolopyrimidines. 
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Figure-19 
 
? Azine approach 
 
Dihydropyrimidines are well-known calcium channel blockers. According to 
the literature analogous derivatives are anti-inflammatories. Thus Bo´szing and co-
workers63 decided to synthesize the pyrimidothiazines and assay these compounds for 
the same profile. Acute anti-inflammatory activity was tested by inhibition of the 
carrageenan-induced paw edema in rats62 (Figure 20). 
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Figure 20 
 
Adam et al.63 filed US patent for phenyl substituted thiazolo pyrimidine 
derivatives synthesized from DHPM (figure- 21). These compounds and their slats 
are novel and are distinguished by valuable therapeutic properties. Specifically it has 
been found that the compound of Markus structure given below was metabotropic 
glutamate receptor antagonists. These compounds are capable of high affinity binding 
to group II mGluR receptors.  
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Figure-21 
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Compounds displayed by general formulae given below exhibit excellent 
adenosine A3 receptor antagonism (figure-22) where A is an optionally substituted 
benzene ring. B may be substituted and R1 is optionally substituted cyclic group.
64 
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Figure-22 
 
Amr, A. E. et al.65described the analgesic and antiparkinsonian activity of 
some thiazolo pyrimidine derivatives as shown below (figure-23). Out of them 
compound of type III are potent antiparkinsonian agents. 
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Figure-23 
 
Matthieu Montes et al.66 reported thiazolopyrimidine structure based 
compound (Figure-24) as CDC25 phosphatases inhibitor. CDC25 phosphatases play 
critical roles in cell cycle regulation and are attractive targets for anticancer therapies. 
Several small non-peptide molecules are known to inhibit CDC25, but many of them 
appear to form a covalent bond with the enzyme or act through oxidation of the 
thiolate group of the catalytic cysteine.  
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Figure-24 
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K. Gewald et al.67 Thiazolo[5,4-d]pyrimidine-1-N-oxides, prepared from 6-
chloro-1,3-dimethyl-5-nitropyrimidinone by reaction with mercapto compounds 
(HSCH2R), followed by base catalyzed dehydrative cyclization, can be easily 
deoxygenated to yield thiazolopyrimidines (figure-25). Reductive deoxygenation by 
treatment of the thiazolopyrimidine oxides with sodium dithionite or oxidative 
deoxygenation with dimethylformamide at reflux temperature can generate the 
desired thiazolo-pyrimidines.  
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Figure-25 
 
L. D. S. Yadav et al.68 demonstrated one-pot reactions of glycine, acetic 
anhydride and thiazole Schiff bases (2a–f) diastereoselectively and expeditiously 
annulated a pyrimidine ring on the thiazole nucleus to yield 6,7-dihydro-5H-
thiazolo[3,2-a]pyrimidin-5-ones (4a–f) under microwave irradiation and solvent-free 
conditions (figure-26). 
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Figure-26 
 
Fatmah A. M Al-Omary  et al.69 developed a novel series of thiazolo[2,3-
b]quinazoline (14-23, 26 and 27), and pyrido[4,3-d]thiazolo[3,2-a] pyrimidine (34-43, 
45 and 46) analogues. The obtained compounds were evaluated for their in-vitro 
antitumor activity at the National Cancer Institute (NCI) 60 cell lines panel assay. 
Among them, four compounds showed remarkable broad-spectrum antitumor activity. 
Two Compounds 22 and 38 were almost nine fold more active than 5-FU, with GI50, 
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TGI, and LC50 values of 2.5,>100, >100; and 2.4, 9.1, 36.2 mM, respectively (figure- 
27). 
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5.3  Biological activity associated with various substituted thiazolo 
[3,2-a] pyrimidine derivatives. 
 
Kappe et al.70 reported that N3-acylated DHPMs can be rapidly synthesized in 
a high throughput fashion by combining microwave-assisted acylations with 
microwave-assisted scavenging techniques. Scavenging experiments can be carried 
out employing either supported nucleophilic amine sequestration reagents or water.70 
N-acylated DHPMs are pharmacologically very important scaffolds as most of 
bioactive DHPMs are N-acylated. N-acylation of DHPM can be performed (figure-
28) as shown below.  
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Figure-28 
 
N3-Substituted DHPMs (Figure-29) have been identified to possess potent 
pharmacological profiles. Following compound exhibited high binding affinity and 
subtype selectivity for the cloned human R1a receptor.71 
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Figure -29 
 
Systematic modifications of above compounds led to identification of highly 
potent and subtype-selective compounds with high binding affinity (Ki 0.2 nM) for 
R1a receptor and greater than 1500-fold selectivity over R1b and R1d adrenoceptors. 
The compounds were found to be functional antagonists in human, rat, and dog 
prostate tissues (figure-30, 31). 
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Modifications to the C5 position also play important role in potency of DHPM 
ring. 4-aryldihydropyrimidinones attached to an aminopropyl-4-arylpiperidine via a 
C-5 amide as selective R1A receptor subtype antagonists. In receptor binding assays, 
these types of compounds generally display Ki values for the R1a receptor subtype <1 
nM while being greater than 100-fold selective versus the R1b and R1d receptor 
subtypes (Figure 32).  Many of these compounds were also evaluated in vivo and 
found to be more potent than terazosin in both a rat model of prostate tone and a dog 
model of intra-urethral pressure without significantly affecting blood pressure.72 
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Figure 32 
Mithun Ashok et al.73 have reported a new series of new 2-(arylidine)-5-(4-
methylthiophenyl)-6-carboethoxy-7-methyl-5H-thiazolo[3,2-a]pyrimidine-3(1H)-
ones. The newly synthesized compounds (figure-33) were screened for their anti- 
bacterial and antifungal activities and have exhibited moderate to excellent growth 
inhibition of bacteria and fungi. 
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Figure-33 
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Hui Zhi et al.74 have developed a novel AchE inhibitors. A docking screening 
model of AchE inhibitor was used to evaluate a series of 5H-thiazolo[3,2-
a]pyrimidine derivatives (Figure-34). The virtual screening hits were analyzed in 
drug likeness and physic chemical features. Therefore were focused to those 
compounds. To investigate the relationship between the bioactivities and the structure, 
10 target compounds with the 5H-thiazolo[3,2-a]pyrimidine scaffold were 
synthesized as potential AchE inhibitors. 
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5.4  Current research work 
 
 The -2H-thiazolo[3,2-a]pyrimidine derivatives have considerable chemical 
and pharmacological importance because of a broad range of biological activities 
displayed by these classes of molecules. As we demonstrated, the tremendous 
biological potential of substituted pyrimidine derivatives encouraged us to synthesize 
some new highly functionalized substituted -2H-thiazolo[3,2-a]pyrimidine 
derivatives. A series of 5H-thiazolo[3,2-a]pyrimidine derivatives 1 was studied with 
respect to the inhibition of I S,3R--ACPD (10~tM)-stimulated GTP y35S binding on 
rat mGlu2 receptor transfected cell membranes.75 Various methodologies have been 
described for the synthesis of substituted pyrimidine derivatives. However, the 
existing methods are suffer with some drawbacks, such as; yield, time, product 
isolation, purification, 
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5.5 Results and discussion 
 
Route of Synthesis for novel substituted 2H-thiazolo[3,2-a] pyrimidine 
derivatives. 
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Where R= Ar-Cl, Ar-Br ,Ar-F, Ar-Cl, Ar-OMe, Ar-Me, 
 
In order to optimize the reaction conditions, N,4-bis(4-fluorophenyl)-1,2,3,4-
tetrahydro-6-isopropyl-2-thioxopyrimidine-5-carboxamide 6a was used as the 
precursor for the synthesis of N,5-bis(4-fluorophenyl)-3,5-dihydro-7-isopropyl-2H-
thiazolo[3,2-a]pyrimidine -6-carboxamide 8a. Initially we examined the reaction of 
K2CO3/ TEA (0.12 mmol), TBAB/TEAB (0.12 mmol) with 6a (0.1 mmol). This 
potassium salt of THPM precursor by reacting with dibromoethane afforded desired 
compounds. In order to find suitable reaction conditions, various solvents (10-15 mL) 
were investigated (Table 1). Complete consumption of the bromine was indicated by 
the disappearance of the yellow-brown color from the reaction mixture, which takes 
about 5-10 minutes depending upon the solvent used. Only in the case of DMF (Table 
2;) warming up of the reaction to 40°C for at least 45 minutes was necessary to assure 
the complete consumption of bromine.  
The reaction performance under different solvent conditions at room 
temperature has been monitored by TLC analysis. It was found that in all other 
Chapter 5                                                                    Synthesis of thiazolo[3,2-a]pyrimidine derivatives 
Department of Chemistry, Saurashtra University, Rajkot-360005  205 
solvents the reactions were not completed within this time. Additionally it was 
observed that prolonged reaction time at room temperature did not yield the desired 
cyclized thiazolo pyrimidine 8a. The reaction temperature was therefore elevated. It 
was observed that open chain intermediate 6a gets converted into the desired thiazolo 
pyrimidine 8a at 80°C. The progress of the reaction was monitored by TLC After 
heating the reactions for 2 hours the best yields were obtained in case of DCE (83%), 
THF (81%), DMF (82%) and iPr-OH (76%), t-BuOH, Toluene. In the case of 
chloroform, where the first step yield was quantitative, the conversion to 8a was 
incomplete. From all experiments 1,2-Dichlormethane (DCM) was chosen as the 
optimal reaction solvent. Compounds were purified by acid-base treatment. 
 
? Brief Spectral Analysis Discussion Compound VBA 8a. 
The structure of compound VBA 8a was established on the basis of their 
elemental analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 
VBA 8a revealed a molecular formula C22H21F2N3OS (m/z 413). The 1H NMR 
spectrum revealed a singlet at δH= 1.24 ppm assigned to 6 protons of (i-prCH3), a 
singlet at δH= 2.28 ppm assigned to 6 protons of (i-prCH3), a singlet at δH= 3.24-3.26 
ppm  assigned to 2 protons of (-CH2), a singlet at δH= 3.78-3.85 ppm  assigned to 2 
protons of (-CH2), a singlet at δH= 5.16 ppm  assigned to 1 protons of  (-ArH-) group 
of asymmetric proton, one singlet at δH= 7.02-7.06 ppm  assigned to 4 proton of   (-
Ar-H) group, one triplet at δH = 7.22-7.25 ppm assigned to protons of Ar-H (2H) , one 
triplet at δH= 7.60-7.63 ppm assigned to protons of Ar-H (2H), one singlet at δH= 
10.17 ppm assigned to –ArCONH groups .  
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Table 1: Synthesis of Novel highly substituted pyrimidine using various a ketene 
dithioacetal. 
 
Entry R R1 Yield % Time h. 
VBA -8a 4-FC6H4 4-FC6H4 92 6-8 
VBA-8b 4-ClC6H4 3,4-(OCH3)2C6H3 90 6-8 
VBA-8c 4-BrC6H4 3,4-(OCH3)2C6H3 92 10-12 
VBA-8d 4-BrC6H4 2,5-(OCH3)2C6H3 86 6-8 
VBA-8e 4-BrC6H4 4-(OH)C6H4 90 6-8 
VBA-8f 4-BrC6H4 3-NO2C6H4 72 8-10 
VBA-8g 4-BrC6H4 4-ClC6H4 88 6-8 
VBA-8h 3-Cl,4-F,C6H3 3,4-(OCH3)2C6H3 84 6-8 
VBA-8i 4-CH3C6H4 4-FC6H4 88 4-6 
VBA-8j 4-CH3C6H4 3-BrC6H4 68 4-6 
VBA-8k 4-CH3C6H4 4-ClC6H4 84 4-6 
VBA-8l 4-OCH3C6H4 4-ClC6H4 90 4-6 
VBA-8m 4-OCH3C6H4 3,4-(OCH3)2C6H3 84 4-6 
VBA-8n 4-ClC6H4 3,5-(OCH3)2C6H3 88 6-8 
VBA-8o 3-Cl,4-F,C6H3 4-OCH3C6H4 84 4-6 
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Figure: 35 Proposed mechanism for the formation of substituted 2H-thiazolo[3,2-
a] pyrimidine. 
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5.6 Conclusion 
 In summary, we have developed a convenient and selective method for the 
synthesis of 2H-thiazolo[3,2-a]pyrimidine derivatives by exploiting the reaction of 
formed dibromoethane with 1,2,3,4-tetrahydro-6-isopropyl-2-thioxopyrimidine of 
type 1. The possibility of introducing a variety of substituents at different positions of 
the 2H-thiazolo[3,2-a]pyrimidine ring system was achieved by this method. The 
present method delivers new screening candidates in an easy way and is well suited 
for robotic synthesis. The achievable 2H-thiazolo[3,2-a]pyrimidine derivatives may 
help in the understanding of the privileged nature of the DHPM core. The present 
methodology gives various functionalized thiazolopyrimidine for biological interest. 
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5.7  Experimental section 
 
 Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZUFTIR-8400 
spectrophotometer using DRS prob. 1H (400 MHz) and 13C(100 MHz) NMR spectra 
were recorded on a BRUKER AVANCE II spectrometer in CDCl3and DMSO 
respectively 13C NMR were recorded on 100 MHz spectrometer, referred to the 
internal solvent signals (77.0for CDCl3 or 40.0 for DMSO-d6). Chemical shifts are 
expressed in δ ppm downfield from TMS as an internal standard. Mass spectra were 
determined using direct inlet probe on a SHIMADZU GCMS-QP 2010 mass 
spectrometer. Solvents were evaporated with a BUCHI rotary evaporator. Melting 
points were measured in open capillaries and are uncorrected. The chemicals used in 
this work were purchased from Merck and Spectrochem Chemical Companies. All 
chemicals were reagent grade and used without further purification, and all solvents 
were freshly distilled before use. 
 
? General process for the synthesis of 4-methyl-3-oxo-N-arylpentanamide 2a-t. 
 A mixture containing the primary amine (10 mmol), methyl isobutyrylacetate 
(10 mmol), and catalytic amount of sodium or potassium hydroxide (10 %) was reflux 
at 110oC for the approximately 15-20 h. The progress of reaction was monitored by 
TLC. After completion of reaction, the solvent was removed under vaccuo when the 
reaction was completed. The solid or oil was crystallized from methanol to give pure. 
 
? General process for the synthesis of substituted N-(Aryl)-4-(4-Aryl)-1,2,3,4-
tetrahydro-6-isopropyl-2-thioxopyrimidine-5-carboxamide VBA-6a-g. 
To a solution of substituted benzaldehyde (1 mmol), 4-methyl-3-oxo-N-
arylpentanamide (1 mmol), thiourea (1.4 mmol) were added to MeOH (10 mL) 
sequentially at room temperature. After the addition of HCl/etidronic acid (1.0 mmol), 
the mixture was stirred for 1 h at ambient temperature. Then reflux reaction mixture at 
70-80°C temp. The progress of reaction was monitored by TLC. The crude product 
was collected by filtration and washed with hexane to give 0.55 g (91%) of THPM 
(8a-o) as brown solid. 
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? General procedure for the synthesis of substituted N-(Aryl)-4-(4-Aryl)-
1,2,3,4-tetrahydro-6-isopropyl-2-thioxopyrimidine-5-carboxamide VBA-8a-o. 
To a solution of the thioxopyrimidine (6a-g) (1mmol, 1equiv.) in 2 ml of 1,2-
dibromoethane (7) (1.5 mmol, 1.5 equiv.) and (K2CO3) (1 mmol, 1equiv.), 
TBAB/TEAB (1mmol, 1equiv.), were dissolved in DMF added slowly at ambient 
temperature. The resulted wine red solution was subjected to shaking until the 
disappearance of the color. The reaction mixture was heated to 80oC for 2 hours. After 
completion of the reaction, the solvent was evaporated under reduced pressure and the 
residue was treated with aqueous solution of saturated NaHCO3 followed by 
extraction with10 ml ethyl acetate/water (1:1) mixture. The organic extracts were 
dried over anhydrous Na2SO4. After filtration the solvent was evaporated under 
reduced pressure and the crude product washed with (10/90, E.A/H mixtures) to 
obtain pure product VBA 8a-o. 
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? Spectral data of the synthesized thiazolo[3,2-a]pyrimidine compounds 
VBA-8a-o. 
 
N,5-bis(4-fluorophenyl)-3,5-dihydro-7-isopropyl-2H-thiazolo[3,2-a]pyrimidine-6-
carboxamide (VBA-8a): Light brown solid; Rf 0.65 (7:3 H-E.A); mp 241-243°C; IR 
(KBr): 3439, 3200, 3144, 3047, 2982, 2929, 2874,1678, 1645, 1614, 1552, 1535, 
1506, 1450, 1410, 1334, 1301, 1220, 1159, 1101, 1047, 1012, 962, 835, 788, 704,  
cm-1; 1H NMR: (400 MHz, DMSO): δH 1.24 (s, 6H, 2 X iprCH3), 2.28 (m, 1H, -
iprCH), 3.24-3.26 (m, 2H, -CH2), 3.78-3.85 (m, 2H, -CH2), 5.16 (s, 1H, -ArCH), 7.02-
7.06 (s, 4H, ArH), 7.22-7.25 (t, 2H, ArH), 7.60-7.63 (t, 2H, ArH), 10.17 (s, 1H, -
ArCONH); 13C NMR: (100 MHz, DMSO) δC  13.83, 18.85, 20.09, 22.10, 26.28, 
28.73, 29.06, 31.31, 45.45, 53.01, 61.45, 114.13, 114.34, 114.76, 114.98, 121.12, 
121.19, 127.96, 128.04, 134.97, 165.49; MS m/z: 413.48(M+); Anal. Calcd. For 
C22H21F2N3OS: C, 63.90; H, 5.12; N, 10.16%. Found: C, 63.78; H, 5.02; N, 10.27%. 
 
N-(4-chlorophenyl)-3,5-dihydro-7-isopropyl-5-(3,4-dimethoxyphenyl)-2H-
thiazolo[3,2-a]pyrimidine-6-carboxamide (VBA-8b): Light brown solid; Rf  0.62 
(7:3 H-E.A); mp 255-257°C; IR (KBr): 3460, 3107, 3034, 2924, 2852, 1672, 1606, 
1548, 1516, 1498, 1462, 1392, 1257, 1211, 1145, 1026, 877, 815, 767, 740, cm-1; 1H 
NMR: (400 MHz, DMSO): δH 1.45 (s, 6H, 2 × -iprCH3), 2.52 (m, 1H, -iprCH), 3.26 (s, 
2H, -CH2), 3.80 (s, 2H, -CH2), 5.29(s, 1H, -ArCH), 6.70-6.89 (m, 4H, ArH), 7.02 (s, 
1H, ArH), 7.38-7.42 (s, 1H, ArH), 7.95 (s, 1H, ArH), 10.63 (s, 1H, -ArCONH); 13C 
NMR: δC (100MHz, DMSO) 19.24, 20.39, 29.02, 55.39, 55.57, 110.12, 110.69, 
116.57, 118.38, 119.62, 121.18, 124.27, 127.48, 148.35, 159.58; MS m/z: 472(M+); 
Anal. Calcd. for C24H26ClN3O3S: C, 61.07; H, 5.55; N, 8.90%.Found: C, 61.28; H, 
5.35; N, 8.82%. 
 
N-(4-bromophenyl)-3,5-dihydro-7-isopropyl-5-(3,4-dimethoxyphenyl)-2H-
thiazolo[3,2-a]pyrimidine-6-carboxamide (VBA-8c): Light brown solid; Rf 0.62 
(7:3 H-E.A); mp 246-248°C; IR (KBr): 3446, 3054, 2978, 2839, 1606, 1546, 1516, 
1494, 1472, 1392, 815, 725, 538, cm-1; MS m/z: 516.45(M+); Anal. Calcd. for 
C24H26BrN3O3S: C, 55.81; H, 5.07; N, 8.14%. Found: C, 55.27; H, 4.99; N, 8.07%. 
 
N-(4-bromophenyl)-3,5-dihydro-7-isopropyl-5-(2,5-dimethoxyphenyl)-2H-
thiazolo[3,2-a] pyrimidine-6-carboxamide (VBA-8d): Light brown solid; Rf 0.62 
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(7:3 H-E.A); mp 250-252°C; IR (KBr): 3462, 3067, 2963, 2812, 1606, 1546, 1516, 
1499, 1472, 1389, 817, 716, 528, cm-1; MS m/z: 516.45(M+); Anal. Calcd. for 
C24H26BrN3O3S: C, 55.81; H, 5.07; N, 8.14%.Found: C, 55.26; H, 5.14; N, 8.77%. 
 
N-(4-bromophenyl)-3,5-dihydro-5-(4-hydroxyphenyl)-7-isopropyl-2H-thiazolo 
[3,2-a]pyrimidine-6-carboxamide (VBA-8e): Light brown solid; Rf 0.58 (7:3 H-
E.A); mp 255-257°C; IR (KBr): 3457, 3062, 2957, 2838, 1606, 1546, 1518, 1502, 
1472, 1393, 817,709, 535, cm-1; MS m/z: 472.4(M+); Anal. Calcd. for 
C22H22BrN3O2S: C, 55.93; H, 4.69; N, 8.90%. Found: C, 55.78; H, 4.58; N, 8.37%. 
 
N-(4-bromophenyl)-3,5-dihydro-7-isopropyl-5-(3-nitrophenyl)-2H-thiazolo[3,2-a] 
pyrimidine-6-carboxamide (VBA-8f): Yellow solid; Rf 0.62 (7:3 H-E.A); mp 262-
264°C; IR (KBr): 3446,  3075,  2946,  2852, 1618, 1595, 1546, 1518, 1506, 1472, 
1399, 835, 804, 729, 514, cm-1; MS m/z: 501.4(M+); Anal. Calcd. for C22H21BrN4O3S: 
C, 52.70; H, 4.22; N, 11.17%. Found: C, 52.49; H, 4.87; N, 11.47%. 
 
N-(4-bromophenyl)-5-(4-chlorophenyl)-3,5-dihydro-7-isopropyl-2H-thiazolo[3,2-
a] pyrimidine-6-carboxamide (VBA-8g): Yellow solid; Rf 0.56 (7:3 H-E.A); mp 
248-250°C; IR (KBr): 3455, 3069, 2953, 2841, 1609, 1548, 1515,1503, 1467, 1384, 
847, 719, 503, cm-1; MS m/z: 490.84(M+); Anal. Calcd. for C22H21BrClN3OS C, 
53.83; H, 4.31; N, 8.56%. Found: C, 53.16; H, 4.75; N, 8.17% 
 
N-(3-chloro-4-fluorophenyl)-3,5-dihydro-7-isopropyl-5-(3,4-dimethoxyphenyl)-
2H-thiazolo[3,2-a]pyrimidine-6-carboxamide (VBA-8h): Light brown solid; Rf 
0.60 (7:3 H-E.A); mp 248-250°C; IR (KBr): 3460, 3107, 3034, 2924, 2852, 1680, 
1606, 1552, 1498, 1465, 1392, 1332, 1257, 1184, 1143, 1111, 1031, 877, 829, 802, 
767,  cm-1; 1H NMR: (400 MHz, DMSO) δH 1.61 (s, 3H, -iprCH3), 1.89 (s, 3H, -
iprCH3), 2.52 (m, 1H, -
iprCH), 3.79-3.81 (s, 6H, -2X-OCH3), 3.27-3.32 (m, 2H, -
CH2), 3.43-3.50 (m, 2H, -CH2), 5.51 (s, 1H, -ArCH), 6.71-6.73 (d, 1H J =8 Hz, ArH), 
6.79-6.81 (d, 1H J =8 Hz, ArH), 6.87 (m, 1H, ArH), 7.14-7.19 (t, 1H,  ArH), 7.51-
7.53 (s, 1H, ArH), 7.95-7.97 (d, 1H J =8 Hz, ArH), 10.49 (s, 1H, -ArCONH); 13C 
NMR: (100 MHz, DMSO) δC 19.06, 20.25, 22.10, 26.48, 28.31, 29.03, 29.23, 31.37, 
45.23, 53.32, 54.03, 55.35, 55.69, 61.25, 110.17, 110.50, 115.99, 116.20, 118.46, 
119.26, 119.45, 121.16, 123.79, 125.03, 133.73, 135.68, 135.71, 147.83, 148.17, 
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152.09, 154.52, 162.48, 168.80: MS m/z: 489.99(M+); Anal. Calcd. for 
C24H25ClFN3O3S: C, 58.83; H, 5.14; N, 8.58%. Found: C, 58.97; H, 5.75; N, 8.47%. 
 
5-(4-fluorophenyl)-3,5-dihydro-7-isopropyl-N-p-tolyl-2H-thiazolo[3,2-a] 
pyrimidine-6-carboxamide (VBA-8i): Light brown solid; Rf 0.58 (7:3 H-E.A); mp 
268-270°C; IR (KBr): 3428, 3048, 2927, 2849, 1654, 1541, 1509,1435, 1254, 862, 
705,  cm-1; MS m/z: 409.52(M+); Anal. Calcd. for C23H24FN3OS: C, 67.46; H, 5.91; 
N, 10.26%. Found: C, 67.87; H, 5.58; N, 10.07%. 
 
5-(3-bromophenyl)-3,5-dihydro-7-isopropyl-N-p-tolyl-2H-thiazolo[3,2-a] 
pyrimidine-6-carboxamide (VBA-8j): Yellow solid; Rf 0.58 (7:3 H-E.A); mp 247-
249°C; IR (KBr): 3435, 3039, 2947, 2838, 1663, 1547, 1517, 1443, 1259, 857, 735, 
540, cm-1 ; MS m/z: 470.43(M+); Anal. Calcd. for C23H24BrN3OS: C, 58.72; H, 5.14; 
N, 8.93%. Found: C, 58.58; H, 5.25; N, 8.72%. 
 
5-(4-chlorophenyl)-3,5-dihydro-7-isopropyl-N-p-tolyl-2H-thiazolo[3,2-a] 
pyrimidine-6-carboxamide (VBA-8k): Light brown solid; Rf 0.58 (7:3 H-E.A); mp 
237-239°C; IR (KBr): 3414, 3029, 2956, 2823, 1659, 1552, 1519,1452, 1262, 838, 
718, cm-1; MS m/z: 425.97(M+); Anal. Calcd. for C23H24ClN3OS: C, 64.85; H, 5.68; 
N, 9.86%. Found: C, 64.97; H, 5.39; N, 9.02%. 
 
5-(4-chlorophenyl)-3,5-dihydro-7-isopropyl-N-(4-methoxyphenyl)-2H-thiazolo 
[3,2-a]pyrimidine-6-carboxamide (VBA-8l): Light brown solid; Rf 0.60 (7:3 H-
E.A); mp 244-246°C; IR (KBr): 3510, 3045, 2927, 2823, 1652, 1563, 1516, 1447, 
1278, 849, 723, cm-1; MS m/z: 441.97(M+); Anal. Calcd. for C23H24ClN3O2S: C, 
62.50; H, 5.47; N, 9.51%. Found: C, 62.28; H, 5.76; N, 9.23%. 
 
3,5-dihydro-7-isopropyl-5-(3,4-dimethoxyphenyl)-N-(4-methoxyphenyl)-2H-
thiazolo[3,2-a]pyrimidine-6-carboxamide (VBA-8m): Light brown solid; Rf 0.64 
(7:3 H-E.A); mp 255-257°C; IR (KBr): 3485, 3032, 2957, 2848, 1645, 1557, 1508,  
1447, 1264, 1104, 878, 756, cm-1; MS m/z: 467.58(M+); Anal. Calcd. for 
C25H29N3O4S: C, 64.22; H, 6.25; N, 8.99%. Found: C, 64.65; H, 6.07; N, 8.45%. 
 
3,5-dihydro-7-isopropyl-5-(3,4-dimethoxyphenyl)-N-p-tolyl-2H-thiazolo[3,2-a] 
pyrimidine-6-carboxamide (VBA-8n): Light brown solid; Rf 0.66 (7:3 H-E.A); mp 
262-264°C; IR (KBr): 3485, 3354, 3073, 2968, 2875, 1645, 1542, 1516, 1457, 1218, 
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1115, 863, 738, cm-1; MS m/z: 451.58(M+); Anal. Calcd. for C25H29N3O3S: C, 66.49; 
H, 6.47; N, 9.31%. Found: C, 66.58; H, 6.23; N, 9.62%. 
 
N-(3-chloro-4-fluorophenyl)-5-(4-chlorophenyl)-3,5-dihydro-7-isopropyl-2H-
thiazolo[3,2-a]pyrimidine-6-carboxamide (VBA-8o): Light  brown solid; Rf 0.58 
(7:3 H-E.A); mp  262-264°C; IR (KBr): 3494, 3342, 3078, 2974, 2867, 1645, 1542, 
1522, 1459, 1205, 1138, 854, 715, cm-1; MS m/z: 456.32(M+); Anal. Calcd. for 
C22H12Cl2FN3OS: C, 57.91; H, 2.65; N, 9.21%. Found: C, 57.09; H, 2.73; N, 9.37%. 
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5.8 Spectral data of the synthesized compounds VBA 8 a-o 
 
1H NMR spectrum of VBA-8a 
 
 
 
 
13C NMR spectrum of VBA- 8a 
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DEPT13C NMR spectrum of VBA 8a 
 
 
 
 
1H NMR spectrum of VBA- 8b 
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13C NMR spectrum of VBA- 8b 
 
 
 
 
DEPT13C NMR spectrum of VBA- 8b 
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1H NMR spectrum of VBA- 8h 
 
 
 
 
13C NMR spectrum of VBA- 8h 
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DEPT13C NMR spectrum of VBA- 8h 
 
 
 
 
Mass spectrum of VBA- 8a 
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Mass spectrum of VBA- 8b 
 
 
 
 
Mass spectrum of VBA- 8h 
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Mass spectrum of VBA- 8l 
 
 
 
IR spectrum of VBA 8a 
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IR spectrum of VBA 8b 
 
 
 
IR spectrum of VBA 8h 
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Chemical Purity of VBA 8a 
 
UPLC: 
Column: Water Acqulity C18 ( 100 X 2.1 mm)     
Injection volume: 1 µL,                          
Mobile phase: 0.05% TFA in H2O: ACN (30:70) premix; 
Diluent: Methanol 
Column Temp-30°C;  
Flow-0.2mL/min. 
Wave length: 254 
HPLC Mode: Gradient 
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CHAPTER 6 
 
SYNTHESIS OF NOVEL ISOXAZOLE BEARING N-
SUBSTITUTED PYRAZOLE DERIVATIVES. 
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6.1 INTRODUCTION   
 
Isoxazole is a five member heterocyclic compound having two hetero atoms 
oxygen at position 1 and nitrogen at position 2. In 1888, Claisen et al1 have first 
synthesized an isoxazole molecule (Figure-1) with the reaction of 1,3-diketone with 
hydroxylamine.1 Subsequently a solid foundation for the chemistry of isoxazole was 
laid down by Claisen and his students. It was shown to possess typical properties of 
an aromatic system but under certain reaction conditions. Particularly in reducing or 
basic media, it becomes very highly labile. 
 
N
O  
 
Figure-1 
 
The next important contribution to the chemistry of isoxazoles was made by 
Quelico.2 In 1945, when he began to study the formation of isoxazoles from nitrile N-
oxide and unsaturated compounds. 
 
6.2 Synthesis of functionalized isoxazoles using various synthetic 
approaches. 
 Henry Feuer and Sheldon Markofsky3,4 using the Michael-type addition 
between sodium 1-alkane nitronates and a-nitro olefins, which were generated insitu 
from 2-nitroalkyl acetates leads largely to the formation of 3,5-dialkyI isoxazoles. The 
latter also are obtained by the demethylolation of 2-alkyl-2,4-dinitro 1-alkanols and 
by the rearrangement of secondary 8-dinitroalkanes in weakly basic media. The 
Michael-type addition between 2-alkane nitronates and α-nitro olefins can really 
proceeds in reasonably good yields.5-9 In contrast, 1-alkane nitronates give the desired 
Michael adducts, secondary α-dinitro alkanes, only in poor yields, No explanations 
have been given to account for the poor yields in this reaction. however, reports in the 
literature in which attempts to prepare phenyl-substituted α -dinitro alkenes gave rise 
largely to isoxazoles and isoxaoline N-oxides10-12 For example, Heim10obtained in the 
base-catalyzed reaction between phenyl nitro methane and benzaldehyde, in addition 
to 1,2,3-triphenyl- l,3-dinitropropane and nitrostilbene, 3,4,5- triphenylisoxazole. 
Heim and other workers11,13-15 were able to show that phenyl-substituted α-dinitro 
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compounds were unstable in the presence of base and eliminated nitrous acid to form 
isoxazoline N-oxides and isoxazoles (Figure-2). 
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Figure-2 
J. P. Ferris16 The mechanisms of the photochemical conversion of isoxazoles 
to oxazoles and ketoketenimines have been investigated. Isonitrile 14 was detected by 
an IR band at 2160 cm-l in the  photo conversion of 5 to 15 at -77'. Compound14 was 
further identified by independent synthesis and by hydrolysis to formamide 17 in acid. 
IR bands at1690 and 1655 cm-l were consistent with the hypothesis that azirine 13 is 
the precursor to isonitrile 14. It was postulated that a vinyl nitrene was the immediate 
precursor to 13. Photolysis of 10 at -77 or -1960C resulted in the formation of an IR 
band at 2050 cm-1. This band was assigned to ketoketenimine 23. The structure of 23 
was proved by independent synthesis and trapping with water. No intermediates in the 
photochemical conversion of 10 to 21were detected by trapping or low-temperature 
IR studies. New syntheses of isoxazoles 5 and 10 were developed (Figure-3). 
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Figure-3 
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Tweedie S. R. et al.17 have synthesized a palladium-catalyzed couplings of 
heteroaryl amines with aryl halides using sodium phenolate as the stoichiometric base 
(Figure-4). 
 
O
N
NH2 CN
Br
HN
O
N
Pd2(dba)3, ligand
base
MW, 2 h
Br
 
 
Figure-4 
 
Yavari I. et al.18 were synthesized isoxazole derivatives (Figure-5) through the 
reaction of activated acetylenes and alkyl 2-nitroethanoates in the presence of 
triphenylphosphine. 
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NO2 P(Ph)3
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N
MeOC CO2Et
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Figure-5 
 
Burkhart D. J. et al.19 have synthesized the 4-acetyl-5-methyl-3-isoxazoyl 
carboxylate (Figure-6) by the reaction of α-halo oxime with 1,4-diketone in presence 
of base. Further, the isoxazole smoothly lithiated at the 5-methyl position and 
followed by quenched the anion with a variety of electrophiles such as alkyl halides, 
aldehyde, TMSCl and Me3SnCl in good to excellent yields. 
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Figure-6 
 
Suzuki K. et al.20 have synthesized functionalized isoxazole derivatives 
(Figure-7) by cyclocondensation of C-chlorooximes with cyclic 1,3-diketones in the 
presence of base. 
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Figure-7 
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Lauten M. et al.21 have synthesized highly substituted isoxazole derivatives 
(Figure-8) by the reaction of N-acetoacetyl derivatives and hydroxyl amine 
hydrochloride in methanol using sodium acetate. 
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Figure-8 
 
Kislyi V. P. et al22 have prepared 4-amino-5-benzoyl (acetyl) isoxazole-3-
carboxamides (Figure-9) by the cyclization of α-hydroxyimino nitriles o-alkylated 
with bromo acetophenones (bromoketone) in presence of lithium salt.  
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Figure-9 
 
Holzer W. et al23 have synthesized 1,3-disubstituted 4-benzoyl-5-
hydroxypyrazoles with phosphorusoxytrichloride affords the corresponding 4-
benzoyl-5-chloropyrazoles. Reaction of the latter with hydroxylamine leads to 
oximes, which can be cyclized to novel 3-phenyl-6H-pyrazolo [4,3-d] isoxazoles 
(Figure-10) by treatment with sodium hydride in dimethylformamide. 
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Figure-10 
 
Bourbeau M. P. et al24 have synthesized series of 4-alkyl-5-aminoisoxazoles 
(Figure-11) in high yield by nucleophilic addition of lithiated alkyl nitriles to α-
chlorooximes. The scope and limitations of this reaction were examined by varying 
the nature of the nitrile and chloride oxime. 
 
Chapter 6                                                                                                      Highly Substituted Isoxazoles 
Department of Chemistry Saurashtra University Rajkot-360005.  230 
R Cl
N
HO
R' CN -78 oC
15 min
N
OH2N
R1 R
R= aryl, heteroaryl, alkyl
R1 = alky, aryl, benzyl
t-BuLi
 
Figure-11 
 
Recentyl, Dong D. and coworkers25 have developed an efficient and divergent 
synthesis of highly substituted isoxzoles using cyclopropyl oximes (Figure-12). 
Under Vilsmeier conditions (POCl3/CH2Cl2), substituted isoxazoles were synthesized 
from 1-carbamoyl, 1-oximyl cyclopropanes via sequential ring-opening, 
chlorovinylation, and intramolecular aza-cyclization. 
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R = Me, Ph  
 
Figure-12 
Duan H. et al.26 have reported a catalytic cascade synthesis of isoxazoline-N-
oxide (Figure-13) through proline-catalyzed nitroalkene activation. A large substrate 
scope was obtained with good to excellent yields. Mechanistic studies were revealed 
that intramolecular cyclization as the rate-determining step, giving only trans isomers 
in all cases. 
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Figure-13 
 
Daidone G. et al.27 were obtained N-(5-methylisoxazol-3-yl)-2-
aminobenzamide derivatives (Figure-14) starting from the 2-nitroaroyl chlorides and 
3-amino-5-methylisoxazole in presence of stannous chloride and hydrochloric acid.  
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Figure-14 
 
 In 1995, Junjuppa H. et al28 have synthesized some novel isoxazole fused 
estrone (Figure-15) derivatives via α-oxoketene dithioacetal.  
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Figure-15 
 
Mahata P. K. et al29 have synthesized 3-dimethoxymethyl-5-(methylthio) 
isoxazole derivatives (Figure-16) with mask or unmask aldehyde functionality by 
cyclocondensation reaction of 1,1-dimethoxy-4,4-bis(methylthio)but-3-en-2-one as 
three carbon synthon with hydroxylamine in alcohol. 
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Figure-16 
 
 Dieter R. K. et al30 have demonstrated that α-oxoketene dithioacetals derived 
from various aliphatic or aromatic ketones afforded oximes, upon treatment with 
hydroxylamine in ethanol at reflux. They were further converted the oximes into 
isoxazoles upon treatment with Amberlyst 15 ion exchange resin (Figure-17). 
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Figure-17 
 
? Synthesis of functionalized isoxazoles using combinatorial chemistry 
approach. 
Recently, Tu S. J. et al31 have developed a series of new polycyclic-fused 
isoxazole [5,4-b]pyridines (Figure-18) through a one-pot tandem reaction under 
microwave irradiation in water without any use of additional reagent or catalyst. The 
synthetic protocol represents a green one and makes this methodology suitable for 
library synthesis in drug discovery efforts.  
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Figure-18 
 
Laborde E. et al32 have developed an efficient three-component, two-step 
“catch and release” solid-phase synthesis of 3,4,5-trisubstituted isoxazoles (Figure-
19). The reaction involves a base-promoted condensation of a 2-sulfonyl acetonitrile 
derivative 1 with an isothiocyanate 2 and in situ immobilization of the resulting 
thiolate anion 3 on Merrifield resin. Reaction of the resin-bound sulfonyl intermediate 
4 with hydroxylamine, followed by release from the resin and intramoleculer 
cyclization, afforded 3,5-diamino-4-(arylsulfonyl)-isoxazoles 5. However, this 
methodology has some drawback such as; long reaction time, isolation of product and 
high reaction temperature.  
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Figure-19 
 
In 2008, Waldo J. P. et al.33 have reported solution phase synthesis of a diverse 
library of highly substituted isoxazoles (Figure-20). The reaction involved 
iodocyclization of o-methyloximes of 2-alkyn-1-ones affords 4-iodoisoxazoles, which 
undergo various palladium-catalyzed reactions to yielded 3,4,5-trisubstituted 
isoxazoles. The palladium-catalyzed processes have been adapted to parallel synthesis 
utilizing commercially available boronic acid, acetylene, styrene, and amine 
sublibraries. Accordingly, a diverse 51-member library of  
3,4,5-trisubstituted isoxazoles has been generated. 
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Figure-20 
 
Kurth M. J. et al.34 have constructed a library of 3-Aryl-4,5-dihydroisoxazole-
5-carboxamides (Figure-21). They were investigated the reaction order (nitrile oxide 
1,3-dipolar cycloaddition followed by amide formation, or vice versa) both 
experimentally and computationally to determine which route would result in the 
highest yields, minimize purification efforts, and give higher 1,3-dipolar 
cycloaddition regioselectivity.  
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Figure-21 
 
E. Bey et al.35 The 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) 
catalyses the reduction of the weakly active estrone (E1) into the most potent 
estrogen, 17b-estradiol (E2). E2 stimulates the growth of hormone dependent diseases 
via activation of the estrogen receptors (ERs). 17b-HSD1 is often over-expressed in 
breast cancer cells. Thus, it is an attractive target for the treatment of mammary 
tumours. The combination of a ligand- and a structure-based drug design approach led 
to the identification of bis(hydroxyphenyl) azoles as potential inhibitors of 17b-
HSD1. Different azoles and hydroxy substitution patterns were investigated. The 
compounds were evaluated for activity and selectivity with regard to 17b- HSD2, ERa 
and ERb. The most potent compound was 3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-
yl]phenol (18, IC50 = 0.31 lM), showing very good selectivity, high cell permeability 
and medium CaCo-2 permeability (figure-22). 
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K. F. McClure et al.36 Have described structure–activity relationship, in vivo 
activity, and metabolic profile for a series of triazolopyridine-oxazole based p38 
inhibitors are described. The deficiencies of the lead structure in the series, CP-
808844, were overcome by changes to the C4 aryl group and the triazole side-chain 
culminating in the identification of several potential clinical candidates (figure-23). 
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Figure-23 
 
6.3      Biological activity of various substituted isoxazole derivatives 
 
 The biological activity of substituted isoxazoles37 has made them a focus of 
medicinal chemistry over the years. Isoxazoles are potent, selective agonists at human 
cloned dopamine D4 receptors38 and  exhibit GABAA antagonist39, analgesic, 40 
antiinflammatory40, ulcerogenic40, antimicrobial41, antifungal41, COX-2 inhibitory,42 
antinociceptive,43 and anticancer44 activity. 
 
 Cushman M. et al.45 have designed benzo[d]isoxazole and oxazolidine-2-one 
derivatives and evaluated as a new series of potent HIV-1 non-nucleoside reverse 
transcriptase inhibitors with anti-HIV activity. The most promising compound in this 
series was ADAM (Figure-24), with EC50 values of 40 μM (vs HIV-1RF) and 20 
μM(vs HIV-1IIIB). Methyl 5-((Z)-5- (methoxycarbonyl)-1- (3-methoxy-7-
methylbenzo [d] isoxazole-5-yl) pent-1-enyl-2-methoxy-3-methylbenzoate also 
inhibited HIV-1 reverse transcriptase with an IC50 of 0.91 μM. ADAM 4 has an 
antiviral EC50 of 0.6 μM in CEM-SS cells and a plasma half-life of 51.4 min. 
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Figure-24 
 
 HIV-1 is the etiological agent of AIDS, one of the world’s most serious health 
problems with about 33 million people infected worldwide in 2007. The reverse 
transcriptase (RT) of HIV-1 is an essential enzyme in HIV replication and has been a 
key target in anti-AIDS drug discovery. The non-nucleoside reverse transcriptase 
inhibitors (NNRTIs) nevirapine, delavirdine, and efavirenz have been approved by the 
Food and Drug Administration (FDA) for the treatment of AIDS.46 They are very 
useful drugs in combination therapy with nucleoside analogues (NRTIs) and protease 
inhibitors (PIs)47-48 for the treatment of AIDS. Recently, the NNRTI etravirine was 
approved by the FDA for treatment of antiretroviral drug-resistant HIV infections. 
The cytotoxicities of the newly synthesized ADAMs were determined along with their 
abilities to inhibit the cytopathic effect of HIV-1 in cell culture. The inhibition of 
HIV-1 RT by the ADAMs, and their metabolic stabilities in rat plasma were also 
investigated. 
 
Liljefors T. et al.49 have synthesized a series of 4-aryl-5-(4-piperidyl)-3-
isoxazololes and evaluated for GABAA antagonists. The meta-phenyl-substituted 
compounds and the para-phenoxy-substituted compound (Figure-25) all display high 
affinities (Ki = 10-70 nM) and antagonist potencies in the low nanomolar range (Ki = 
9-10 nM).  
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Figure-25 
 
 Shvets N. et al.50 were demonstrated that the 2,3,5-substituted 
perhydropyrrolo[3,4-d]isoxazole-4,6-dione (Figure-26) derivatives have potent 
antibacterial activity. The reaction involved the cycloaddition reaction of N-methyl-C-
Chapter 6                                                                                                      Highly Substituted Isoxazoles 
Department of Chemistry Saurashtra University Rajkot-360005.  236 
arylnitrones with N-substituted maleimides. Most of the compounds exhibited high 
activity against Enterococcus faecalis (ATCC 29212) and Staphylococcus aureus 
(ATCC 25923). 
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Figure-26 
 
 Due to the exceptional anticonvulsant activity displayed by substituted aniline 
enaminones, related pyridine derivatives51 and phenothiazines, the further 
investigation of various aromatic heterocycles was undertaken and found that the 
isoxazoles are important heterocycles for the treatment of convulsant diseases. The 
reaction of cyclic 1,3-diketo esters with  aminoisoxazole derivatives led to a series of 
potent anti-maximal electroshock analogues. Sodium channel binding studies, as well 
as evaluations against pentylenetetrazol, bicuculline, and picrotoxin on isoxazole were 
all negative, leading to an unknown mechanism of action. X-ray diffraction patterns 
of a representative of the 3-amino series (Figure-27) unequivocally display the 
existence of intramolecular hydrogen bonding of the nitrogen to the vinylic proton in 
the cyclohexene ring, providing a pseudo three ring structure. 
 
NH
N
O
O
H3C
RO2C
R1R = CH3, C2H5
R1= H, CH3  
 
Figure-27 
 
 Giovannoni M. P. et al.52 have synthesized a number of arylpiperazinyl 
alkylpyridazinones and tested for their analgesic activity. They were observed that 
many of the tested molecules, at the dose of 20 mg kg-1 p.o., showed high 
antinociceptive activity, in particular, substituted lead (Figure-28) a compound which 
was able to reduce the number of abdominal constrictions by more than 50% in 
writhing test. They were investigated the mechanism of action of this compound, 
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which shown that it carries out its analgesic action through the inhibition of reuptake 
of noradrenaline.  
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Cl
 
 
Figure-28 
 
 Christian Peifer et al.53 have reported the discovery of isoxazole (Figure-29) 
as a potent dual inhibitor of p38α (IC50= 0.45 μM) and CK1δ (IC50= 0.23 μM). 
Among the synthesized isoxazoles, selected compounds were profiled over 76 kinases 
and evaluation of their cellular efficacy showed 18 (CKP138) to be a highly potent 
and dual-specific inhibitor of CK1δ and p38α. 
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Figure-29 
 
In 2006, Johnson & Johnson Pharmaceutical Research & Development54, has 
been reported the synthesis of a series of 7-amino-3a,4-dihydro-3H-[1] 
benzopyrano[4,3-c] isoxazole (Figure-30) derivatives using substituted 
salisaldehydes and ethyl 4-bromocrotonate. Among the synthesized isoxazoles, some 
of which proved to be the most potent α2-adrenoceptor blockers with potent serotonin 
(5-HT) reuptake inhibiting activity. Serotonin is one of the important monoamine for 
human body and the deficit of 5-HT mainly lead to the depression. 
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Figure-30 
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Carr J. B. et al55 have been synthesized a series of highly substituted 
isoxazoles (Figure-31) and screened for anthelmintic activity at doses ranging from 
16 to 500 mg/kg orally against the rat roundworm, Nlppostrongjlus Erazikensis. They 
were found that the newly synthesized isoxazole derivatives have potent anthelmintic 
activity. 
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Figure-31 
 
? Biologically active isoxazoles containing alkyl, amide and sulfone groups 
Isoxazoles bearing sulfones and carboxamide moieties demonstrated to have 
significant pharmacological applications. For examples, COX-2 selective inhibitor, 
valdecoxib (Figure-30)56 is currently prescribed for the treatment of arthritis and 
inflammatory diseases. These COX-2 inhibitors exhibited anti-inflammatory activity 
with reduced gastrointestinal side effects. Moreover, oxacillin (Figure-32)57 and its 
derivatives are useful compounds because of their narrow spectrum anti biotic 
properties.57 
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 Some N-phenyl and N-benzyl-substituted amido (Figure-33) analogs of COX-
2 selective tricyclic non-steroidal anti-inflammatory drugs have been synthesized by 
Balsamo A. and coworkers58 with the aim to obtain information on the structural 
requirements for the COX-inhibitory activity. The newly synthesized compounds 
were tested in vitro for their inhibitory properties only towards COX-2 enzyme by 
measuring prostaglandin E2 (PGE2) production on activated J774.2 macrophages. 
Some of the new compounds showed a modest activity, with percentage inhibition 
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values near 30% at a concentration of 10 μM. The biological data was indicates that 
the N-phenyl-substituted amides present in isoxazole moiety with steric hindrances 
may prevent a good interaction with COX-2 active site. 
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Figure-33 
 
 Aldo Balsamo et al.58 have reported several heteroaromatic analogs of (2-aryl-
1-cyclopentenyl-1-alkylidene)-(arylmethyloxy)amine COX-2 inhibitors (Figure-34), 
in which the cyclopentene moiety was replaced by pyrazole, thiophene or isoxazole 
ring, were synthesized, in order to verify the influence of the different nature of the 
central core on the COX inhibitory properties of these kinds of molecules. Among the 
compounds tested, only the 3-(p-methylsulfonylphenyl) substituted thiophene 
derivatives, showed a certain COX-2 inhibitory activity, accompanied by an 
appreciable COX-2 versus COX-1 selectivity. Only one of the 1-(p-
methylsulfonylphenyl) pyrazole compounds displayed a modest inhibitory activity 
towards both type of isoenzymes, while the pyrazole 1-(p-aminosulfonylphenyl) 
substituted proved to be significantly active only towards COX-1. All the isoxazole 
derivatives were inactive on both COX isoforms. 
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N
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Figure-34 
 
 Habeeb A. G. et al.59 were also reported the synthesis of 4,5-diphenyl-4-
isoxazolines (Figure-33) possessing a variety of substituents (H, F, MeS, MeSO2) at 
the para-position of one of the phenyl rings and evaluated as analgesic and selective 
COX-2 inhibitory anti-inflammatory agents. Although the 4,5-phenyl-4-isoxazolines 
(Figure-35), which do not have a methyl at C3, exhibited potent analgesic and anti-
inflammatroy activities, those compounds evaluated  were not selective inhibitors of 
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COX-2. In contrast, 2,3-dimethyl-5-(4-methylsulfonylphenyl)-4-phenyl-4-isoxazoline 
exhibited excellent analgesic and anti-inflammatory activities, and it was a potent and 
selective COX-2 inhibitor (COX-1, IC50) 258 μM; COX-2, IC50) 0.004 μM).  
O
N
Me
R1
R2
R3
R1= H, Me
R2, R3=H, F, SMe, SO2Me
 
Figure-35 
 A fluoro substituent at the para position of the 4-phenyl ring was also a 
selective (SI =3162) but less potent (IC50 =0.0316 μM) inhibitor of COX-2 than 2,3-
dihydro-2,3-dimethyl-5-(4-(methylsulfonyl)phenyl)-4-phenylisoxazole. A molecular 
modeling for 4-(4-fluoro phenyl)-2,3-dihydro-2,3-dimethyl-5-(4-(methyl sulfonyl) 
phenyl)-4-phenylisoxazole showed that the S atom of the MeSO2 substituent is 
positioned about 6.460A  inside the entrance to the COX-2 secondary pocket (Val523) 
and that a C3 Me (2,3-dihydro-2,3-dimethyl-5-(4-(methylsulfonyl)phenyl)-4-
phenylisoxazole, 4-(4-fluorophenyl)-2,3-dihydro-2,3dimethyl-5-(4-(methylsulfonyl) 
phenyl)-4-phenylisoxazole) central isoxazoline ring substituent is crucial to selective 
inhibition of COX-2 for this class of compounds. 
 
 Talley J. J. et al.60 have synthesized sodium salt of N-[[(5-Methyl-3-phenyl 
isoxazol-4-yl)-phenyl]sulfonyl]propanamide, parecoxib sodium (Figure-36) and 
evaluated as a potent and selective inhibitor of COX-2 for parenteral administration. 
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R= CH3, CH2CH3, CH2CH2CH3  
 
Figure-36 
 
 Among the most potent and selective COX-2 inhibitors that have been 
identified is the isoxazole sulfonamide valdecoxib (Figure-32). In addition, 
sulfonamide valdecoxib possesses exceptional anti-inflammatory activity in vivo.61 
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Talley et al have developed an injectable COX-2 inhibitor with a water-soluble 
prodrug of sulfonamide valdecoxib that would undergo biotransformation in vivo.  
 
Moreover, the 3-substituted phenyl-5-isoxazolecarboxaldehydes62 has been 
identified as activated aldehydes for the generation of isoxazole-based combinatorial 
libraries on solid phase through automation. Three highly functionalized isoxazole-
based libraries (Figure-37) comprising of  compounds each have been synthesized in 
parallel format using Baylis Hillman reaction, Michael addition, reductive amination 
and alkylation reactions. With an objective of lead generation all the three libraries 
were evaluated for their antithrombin activity in vivo. All the compounds obtained 
were evaluated for their antithrombotic activity in vivo.  Swiss mice (20–25 g, from 
CDRI animal colony) were used in a group of at least 10 animals each. Thrombosis 
was induced by infusion of a mixture of 15 mg collagen and 5 mg adrenaline in a 
volume of 100 mL into the tail vein of each mouse. The compounds were 
administered at 30 μ mol/kg by oral route 1 h prior to the thrombotic challenge. The 
antithrombotic effects of these compounds were assessed by the percentage protection 
offered by these agents to mice from death or paralysis following thrombotic 
challenge using aspirin as a standard. 
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Figure-37 
 
 
 
 
 
 
 
 
 
Chapter 6                                                                                                      Highly Substituted Isoxazoles 
Department of Chemistry Saurashtra University Rajkot-360005.  242 
6.4  Aim of Current research work 
 
 The (Z)-1-(1-(3,5-dichloro-2-fluorophenyl)ethylidene)-2-phenylhydrazine (3) 
was used as the precursor for the synthesis of 3-(2,4-dichloro-5-fluorophenyl)-1-
phenyl-1H-pyrazole-4-carbaldehyde (4). Initially we synthesized the 1-(3,5-dichloro-
2-fluoro phenyl ) ethanone (1) (0.12 mmol), by reacting 1-phenylhydrazine(0.12 
mmol) at room temperature in the presence of acetic acid/etidronic acid (0.12 mmol) 
in methanol as a solvent. Complete consumption of the phenyl hydrazine was 
indicated by the disappearance of the brown color from the reaction mixture, which 
takes about 15-20 minutes depending upon the solvent used. The (Z)-1-(1-(3,5-
dichloro-2-fluoro phenyl) ethylidene)-2-phenyl hydrazine (3) (0.01M) was added in a 
mixture of Vilsmeir-Haack reagent (Prepared by 5 mL POCl3 cooled in ice and 
dropwise addition of  15 mL of DMF) and the reaction mixture was stirred for 30 min 
at 0-5°C. Then the reaction mixture was taken at room temperature and reflux for 6-8 
hrs. The progress of reaction was monitored by TLC. The reaction was then poured in 
to crushed ice and filtered the separated product of 3-(2,4-dichloro-5-fluorophenyl)-1-
phenyl-1H-pyrazole-4-carbaldehyde (4) was with hexane/ petroleum ether. Further, 
the reaction of various acetophenone with 3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-
1H-pyrazole-4-carbaldehyde in the presence of ethanol and KOH afforded the novel 
pyrazole derivatives. The presented method delivers new screening candidates in an 
easy way and is well suited for robotic synthesis of (E)-3-(3-(2,4-dichloro-5-
fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenyl prop -2-en-1-one. Moreover, the 
(E)-3-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenyl prop-2-
en-1-one derivatives (VBA 6a-p) in the presence of hydroxylamine hydrochloride and 
sodium acetate afforded the isoxazole (VBA 7a-p) core at ambient temperature. To 
achieve the ultimate goal of diversity, a stepwise approach will be used with 
exploration and careful optimization of each synthetic step. 
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6.5 Results and discussion 
Route of Synthesis of novel substituted isoxazole derivatives. 
Scheme-01 
 
Scheme-02 
 
Scheme-03 
 
Where R= Ar-Cl, Ar-Br, Ar-F, Ar-Cl, 
Scheme-04 
N
N Cl
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Preparation of the target compounds was initiated by the reaction of phenyl 
hydrazine (2) with 3,5 dichloro-2-fulorophenyl ethanone (1a-k) in toluene at reflux 
temperature to afford the (Z)-1-(1-(3,5-dichloro-2-fluorophenyl)ethylidene)-2-
phenylhydrazine (3) in acidic condition at rt to 80-90% yields (Scheme-1). This 
product undergoes reaction with POCl3 and DMF to afford corresponding 3-(2,4-
dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde (4) which on reaction 
with various acetopheneone (5) in the presence of base to form ethyl 5-((ethoxy 
carbonyl)methylthio)-4-(phenylcarbamoyl)-3-isopropylthiophene-2-carboxylate 
(VBA 6a-p). The reaction of VBA 6a-p with hydroxylamine hydrochloride in the 
presence of sodium acetate to form 3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-4-(3-
phenylisoxazol-5-yl)-1H-pyrazole (VBA 7a-p). 
  
 Sixteen different chalcones were synthesized bearing various electron 
donating and electron withdrawing groups such as R=; 2,4-(Cl)2; 3,4-(CH3)2, 4-CH3;4-
OCH3; 4-OCH2CH3; 3-NO2; 4-Br; 4-OH; 4-NH2; on the phenyl ring. Thus, it has been 
found that reaction of substituted chalcone (VBA 6a-P) derivatives with 
Hydroxylamine hydrochloride in the presence of sodium acetate (Scheme-4) gave the 
novel isoxazole (VBA7a-p). 
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Table 1: Synthesis of novel highly substituted isoxazole. 
 
Entry R Yield % Time h. 
VBA -7a C6H5 90 10-12 
VBA-7b 4-CH3C6H4 88 10-12 
VBA-7c 4-OCH3C6H4 92 10-12 
VBA-7d 4-OHC6H4 84 12-14 
VBA-7e 2-OHC6H4 86 12-14 
VBA-7f 4-NO2C6H4 88 18-20 
VBA-7g 3-NO2C6H4 84 10-12 
VBA-7h 4-NH2C6H4 92 12-14 
VBA-7i 4-FC6H4 84 10-12 
VBA-7j 4-ClC6H4 90 10-12 
VBA-7k 2,4-Cl2C6H3 86 8-10 
VBA-7l 4-BrC6H4 92 10-12 
VBA-7m 2-C5H4N 82 10-12 
VBA-7n 3-CH3C5H3N 80 10-12 
VBA-7o 2-C4H3S 82 12-14 
VBA-7p 4-OC2H5C6H4 88 8-10 
 
 
The structure of compound VBA-7h was established on the basis of their 
elemental analysis and spectral data (MS, IR, and 1H NMR). The analytical data for 
VBA-7h revealed a molecular formula C24H15Cl2FN4O (m/z 465). The 1H NMR 
spectrum revealed one singlet at δH= 3.94 ppm assigned to 2 protons of (-NH2) group 
of amine, a doublet at δH= 6.69-6.71 ppm  assigned to 2 protons of (Ar-NH2) ring, a 
singlet at δH= 7.26ppm  assigned to 1 protons of (Ar-Cl) ring, a multiplet at δH= 7.35-
7.42ppm  assigned to 2 protons of (Ar-NH2) ring, a multiplet at δH= 7.48-7.59ppm  
assigned to 5 protons of phenyl ring, a singlet at δH= 7.77 ppm  assigned to 1 protons 
of (Ar-Cl) ring, a doublet at δH= 7.79ppm  assigned to 1 protons of  Ar-H isoxazole 
ring, a singlet at δH= 8.46ppm  assigned to 1 proton of   Ar-H pyrazole ring). 
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The mechanism (Figure-36) the binucleophile hydroxyl amine attack on β 
carbon of chalcone derivative as a nuclelophile and form anion 2. Further, the 
formation of isoxazole 4 occurs by cyclization removal of water molecule.  
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Figure: 36 Proposed mechanism for the formation of substituted isoxazole 
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6.6 Conclusion 
 In conclusion, we have demonstrated that preparation of (Z)-1-(1-(3,5-
dichloro-2-fluorophenyl)ethylidene)-2-phenylhydrazine 3a using etidronic acid at 
room temperature stirred 10-15 min. The use of etidronic acid afforded the product in 
good yield. A highly efficient and prior art process for the preparation of (E)-3-(3-
(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one 
derivatives. The reaction time and initial cyclization as well as an easy to handle 
sodium acetate catalyst provide an appealing alternative for currently available 
approaches to highly substituted isoxazole. 
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6.7 EXPERIMENTAL SECTION 
 Thin-layer chromatography was accomplished on 0.2-mm precoated plates of 
silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365nm) 
or with an iodine vapor. IR spectra were recorded on a SHIMADZUFTIR-8400 
spectrophotometer using DRS prob. 1H (400 MHz) and 13C(100 MHz) NMR spectra 
were recorded on a BRUKER AVANCE II spectrometer in CDCl3 and DMSO 
respectively 13C NMR were recorded on 100 MHz spectrometer, referred to the 
internal solvent signals (77.0for CDCl3 or 40.0 for DMSO-d6). Chemical shifts are 
expressed in δ ppm downfield from TMS as an internal standard. Mass spectra were 
determined using direct inlet probe on a SHIMADZUGCMS-QP 2010 mass 
spectrometer. Solvents were evaporated with a BUCHI rotary evaporator. Melting 
points were measured in open capillaries and are uncorrected. The chemicals used in 
this work were purchased from Merck and Spectrochem Chemical Companies. All 
chemicals were reagent grade and used without further purification, and all solvents 
were freshly distilled before use. 
 
? General synthesis of (Z)-1-(1-(3,5-dichloro-2-fluorophenyl)ethylidene)-2-
phenylhydrazine 
 A mixture containing the phenylhydrazine (10 mmol), 3,5 dichloro-2-
fulorophenyl ethanone (10 mmol), and catalytic amount of glacial acetic acid or 
Hydrochloric acid in the methanol stirred 15-20 min. The reaction was monitored by 
TLC. After completion of reaction, the reaction was cooled at 0-5°C temp for 2-3 hrs. 
Then crude product was filtered washed with hexane/methanol and obtained white 
product. 
 
? General synthesis of 3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-
pyrazole-4-carbaldehyde. 
 To solution of (Z)-1-(1-(3,5-dichloro-2-fluorophenyl) ethylidene -2-phenyl 
hydrazine (0.01M) was added in a mixture of Vilsmeir-Haack reagent (Prepared by 5 
mL POCl3 cooled in ice and dropwise addition of 15 mL of DMF) and This reaction 
mixture was stirred for 30 min at 0-5 °C. Then the reaction mixture was taken at room 
temperature and reflux for 6-8 hrs. The progress of reaction was monitored by TLC. 
After the compilation of reaction take 30 min at room temperature. The reaction 
mixture was poured into crushed ice followed by neutralization using sodium 
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bicarbonate. The crude product was washed hexane and petroleum ether. The product 
was crystallised from methanol/Isopropyl.  
? General synthesis of(E)-3-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-
pyrazol-4-yl)-1-phenylprop-2-en-1-one. 
 To take 3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazole-4-
carbaldehyde (0.01M) and substituted acetophenone (0.01M) in ethanol (40mL), 40% 
KOH added till the solution become basic. The reaction mixture was stirred for 30-45 
minutes. Than the reaction mixture was reflux 10-12 hrs. The progress of reaction was 
monitored by TLC. After the compilation of reaction take 30 min at room 
temperature. The reaction mixture was poured into crushed ice. The crude product 
was washed hexane and petroleum ether. The product was crystallised from 
methanol/Isopropyl.  
 
? General synthesis of 3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-4-(3-phenyl 
isoxazol -5-yl)-1H-pyrazoleVBA 7a-p. 
 To solution of anhydrous sodium acetate (20 mmol), hydroxylamine hydro 
chloride (20 mmol) in ethanol/methanol/Isopropyl alcohol (30ml) and (E)-3-(3-(2,4-
dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one 
(10mmol).  The reaction mixture was reflux 10-12 hrs on water bath. The progress of 
reaction was monitored by TLC. The progress of reaction was monitored by TLC. 
After the compilation of reaction take 30 min at room temperature. The reaction 
mixture was poured into crushed ice. The crude product was washed hexane and 
petroleum ether. The residue was crystallised from methanol/Isopropyl alcohol to give 
VBA 7a-p. 
? Spectral data of the synthesized Isoxazole compounds VBA 7a-p. 
 
3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-4-(3-phenylisoxazol-5-yl)-1H-pyrazole 
(VBA-7a): Lemon yellow solid; Rf  0.32 (7:3 H-E.A); mp 141-143°C; IR (KBr): 3035, 
2964, 2812, 1624, 1526, 1447, 1357, 1328, 1208, 1129, 1009, 880, 829, 768, 735, 
689, cm-1; MS m/z: 450.29(M+); Anal. Calcd. for C24H14Cl2FN3O: C, 64.02; H, 3.13; 
N, 9.33%. Found: C, 64.58; H, 308; N, 9.07%. 
 
3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-4-(3-p-tolylisoxazol-5-yl)-1H-pyrazole 
(VBA-7b): Light Yellow solid; Rf 0.30 (7:3 H-E.A); mp 185-187°C; IR (KBr): 3048, 
Chapter 6                                                                                                      Highly Substituted Isoxazoles 
Department of Chemistry Saurashtra University Rajkot-360005.  250 
2978, 2835, 1616, 1539, 1458, 1364, 1322, 1219, 1124, 1025, 872, 818, 745, 675, cm-
1; MS m/z: 464.32(M+); Anal. Calcd. for C25H16Cl2FN3O: C, 64.67; H, 3.47; N, 
9.05%.Found: C, 64.12; H, 3.05; N, 9.47%. 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(4-methoxyphenyl)isoxazol-5-yl)-1-phenyl-
1H-pyrazole (VBA-7c): Lemon yellow solid; Rf 0.34 (7:3 H-E.A); mp 206-208°C; IR 
(KBr): 3056, 2985, 2856, 1616, 1539, 1458, 1356, 1328, 1219, 1115, 1025, 855, 812, 
755, 730, 692, cm-1; MS m/z: 480.32(M+); Anal. Calcd. for C25H16Cl2FN3O2: C, 
62.51; H, 3.36; N, 8.75%. Found: C, 62.72; H, 3.18; N, 8.35%. 
 
4-(5-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)isoxazol-3-
yl)phenol (VBA-7d): Lemon yellow solid; Rf  0. 36 (7:3 H-E.A); mp 210-212°C; IR 
(KBr): 3445, 3027, 2975, 2897, 1635, 1539, 1445, 1428, 1365, 1348, 1228, 1108, 
1018, 849, 818, 758, 738, 707, 682, cm-1; MS m/z: 466.29(M+); Anal. Calcd. for 
C24H14Cl2FN3O2: C, 61.82; H, 3.03; N, 9.01%. Found: C, 61.47; H, 3.38; N, 9.87%. 
 
2-(5-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)isoxazol-3-
yl)phenol (VBA-7e): Pale yellow solid; Rf 0.36 (7:3 H-E.A); mp 215-217°C; IR 
(KBr): 3427, 3015, 2988, 2882, 1625, 1542, 1445, 1421,1365, 1348, 1232, 1108, 
1032, 849, 818, 758, 738, 707, 682, cm-1; MS m/z: 466.29(M+); Anal. Calcd. for 
C24H14Cl2FN3O2: C, 61.82; H, 3.03; N, 9.01%. Found: C, 61.69; H, 3.27; N, 9.15%. 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(4-nitrophenyl)isoxazol-5-yl)-1-phenyl-1H-
pyrazole (VBA-7f): Light Yellow solid; Rf 0.34 (7:3 H-E.A); mp 212-214°C; IR 
(KBr): 3065, 2968, 1596, 1530, 1445, 1365, 1348, 1218, 1108, 1032, 856, 807, 762, 
745, 721, 675, cm-1; MS m/z: 495.29(M+); Anal. Calcd. for C24H13Cl2FN4O3: C, 
58.20; H, 2.65; N, 11.31%. Found: C, 58.14; H, 2.73; N, 11.05%. 
 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(3-nitrophenyl)isoxazol-5-yl)-1-phenyl-1H-
pyrazole (VBA-7g): Light Yellow solid; Rf 0.34 (7:3 H-E.A); mp 218-220°C; IR 
(KBr): 3078, 2975, 1608, 1530, 1445, 1365, 1348, 1210, 1108, 1045, 833, 807, 762, 
745, 721, 675, cm-1; MS m/z: 495.29(M+); Anal. Calcd. for C24H13Cl2FN4O3: C, 
58.20; H, 2.65; N, 11.31%. Found: C, 58.09; H, 2.78; N, 11.17%. 
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4-(5-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)isoxazol-3-
yl)benzenamine (VBA-7h): Lemon yellow solid; Rf  0.32 (7:3 H-E.A); mp 208-
210°C; IR (KBr): 3545, 3178, 2997, 1612, 1502, 1458, 1375, 1348, 1180, 1095, 1062, 
962, 855, 829, 788, 756, 721, 682, cm-1; 1H NMR: (400 MHz, CDCl3) δH 3.94 (s, 2H, 
-NH2), 6.69-6.71 (d, 2H, ArNH2), 7.26 (s, 1H, Ar-Cl), 7.35-7.42 (m, 2H, ArNH2), 
7.48-7.59 (m, 5H, Ar-H), 7.77 (s, 1H, Ar-Cl), 7.79 (d, 1H, Ar-H isoxazole ring),  8.46 
(s, 1H, -Ar-H pyrazole ring), 13CNMR: (100 MHz, CDCl3) δC 95.44, 99.99, 112.95, 
114.79, 119.41, 126.79, 127.45, 129.66, 131.27, 139.36, 148.43, 170.70; MS m/z: 
465.31(M+); Anal. Calcd. for C24H15Cl2FN4O: C, 61.95; H, 3.25; N, 12.04%. Found: 
C, 60.11; H, 3.05; N, 12.09%. 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(4-fluorophenyl)isoxazol-5-yl)-1-phenyl-1H-
pyrazole (VBA-7i): Lemon yellow solid; Rf  0.28 (7:3 H-E.A); mp 217-219°C; IR 
(KBr): 3088, 2958, 1588, 1525, 1436, 1358, 1326, 1232, 1117, 1049, 877, 819, 778, 
738, 717, 685, cm-1; 1H NMR: (400 MHz, CDCl3) δH 6.64-6.66 (d, 2H, Ar-F), 7.12-
7.14 (d, 1H, Ar-Cl2), 7.25-7.32 (m, 5H, Ar-H),  7.57-7.58 (d, 2H, Ar-Cl2), 7.74-7.75 
(d, 2H, Ar-F), 8.15 (s, 1H, Ar-H isoxazole ring),  10.91 (s, 1H, -Ar-H pyrazole ring); 
13C NMR: (100 MHz, CDCl3) δC 22.07, 22.36, 24.76, 28.47, 30.21, 30.52, 30.97, 
99.49, 113.59, 118. 08, 118.08, 118.22,  123.60, 126.98, 127.30, 128.81, 129.27, 
130.85, 139.39, 154.41, 158.77; MS m/z: 468.28(M+); Anal. Calcd. for 
C24H13Cl2F2N3O: C, 61.56; H, 2.80; N, 8.97%. Found: C, 61.15; H, 2.28; N, 8.54%. 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(4-chlorophenyl)isoxazol-5-yl)-1-phenyl-1H-
pyrazole (VBA-7j): Lemon yellow solid; Rf 0.29 (7:3 H-E.A); mp 207-209°C; IR 
(KBr): 3057, 2939, 1579, 1517, 1418, 1339, 1310, 1228, 1107, 1075, 879, 827, 767, 
735, 715, 698, cm-1; MS m/z: 484.74(M+); Anal. Calcd. for C24H13Cl3FN3O: C, 59.47; 
H, 2.70; N, 8.67%. Found: C, 59.25; H, 2.58; N, 8.48%. 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(2,4-dichlorophenyl)isoxazol-5-yl)-1-phenyl-
1H-pyrazole (VBA-7k): Lemon yellow solid; Rf 0.28 (7:3 H-E.A); mp 225-227°C; 
IR(KBr): 3057, 2837, 1676, 1645, 1590, 1452, 1320, 1300, 1228, 1134, 960, 904, 
821, 785, 690, cm-1; MS m/z: 519.18(M+); Anal. Calcd. for C24H12Cl4FN3OC, 55.52; 
H, 2.33; N, 8.09%. Found: C, 55.28; H, 2.07; N, 8.56% 
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4-(3-(4-bromophenyl)isoxazol-5-yl)-3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-
pyrazole (VBA-7l): Lemon yellow solid; Rf 0.29 (7:3 H-E.A); mp 232-234°C; IR 
(KBr): 3078, 2862, 1708, 1665, 1507, 1447, 1377, 1300, 1134, 1025, 945, 904, 813, 
744, 690, cm-1; MS m/z: 529.19(M+); Anal. Calcd. for C24H13BrCl2FN3O: C, 54.47; H, 
2,48; N, 7.94%. Found: C, 54.57; H, 2,39; N, 7.85%. 
 
2-(5-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)isoxazol-3-
yl)pyridine (VBA-7m): Lemon yellow solid; Rf 0.27 (7:3 H-E.A); mp 244-246°C; IR 
(KBr): 3062, 2885, 1715, 1669, 1515, 1447, 1382, 1307, 1142, 1017, 895, 807, 762, 
697, cm-1; MS m/z: 451.28(M+); Anal. Calcd. for C23H13Cl2FN4O: C, 61.21; H, 2.90; 
N, 12.42%. Found: C, 61.48; H, 2.65; N, 12.25%. 
 
2-(5-(3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)isoxazol-3-yl)-3-
methylpyridine (VBA-7n): Lemon yellow solid; Rf  0.29 (7:3 H-E.A); mp 255-
257°C; IR (KBr): 3048,  2925, 2845, 1709, 1665, 1517, 1449, 1378, 1318, 1137, 
1012, 935, 897, 827, 754, 712, cm-1; MS m/z: 465.31(M+); Anal. Calcd. for 
C24H15Cl2FN4O: C, 61.95; H, 3.25; N, 12.04%. Found: C, 61.21; H, 3.90; N, 12.42%. 
 
 
3-(2,4-dichloro-5-fluorophenyl)-1-phenyl-4-(3-(thiophen-2-yl)isoxazol-5-yl)-1H-
pyrazole (VBA-7o): Lemon yellow solid; Rf  0.25 (7:3 hexane-EtOAc); mp 262-
264°C; IR (KBr): 3105, 1651, 1500, 1019, 1313, 1291, 1220, 1151, 1019, 915, 839, 
762, 718, cm-1; MS m/z: 456.32(M+); Anal. Calcd. for C22H12Cl2FN3OS: C, 57.91; H, 
2.65; N, 9.21%. Found: C, 57.77; H, 2.29; N, 9.58%. 
 
 
3-(2,4-dichloro-5-fluorophenyl)-4-(3-(4-ethoxyphenyl)isoxazol-5-yl)-1-phenyl-1H-
pyrazole (VBA-7p): White solid; Rf 0.38 (7:3 H-E.A); mp 262-264°C; IR (KBr): 
3085, 2942, 2827, 1725, 1647, 1512, 1428, 1357, 1305, 1145, 1105, 1019, 907, 882, 
762, 698, cm-1; MS m/z: 494.34(M+); Anal. Calcd. for C26H18Cl2FN3O2: C, 63.17; H, 
3.67; N, 8.50%. Found: C, 63.35; H, 3.57; N, 8.19%. 
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6.8 Spectral data of the synthesized compounds (VBA 7 a-p) 
 
13C NMR spectrum of VBA-7b 
 
1H NMR spectrum of VBA-7h 
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Expanded 1H NMR spectrum of VBA-7h 
 
 
13C NMR spectrum of VBA-7h 
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1H NMR spectrum of VBA-7i 
 
13C NMR spectrum of VBA-7i 
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Mass spectrum of VBA-7a 
 
 
Mass spectrum of VBA-7b 
 
 
 
 
 
N
N
Cl
ClF
N
O
m/z=450
N
N
Cl
ClF
N
O
m/z=464
Chapter 6                                                                                                      Highly Substituted Isoxazoles 
Department of Chemistry Saurashtra University Rajkot-360005.  257 
Mass spectrum of VBA-7d 
 
 
 
Mass spectrum of VBA-7h 
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Mass spectrum of VBA-7p 
 
 
 
IR spectrum of VBA-7K 
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IR spectrum of VBA-70 
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Research Summary 
 
 The work comprised in the Thesis entitled “Studies on Some Bioactive 
Heterocyclic Analogs” is summarized as follows. 
 
In Chapter 1, we have presented an efficient two step protocols for the 
synthesis of diversely substituted highly substituted Thiophene. a facile and 
convenient route of synthesis for highly substituted thiophenes based on the reactions 
of 1,3-dicarbonyl compounds with carbon disulfide and alkyl bromide catalyzed by 
TEAB/TBAB in the presence of K2CO3 in water has been developed. The main 
advantage of the reaction is simple procedure, mild conditions and high yields 
observed at room temperature. The present methodology will be beneficiary in 
organic synthesis for the synthesis of highly substituted thiophenes in easy way. The 
Structure of VBA 1-36 was established on the basis of its reported physical and 
spectral data. Out of 36 compounds were Screened for anti microbial susceptibility 
assay 12 compounds shown positive activity against microbes. 
 
In Chapter 2, we reported a facile synthesis of highly substituted pyrazoles 
having N-alkylated with benzyl chloride/p-nitro benzyl bromide was first investigated 
under a variety of reaction conditions. Best results were obtained when the reaction 
was conducted in the presence of K2CO3, KI, TBAB/TEAB in H2O DMF and 
acetonitrile furnishing only one N-phenyl-1H-pyrazole in high yield. The structure of 
was established on the basis of its reported physical and spectral data. Out of 22 
compounds screened for antimicrobial susceptibility assay 6 compounds shown 
positive activity against microbes. 
 
 In Chapter 3, we have demonstrated various ketene dithioacetals has been 
identified as a versatile intermediate for the reaction of 2-amino-6-methoxy-5-methyl-
N-arylpyrimidine-4-carboxamide in high yields at ambient temperature. The present 
method is concise and efficient. The main advantage of this process is easy work up 
process and high yield of the diversify pyrimidine derivatives for biological interest. 
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 In Chapter 4, we developed a new simple and versatile strategy for the 
synthesis of N-phenyl-6H-pyran-3-carboxamide derivatives by exploiting the reaction 
of ketene dithioacetals with ethyl cyanoacetate. The method offers several advantages 
including high yields of products and an easy experimental work-up procedure. The 
newly developed process is very useful for the syntheses of N-phenyl-6H-pyran-3-
carboxamide derivatives for biological interest. 
 
 In Chapter 5 we have developed a convenient and selective method for the 
synthesis of 2H-thiazolo[3,2-a]pyrimidine derivatives by exploiting the reaction of 
formed dibromoethane with 1,2,3,4-tetrahydro-6-isopropyl-2-thioxopyrimidine. The 
possibility of introducing a variety of substituents at different positions of the 2H-
thiazolo[3,2-a]pyrimidine ring system was achieved by this method. The present 
method delivers new screening candidates in an easy way and is well suited for 
robotic synthesis. The achievable 2H-thiazolo[3,2-a]pyrimidine derivatives may help 
in the understanding of the privileged nature of the DHPM core. The present 
methodology gives various functionalized thiazolopyrimidine for biological interest. 
 
 In Chapter 6, we have demonstrated that preparation of (Z)-1-(1-(3,5-dichloro-
2-fluorophenyl)ethylidene)-2-phenylhydrazine using etidronic acid at room 
temperature. The use of etidronic acid afforded the product in good yield. A highly 
efficient and prior art process for the preparation of (E)-3-(3-(2,4-dichloro-5-
fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one derivatives. The 
reaction time and initial cyclization as well as an easy to handle sodium acetate 
catalyst provide an appealing alternative for currently available approaches to highly 
substituted isoxazole. 
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